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Chapter 1: General Introduction 
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1.1 Focus and scope of the dissertation 
 
This dissertation focuses on priority setting policy in the response to HIV and 
AIDS. The demand for healthcare always exceeds its supply, so priority setting is 
inevitable. Today this focus on priority setting is even more relevant because the 
aim to end AIDS as a public health threat is faced with the reality of shrinking 
political and financial resources to end AIDS (Graham-Harrison, 2016; KFF & 
UNAIDS, 2016; “Thirty years of a disease: The end of AIDS?,” 2011; UNAIDS, 
2016d). But above all, with limited resources, a prioritized HIV response is 
imperative in order to equitably treat the most vulnerable populations at risk of or 
living with HIV. 
 
Priority setting in global health dates back to the 1980s (Glassman et al., 2012). A 
number of methods have been developed and attempted since then to aid explicit 
and rational priority setting (Baltussen & Niessen, 2006; Kenny & Joffres, 2008). 
However, priority setting processes in low- and middle-income countries (LMIC), 
and also in high-income countries, frequently fail to meet expectations (Glassman 
et al., 2012; Hipgrave, Alderman, Anderson, & Soto, 2014; Sabik & Lie, 2008). 
Reviews of priority setting point to two factors that contribute to the failure of 
aided prioritization processes. First, decisions are informed by poor or no evidence 
on the decision choices and the consequence of those choices (Glassman et al., 2012; 
Kenny & Joffres, 2008; Sabik & Lie, 2008). Second, priority setting processes 
frequently neglect to involve stakeholders in decision-making (Glassman et al., 
2012; Ham, 1997; Kenny & Joffres, 2008; Sabik & Lie, 2008). In a review of different 
methods of priority setting, Multi-Criteria Decision Analysis (MCDA) was 
proposed as a framework that may work well in LMIC although it requires more 
experience in its application (Hipgrave et al., 2014). 
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This dissertation focuses on the appropriateness and applicability of the MCDA 
framework to prioritizing the HIV response. It takes this perspective while 
considering the two previously mentioned problems that afflict prioritization 
processes: lack of stakeholder involvement and lack of quality evidence for 
decisions. To apply the MCDA framework and study its applicability, it is 
necessary to identify relevant criteria for decision-making and to have reliable and 
good quality evidence (Crown, 2009). So the criteria that are relevant to the HIV 
response, as well as the state of evidence on HIV, are systematically reviewed in 
this dissertation. 
 
Although the dissertation takes stock of relevant criteria globally and evaluates the 
state of evidence for prioritization across countries, actual HIV programs are 
always implemented at the national or sub-national level. This dissertation 
therefore focuses on one country – Viet Nam - as a case study of the feasibility of 
applying MCDA, using country relevant criteria and evidence. As a transitioning 
economy (World Bank, 2013), and also one designated as a "fast-track" country by 
major development partners (Emond, 2017), Viet Nam offers an interesting case 
study due to the challenges it faces in financing the response to a sizable HIV 
epidemic. Since its graduation to LMIC status, a major challenge for Viet Nam has 
been the rapid decline in donor funded HIV programs and the subsequent 
prioritization of programs with available resources. Another challenge has been 
the inclusion of the growing voices of civil society in the priority setting process. 
 
Findings of this dissertation can be used to inform and guide priority-setting 
policies in the HIV response, and potentially other communicable diseases faced 
with scarcity of resources and the imperative of reducing disease burden and risk. 
Findings of this dissertation also contribute to implementation science in testing 
the adequacy of a priority setting process in the HIV response. 
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The analysis of the decisions or their outcomes is outside of the scope of this 
dissertation. The analysis of the relevance of different theories of prioritization is 
also outside of the scope of the dissertation. 
 
The following sections introduce an overview of the history of HIV, discuss in 
depth the problems of prioritization, review the theoretical origins and debate 
around prioritization including gaps in research, and introduce the research 




In 1982, the United States’ Centers for Disease Control and Prevention (CDC) first 
used the term Acquired Immune Deficiency Syndrome or AIDS, to refer to the 
condition of diminished resistance to diseases afflicting an increasing number of 
young, previously healthy gay men, and people who inject drugs (Centers for 
Disease Control, 1982). By 1983, doctors at the Pasteur Institute in France reported 
the discovery of the virus, the human immunodeficiency virus or HIV, which 
could be the cause of AIDS (Barre-Sinoussi et al., 1983). By the end of the 
millennium, it was estimated that there were 28.9 million people living with HIV in 
the world (UNAIDS, 2015). Today there are over two million new infections and 
one million AIDS deaths estimated annually. Around two thirds of these new HIV 
infections are occurring in Sub-Saharan Africa. 
 
Given the lack of information on HIV in the early years of the epidemic, people 
living with the disease, or at-risk of infection, created communities to exchange 
information and test potential treatments (NYPL, 2015). Political response to the 
HIV epidemic grew out of activism of these communities of people. A number of 
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institutions were also established in response to the HIV emergency. The late 1980s 
saw the genesis of many National AIDS Commissions which were public 
institutions set up to coordinate the HIV response in a country afflicted by HIV 
(Spicer et al., 2010). The principle of Three Ones adopted in 2004 reaffirmed the 
coordination role of the National AIDS Commissions (UNAIDS, 2004a). The Three 
Ones calls for “one national AIDS coordinating authority”, “one agreed HIV/AIDS 
action framework” and “one agreed monitoring and evaluation system”.  
 
The financing of the global HIV response has been unprecedented. Between 1996 
and 2003, the global spending on AIDS increased from $300 million to $5 billion 
(KFF, 2002) (UNAIDS, 2004c). By 2014, the total resources available for HIV and 
AIDS in LMIC amounted to $19 billion (UNAIDS, 2016b). The United States is the 
largest bilateral donor to the HIV response, accounting for two-thirds of donor 
government disbursements, followed by the United Kingdom (13.0%), France 
(3.5%), Germany (2.7%) and the Netherlands (2.3%) (KFF & UNAIDS, 2016). 
 
Despite the achievements made in the past three decades, a massive challenge 
remains to test and treat the remaining 15 million people estimated to be living 
with HIV, who are not currently on treatment. Meanwhile, despite the projected 
need to increase AIDS spending from US$19 billion available in 2014 to US$26.2 
billion by 2020, donor spending to address HIV in LMIC declined by more than 
US$1 billion in 2015 (KFF & UNAIDS, 2016; UNAIDS, 2016d). This shortfall in 
funding necessitates priority setting in the national HIV response, particularly in 
LMIC. Recent evidence suggests that re-evaluation of priority policies may be 
advisable even among efficient health systems and populations with high levels of 
health (Defechereux et al., 2012; Koopmanschap, Stolk, & Koolman, 2010; 
Mentzakis, Paolucci, & Rubicko, 2014). 
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A motive that dominates priority setting is social justice. Inequities in risk and the 
burden of disease are reasons in themselves to prioritize certain populations, 
locations and interventions. For example, it is well known that in all countries, key 
vulnerable populations are disproportionately affected by HIV (WHO, 2014b). 
Moreover, evidence shows that people living with or at risk of HIV are at a 
disadvantage in accessing health and employment due to stigma and 
discrimination (GNP+, 2016; UNAIDS, 2016e). And HIV is not only driven by the 
inequalities in health and wealth, but also entrenches them (Cabassi, 2004). The 
principle of social justice is then an imperative that obligates decision-makers to 
prioritize the most vulnerable populations. 
 
At the United Nations General Assembly High Level Meeting in June 2016, 
Member States committed to ending AIDS. A political declaration was adopted 
with time-bound targets and actions that must be achieved by 2020, including 
having 90% of all people living with HIV tested, 90% of people tested on anti-
retroviral treatment, and 90% of people on treatment having suppressed viral loads 
(UNAIDS, 2016a). Over 200 cities and municipalities across the globe, including 
Amsterdam, Johannesburg, Mumbai, Kyiv, Mexico City, and Rio de Janeiro, have 
pledged to achieve the 90-90-90 targets (UNAIDS, 2016c). 
 
Given the aforementioned shortfall in funding, the imperative of social justice, and 
the urgency of reaching targets to end AIDS, a process of priority setting is needed 
in all countries with an HIV epidemic. 
 
1.3 Unsolved HIV priority-setting challenges 
 
Prioritization decisions allocate funding to programs which are the highest 
priority, and withdraw funding from programs that are not considered a high 
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priority. Policymakers routinely make these types of decisions at some level, either 
explicitly or implicitly. Good decisions on effective policies and programs require 
timely, accurate, and relevant information (Stansfield, Walsh, Prata, & Evans, 
2006). Sometimes there is not much information available and decisions become 
intuitive. A review of health priority setting has found that decisions, particularly 
in LMIC, frequently rely on poor or no evidence on the choices available and the 
consequence of those choices (Glassman et al., 2012; Health Metrics Network, 2008; 
Kenny & Joffres, 2008; A. R. Ravindran, 2008; Sabik & Lie, 2008). 
 
A challenge to prioritization is how to meaningfully involve stakeholders in the 
decision-making process. The principle of greater involvement of people living 
with or affected by HIV and AIDS was a cornerstone of the Paris AIDS Summit’s 
Declaration in 1994 (Cabassi, 2004). However, translating these commitments into 
practice is fraught with challenges (Roy & Cain, 2001). Reviews of health priority 
setting processes have found that the stakeholder involvement is frequently 
neglected (Glassman et al., 2012; Ham, 1997; Kenny & Joffres, 2008; Sabik & Lie, 
2008). When stakeholders are involved in priority setting processes, it is not 
evident to what extent and at what level they are involved, and whether their 
participation is meaningful. While the involvement of stakeholders is not a 
guarantee of improved decisions, their exclusion will most certainly jeopardize the 
credibility and acceptance of the decisions (Daniels & Sabin, 2000; Viergever, 
Olifson, Ghaffar, & Terry, 2010). 
 
Without a systematic process in place for priority setting, ad hoc decisions will be 
taken, influenced by heuristics, conventions, intuition and political agendas 
(Baltussen & Niessen, 2006; Dean & Sharfman, 1996; Goddard, Hauck, Preker, & 
Smith, 2006; Hunsmann, 2012; Kapiriri & Martin, 2007; Keeney, 1982; Youngkong, 
Kapiriri, & Baltussen, 2009). Following the introduction of the investment 
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framework in 2011, countries were given the opportunity to use the investment 
case approach to prioritize their HIV response (Schwartländer et al., 2011). The 
investment case is an instrument for strategic decision-making around resource 
allocation (UNAIDS, 2013b). The investment case approach advances involvement 
of stakeholders and use of evidence for priority setting. However, the approach 
misses opportunities in involving stakeholders at critical points in the decision-
making process, and limits its use of decision criteria to where quantifiable 
evidence is available. These conditions may lead to inconsistent decisions, which 
can further exacerbate financial problems, by incurring high and hidden costs 
(Kahneman, Rosenfield, Gandhi, & Blaser, 2016).  
 
1.4 Theoretical origins and debate in priority setting 
 
Prioritization involves making choices, and choices have consequences. These 
consequences can be economical, political, social, and in the domain of health, 
clinical, in nature. Consequently, there are multiple sectorial theories and 
frameworks that guide decision-making. 
 
The core debate in prioritization in the health sector is around a number of 
different theories that guide the distribution of health resources from perspectives 
of utility, cost-effectiveness and equity (Cleary, 2010; Mahapatra, 2002; Mooney, 
1987; Newdick, 2005). These theoretical frameworks for rational prioritization can 
be separated into two camps: the substantive and the procedural solutions 
(Newdick, 2005; Vlek, 1984). Substantive rationality is exercised when the 
appropriate solutions have been chosen. Procedural rationality is exercised when 
appropriate procedures have been taken to choose a solution. Another dimension 
to substantive or procedural rationality is the values which serve decision-makers 
in setting priorities (Wenstøp & Magnus, 2001). Unless specific and enforced rules 
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guide the decision-making, it is important for values to be explicit and well 
founded in a value-focused rational priority setting process. The substantive 
solutions are essentially guided by cost-effectiveness, where effectiveness is ruled 
by the number of quality-adjusted life years gained. Procedural prioritization does 
not have a pre-defined set of criteria, but is rather decided on through a systematic 
process. 
 
Numerous studies have used the substantive cost-effectiveness paradigm for 
prioritization. The United Nations Development Programme and the World Bank 
notably use cost of interventions together with global-burden-of-diseases rankings, 
a framework widely used to guide health research priorities (Lopez, Mathers, 
Ezzati, Jamison, & Murray, 2006), to prioritize the allocation of resources for health 
interventions (Mahapatra, 2002). There are noted problems with this approach, 
namely the oversimplification of complex problems into one-dimensional cost 
comparisons, aggregation of multiple stakeholder interests into a summary effect, 
and translation of effects at different points in time into a present value calculation 
(Söderbaum, 2006). Some of these shortcomings have been overcome, like a two 
stage cost-effectiveness analysis, one for short-term, and another for long-term 
consequences (Alistar & Brandeau, 2012). A few cost-effectiveness studies compare 
effectiveness defined in terms of maximized population health to equitable health 
in the population (Cleary, 2010; Lasry, Zaric, & Carter, 2007). McGough et al 
considered “fair chance” and “best outcome” - variations on equity and maximum 
health respectively - in setting priorities for rationing antiretroviral treatment to 
HIV positive patients (McGough, Reynolds, Quinn, & Zenilman, 2005). However, 




Under conditions of complexity, lack of information, and high uncertainty, 
substantive rationality gives way to procedural rationality in deciding the best 
course of action (Vlek, 1984). A number of theorists have operationalized the 
procedural solution with a finite set of criteria, like Musgrove’s nine criteria of 
public health care spending (Musgrove, 1999). Tromp and Baltussen propose a 
multi-criteria health priority setting aid that includes 31 criteria under five 
categories (Tromp & Baltussen, 2012). Gericke et al identified five criteria to inform 
priority setting in health (Gericke, Kurowski, Ranson, & Mills, 2005). Research on 
deciding on adoption of new vaccines and immunization policy analysis, has 
resulted in its own set of criteria (Bryson, Duclos, Jolly, & Bryson, 2010; Burchett, 
Mounier-Jack, Griffiths, & Mills, 2012). 
 
The kaleidoscope of priority setting frameworks, and a plethora of priorities 
advocated by researchers and lobbyists, is problematic particularly in LMIC where 
institutional mechanisms are not in place to assess priorities. Additionally, there is 
often no consensus between donors and national policymakers on what should be 
prioritized, due to the different frameworks used (Glassman et al., 2012). Where 
frameworks consider multiple criteria, the lack of information, conflicting criteria, 
and subjective preferences of decision-makers paralyzes the decision-making 
process and renders the final results inconclusive (Miller, Barrett, & Henderson, 
2006; Xu & Yang, 2001).   
 
Dean and Sharfman’s Strategic Decision-Making Effectiveness Model links 
decision process with decision effectiveness. The model’s constructs are procedural 
rationality, which is positively related to decision-making effectiveness, and 
political behavior, which is negatively related to decision-making effectiveness 
(Dean & Sharfman, 1996). The multi-criteria analytical framework addresses the 
two constructs of the strategic decision-making model, political behavior and 
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procedural rationality (Crown, 2009). The multi-criteria analytical framework 
attenuates the effect of political behavior, by exposing the variety of views and the 
consequences of individual decisions, ultimately leading to greater consensus. The 
multi-criteria analytical framework also aids procedural rationality, by 
synthesizing full and relevant information and overcoming the complexity faced 
by decision-makers in processing an overload of data and criteria in a short time.  
 
This dissertation is framed under the MCDA, because it is an applied approach, 
which is grounded in decision theory. MCDA models multiple objectives of 
decision-makers and their value trade-offs so that choices being considered can be 
compared consistently and transparently (Keeney & Raiffa, 1993; Peacock, Mitton, 
Bate, McCoy, & Donaldson, 2009). The main steps in the MCDA process are (1) 
exploration and definition of the problem, (2) selection and structuring the criteria, 
(3) developing alternative options, (3) scoring the alternatives, (4) weighting the 
criteria, (5) calculating aggregate scores, uncertainty and reporting findings (Marsh 
et al., 2016). MCDA does not mimic humans’ decision-making behavior and 
instead includes procedures helping people to identify courses of actions in a 
manner that is analytically robust and consistent in light of the available 
information and people's preferences. 
 
In the health sector, a multi-criteria approach is seldom used for prioritization, and 
rarely used in health policy setting, often remaining in the realm of literature or 
piloting (Glassman et al., 2012; Musgrove, 1999). Figure 1.1 below shows the 
dimensions and extent of research in criteria-based decision analysis in the broader 
health arena and specifically in the HIV response. 
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Figure 1.1 Extent of research and use of criteria in health and in HIV 
response for decision analysis 
  
Single/Dual Criteria Multiple Criteria 
Health 
Extensive and on-going 
research and operational use of 
Global Burden of Disease1, and 
WHO Cost Effective Analysis2 
Nine criteria for health 
spending 3 , WHO HSPF 4 , 
MCDA use in UK, Norway, 
Portugal, Ghana, Nepal, China, 
Brazil, New Zealand, etc. 
HIV/AIDS 
Numerous models to prioritize 
the HIV response such as 
Investment Framework 5 , 
REACH6, GOAL7, AVERT8 
An extensive desk review 
identified only one study 
where MCDA was applied to 
prioritize HIV interventions, in 
Thailand9 
 
While not an exhaustive catalogue of all research in health priority setting, the 
figure shows the limited scope and scale of research in use of multi-criteria 
prioritization of the HIV response. 
 
To date, however, no studies have considered the multiple criteria relevant to 
stakeholders for prioritization of a comprehensive national HIV response. Research 
on prioritization and HIV has either focused on a limited set of interventions, like 
treatment regimens or prevention methods, or not involved all relevant 
stakeholders in the priority setting process. They have not considered the complex 
decision situation faced by a group of experts and non-experts in prioritizing a 
comprehensive package of interventions that go into a national HIV response. The 
                                                        
1 (Lopez et al., 2006) 
2 (Edejer et al., 2003) 
3 (Musgrove, 1999) 
4 (World Health Organization, 2007) 
5 (Schwartländer et al., 2011) 
6 (Alistar, Brandeau, & Beck, 2013) 
7 (Futures Institute, 2013) 
8 (Rehle et al., 1998) 
9 (Youngkong et al., 2010) 
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rigor of methods also varies between studies, and some do not use an evidence-
based framework for decision analysis. Therefore, the application of the framework 
is in the focus of this dissertation. 
 
1.5 Specific research questions 
 
The aim of this research is to study the appropriateness and applicability of the 
MCDA framework, for prioritizing the HIV response in a multi-stakeholder 
decision-making process. Building the analytical model requires knowing the 
multiple criteria that are relevant to the HIV response (Crown, 2009). So our first 
research question is: 
 
Q1: What are the relevant criteria to prioritize the programs, policies, investments, 
workforce and technologies that are utilized in responding to the HIV epidemic? 
 
The multi-criteria analytical framework also requires quality evidence to support 
the analysis of the choices and the potential outcomes of those choices (Crown, 
2009). As discussed before, the lack of reliable and good quality evidence is one of 
the problems that afflict priority setting in global health (Crown, 2009; Glassman et 
al., 2012; Health Metrics Network, 2008; Kenny & Joffres, 2008; A. R. Ravindran, 
2008; Sabik & Lie, 2008). With a focus on evidence quality in the HIV response, our 
second research question is: 
 
Q2: To what extent is reliable and good quality evidence available, accessible and 
used in planning for the HIV response? 
 
Another problem that afflicts priority setting in global health is the lack of 
stakeholder involvement in decision-making (Glassman et al., 2012; Ham, 1997; 
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Kenny & Joffres, 2008; Sabik & Lie, 2008), which jeopardizes the credibility and 
acceptance of the decisions (Daniels & Sabin, 2000; Viergever et al., 2010). Our third 
question therefore explores the difference that inclusion of diverse stakeholders 
makes in decision-making processes: 
 
Q3: What difference does the inclusion of diverse stakeholders make in decision-
making processes of the HIV response? 
 
After clarifying the criteria and how the criteria should be measured, building a 
multi-criteria analytical framework for priority setting requires knowing how 
much importance or weight to put on each criterion (Baltussen & Niessen, 2006; 
Defechereux et al., 2012; Mirelman et al., 2012; Tromp, Prawiranegara, Siregar, 
Sunjaya, & Baltussen, 2015; Wenstøp & Magnus, 2001). Given the importance of 
involvement of key stakeholders living with or at risk of HIV in the decision-
making processes raised earlier in this chapter, it is important to know how 
different stakeholders rate the relative importance of criteria by which the HIV 
response should be prioritized (Baltussen, Stolk, Chisholm, & Aikins, 2006). The 
final question of this dissertation is: 
 
Q4: How do different stakeholders rate the relative importance of criteria for 
prioritizing the HIV response?  
 
This dissertation relies on the participants’ perspectives of the priorities in the HIV 
response to construct a pattern of meaning. In doing so, it uses a mixed method 
approach, with quantitative and qualitative data used to support, expand upon, 
and interpret one another in the course of investigating the research questions. 
With a particular focus on the voices of the most marginalized people – people 
living with HIV or at higher risk of HIV – and contextualized in the policies and 
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political agenda of the times, this dissertation is influenced most by the 
transformative paradigm of research (Creswell, 2009; Mertens, 2009; Somekh & 
Lewin, 2004). 
 
1.6 Dissertation outline 
 
Chapter 2 relates to this research question: What are the relevant criteria to 
prioritize the programs, policies, investments, workforce and technologies that are 
utilized in responding to the HIV epidemic? It systematically reviews the relevant 
criteria to prioritize the HIV response reported in the literature. The findings are 
stratified by a number of dimensions and grouped according to the broader health 
criteria to articulate the relevant criteria and illustrate the gaps. 
 
Chapter 3 relates to this research question: To what extent is reliable and good 
quality evidence available, accessible and used in planning for the HIV response? 
It reviews the quality and extent of evidence used in planning the HIV response. It 
looks at the national HIV strategic plans of 21 countries over a span of fifteen years, 
and analyzes the variation in use of evidence in the planning, as well as variation 
in quality of the evidence. 
 
Chapter 4 relates to this research question: What difference does the inclusion of 
diverse stakeholders make in decision-making processes of the HIV response? It 
explores the underlying causes of gaps in evidence, and the value provided by the 
involvement of stakeholders in the process of priority setting. Through in-depth 
interviews with health program managers, technical experts, and community 
members of people at risk of HIV, a picture emerges on the key motivations for- 
and barriers to- efficient generation and use of quality evidence.  
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Chapter 5 relates to this research question: How do different stakeholders rate the 
relative importance of criteria for prioritizing the HIV response? It conducts an 
experiment to study the preferences and trade-offs made between different HIV 
programs by multiple stakeholders and decision-makers. The experiment involves 
participants from government, civil society, and international development 
partners, and uses modeled scenarios of HIV programs to understand the trade-
offs they make to decide on the preferred program. In doing so, it brings clarity to 
the importance of criteria used in the HIV response priority setting process to 
multiple stakeholders. 
 
Chapter 6 draws together the analysis from the previous chapters with five cross 
cutting key statement. The grounding of these statements are explained, referring 
to various chapters of the dissertation, followed by recommendations and/or policy 
implications. The limits in generalization of the statements are also explained in the 





Chapter 2: A Systematic Review on Priority 

































This chapter draws upon: 
 
Safarnejad A, Groot W, Pavlova M. A Systematic Review on Priority Setting to Halt 




As the 2015 end date of the Millennium Development Goal to halt and reverse the 
AIDS epidemic nears, ambitious new targets and priorities are being considered.  
Faced with financial constraints and competing agenda in global health and 
development, this study explores and articulates the criteria to prioritize the HIV 
response. 
 
We conducted a systematic review of literature to identify the existing criteria. 
Cluster analysis was used to classify the criteria into thematic groupings.  The 
criteria were stratified by a number of dimensions and compared by the frequency 
of their occurrence. HIV/AIDS criteria were also compared with the criteria from 
the health sector. 
 
Thirty unique criteria were identified in the review, and were clustered into 18 
thematic groups.  Equity and severity of disease were the most frequently 
occurring criteria.  Two themes around women/mothers and social justice emerged 
in the analysis.  Our review also found that vulnerable and needy populations 
were more frequently cited as criteria in prioritization of HIV programs than in the 
broader health sector, illustrating the gap in priorities between the sectors, and 
underlining the need to consider multi-sectorial criteria in any possible integration 
of HIV programs into the health systems.  
 
In line with the findings of the study, and recognizing the priorities that 
contributed to the success of the HIV response, we recommend that the discourse 
around prevention among high-risk and vulnerable groups, particularly women 
and girls, be amplified in consideration of policies of prioritization, particularly in 




The sixth of eight Millennium Development Goals adopted by world leaders in 
September of 2000, and reaffirmed in June of 2011, calls for halting and beginning 
to reverse the spread of HIV by 2015 (UN, 2011). Recently, the idea of the “end of 
AIDS” has been discussed in the post-2015 MDG context, with an “elimination” 
vision set for 2030 (Deeks, Lewin, & Havlir, 2013; UNAIDS, 2010b). 
 
These 2015 goals are estimated to require US$22-24 billion in investments globally 
(Schwartländer et al., 2011; UN, 2011), which is a twenty percent increase from the 
estimated US$18.9 billion available for HIV programs in 2012 (UNAIDS, 2013a). 
With new treatment guidelines published by WHO in 2013 recommending earlier 
initiation of patients on antiretroviral treatment (WHO, 2013a), global costs are 
expected to be even higher than previously estimated. Meanwhile, donor funding 
for HIV and AIDS has remained essentially unchanged since 2008 at US$7.86 
billion (The Kaiser Family Foundation & UNAIDS, 2013), placing the burden of 
closing the resource gap on domestic sources in low- and middle-income countries. 
 
In terms of global burden of diseases, HIV and AIDS accounted for 3.3 percent of 
DALYs among 291 causes in 2010 (Christopher J L Murray et al., 2012) and for 2.9 
percent of deaths globally, among over 100 causes (WHO, 2011).  HIV is only one 
of the three diseases named in MDG six (besides malaria and tuberculosis) and the 
three diseases together account for one among the eight goals targeted in the global 
development agenda. 
 
Given these ambitious targets, cost constraints, and competing agenda in global 
health and development, a prioritization in allocation of limited resources is 
needed. In the absence of explicit priority setting, decisions made are those which 
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are the least controversial or favor the social, economic and political elite 
(Ainsworth & Teokul, 2000; Rosen, Sanne, Collier, & Simon, 2005a). To be 
consistent, legitimate, accountable and fair, the priority setting process must have 
an explicit, exhaustive and deliberate set of criteria (Baltussen & Niessen, 2006; 
Bennett & Chanfreau, 2005; Daniels & Sabin, 2000). 
 
A number of studies have reviewed the criteria used in health care priority setting 
(Musgrove, 1999; Tromp & Baltussen, 2012; Vogel et al., 2013). Most notably, 
Guindo et al (Guindo et al., 2012) reviewed and identified 58 healthcare decision 
criteria under nine categories. However, there are no known studies that have 
systematically reviewed relevant criteria to prioritize the programs, policies, 
investments, workforce and technologies that are utilized in responding to the 
epidemic of HIV and AIDS (referred to as “HIV response” hereinafter). As a 
phenomenon with consequences that reach beyond health, and affects human 
rights, social justice, stigma, poverty, food security and gender issues among 
others, HIV is an exceptional disease requiring specialized criteria for priority 
setting. 
 
This study explores the criteria at play in the HIV response priority setting. The 
relevant criteria are identified through a systematic review of literature. The 
identified criteria are mapped to Guindo et al’s general healthcare prioritization 
criteria, and the gaps and overlaps between the two sets are explored. The study 
also explores the differences in criteria when epidemic type and income levels of 
countries are considered. Similarities and differences are also explored according 
to the character (observed/descriptive or recommended/normative), the 
administrative level (global or national level), and the time period in which the 
criteria were elicited. 
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This is the first known review that uses cluster analysis to classify criteria. It 
articulates the criteria relevant to the HIV response for use in priority setting and 
policy making. The criteria elicited in this review are a reflection of how HIV and 





To identify and describe the criteria used in the HIV response priority setting, a 
systematic literature review was conducted. The databases PubMed and Science 
Direct were searched for articles on HIV response priority setting. The search 
strategy involved an optimization of the search terms followed by searching the 
databases with those terms. 
 
A first set of search terms relevant to priority setting were extracted from the 
studies by Guino et al, Tromp & Baltussen, and Musgrove (Guindo et al., 2012; 
Musgrove, 1999; Tromp & Baltussen, 2012). The keywords section, MeSH terms, 
and the title and abstract of these articles were reviewed for key search terms. 
These terms were then used together with HIV and AIDS related terms for an 
initial search in the databases. The resulting articles were scanned and the first five 
articles that met the inclusion criteria and were relevant to HIV response priority 
setting were used to extract additional search terms to add to the existing search 
phrase. Also, the citations in these five relevant articles were scanned, and if any of 
the cited articles were found relevant, the key terms from those articles were also 




The search phrase was entered into the databases to identify relevant articles. The 
abstract and title of the articles were screened to remove articles that did not elicit 
information about priority setting in the HIV response. The remaining articles were 
further screened for relevance. Only articles published since 2000, which were 
dealing with HIV/AIDS criteria for prioritization and considering treatment in 
their set of interventions, were included in this review. The latter exclusion 
criterion regarding treatment was added because it is the only intervention 
currently available to address the goals of eliminating AIDS related deaths. 
Discarding this criterion would admit an implicit prioritization of at-risk-but-
uninfected populations over people living with HIV and AIDS. 
 
Additional exclusion criteria were applied to filter relevant articles. Articles 
dealing with prioritization of health research or health technology, which involved 
a different set of criteria, were excluded. For example, clinical studies researching 
criteria for the selection of different drug regimens to administer to patients were 
excluded. Articles that polled opinions on criteria, or debated the value trade-offs 
of a fixed set of criteria, or promoted increased attention to a single criterion, were 
not included in this review. This is because that type of research does not deal with 
the breadth of criteria involved in decision-making, nor the contextual limitations 
that determine which criteria can be operationalized. Articles that did not elicit an 
operational definition of criteria were excluded. For example mentioning equity 
without discussing the type of equity or how it would be implemented was 
grounds for exclusion. Language of articles was limited to English. 
Search Phrase 
"Health care rationing" OR (("Resource Allocation" OR "Cost-Benefit Analysis" OR 
"Decision Making”) AND ("priority setting” OR "prioritization" OR "prioritisation” OR 




The articles were analyzed using thematic content analysis. The articles were read 
for general impressions. Key terms related to criteria for prioritization were coded 
inductively, during and after the review of articles. Preset concepts (defined in 
healthcare criteria set) and emergent themes (defined after reviewing the articles) 
guided the coding process. Identified codes were then categorized using 
hierarchical cluster analysis. All cluster analysis was run using the R Statistical 
Software version 3.0.2 (RCore, 2013). Another categorization of criteria was done 
by regrouping the codes identified in this systematic review around the themes 
identified in the systematic review of healthcare priority setting criteria (Guindo et 
al., 2012). The ranking of criteria themes according to their frequency of occurrence 
in the HIV and AIDS set and the healthcare set were compared, and thematic gaps 
between the two set were identified. The final analysis saw the stratification of 
articles by administrative level, the income group of countries under study, type of 
the epidemic, whether the article was characterized as normative or descriptive, 




The literature search resulted in a total of 840 records identified through searching 
PubMed and Science Direct databases. These records were screened by their title 
and abstracts and 649 were excluded. The remaining 95 were assessed for 
eligibility, on the basis of their full text, and 66 were excluded. A total of 29 
publications that met the limitations and relevance criteria were included in the 



































Note:  1 Of 727 excluded records, 649 did not pass screening, 65 were not found, and 13 were 
duplicates. 
 
Descriptive characteristics of the included articles 
The 29 articles included in the review were published in 20 different peer-reviewed 
journals (Appendix A). They represent studies from 14 different countries, ten of 
which are from Sub-Saharan Africa. Most articles were published in journals with 
Records identified through 
PubMed search 
(n = 476) 
Records identified through 
Science Direct search 
(n = 364) 
Records after duplicates 
removed 
(n = 822) 
Records retained after screening 
by title & abstract 






Articles included in the review 
(n = 29) 
Full-text articles 
excluded 
(n = 66) 
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impact factors of five or less, although six articles were published in journals with a 
high impact factor (>15). There is a constant increase over the years in the number 
of publications eliciting HIV and AIDS prioritization criteria with a peak in 2005. 
Nearly half of the articles (14/29) are editorials, appearing in commentary, 
viewpoint, and policy review sections of the journal. The remaining articles are 
qualitative, quantitative or mixed-method design studies. The majority of the 
articles (24/29) focus on which populations to prioritize, and the remainder either 
focus on criteria to prioritize interventions or both population and intervention. 
 
Criteria and frequency of occurrence 
During the review, 30 different terms were identified eliciting criteria used in 
priority setting. Some of the terms contain sub-terms that operationally define the 
criteria. For example, equity is defined by sub-terms of gender equity, geographical 
equity, racial equity, and economic equity. Other criteria have distinct and non-
overlapping sub-categories like age, disaggregated as children and adults. Where 
multiple definitions of the same concept have been elicited in the reviewed articles, 
they have been aggregated into a single criterion. Cost-effectiveness for example can 
be contextually measured as “cost per infection averted”, or “cost per DALY which 
is less than GNI per capita”, or “cost per QALY”. 
 
Frequency counting was used to rank order the 30 unique criteria. The top criteria, 
occurring in at least one-third of the publications, are: 1) equity, 2) severity of disease, 
3) human capital, 4) feasibility, 5) adherence (psychological and structural), 6) age, g) 
affordability 7) fairness 8) pregnant women. The unique criteria and proportion of 
publications that elicited them are presented in Table 2.1. 
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Table 2.1 HIV/AIDS related criteria elicited in reviewed articles and 





Severity of disease 72.4 
Human capital 44.8 
Feasibility 44.8 
Adherence – Psychological 41.4 




Pregnant women 34.5 
Gender 31.0 
Sustainability 27.6 
Stigma and Discrimination 27.6 
Coverage 24.1 
Equal Worth of Life 24.1 




Access Selection Committee 17.2 
Health Outcomes 17.2 
Women of Childbearing Age 13.8 
Mothers 13.8 
Parents 13.8 
Profession - Unemployed 13.8 
Innocent Victim 10.3 
Epidemiological/Prevention - At Risk Populations 3.4 
Orphans/Widows 3.4 
Quality of Care 3.4 
Safety of Measure 3.4 
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Thematic grouping of criteria 
To explore the possible thematic groupings, cluster analysis was conducted on the 
criteria. The analysis involved converting the occurrence of criteria into numeric 
data, and applying hierarchical clustering to explore how the criteria grouped 
together. The cluster analysis produced 18 thematic groups from the set of 30 
criteria. For presentation purposes, criteria that occurred in three or fewer articles, 
and did not thematically group together with other criteria in a meaningful way, 
were removed from the dendrogram (Figure 2.2). 
 






Severity of Disease 72.4 
Economics 48.3 
Social Justice 44.8 
Feasibility 44.8 
Adherence – Psychological 41.4 
Adherence – Structural 41.4 
Age 41.4 
Affordability 37.9 
Women / Mothers 37.9 
Fairness 34.5 
Gender 31.0 
Population Effects / Prevention 31.0 
Coverage 24.1 





Figure 2.2 Cluster dendrogram exhibiting grouping of criteria 
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The hierarchical cluster analysis shows a grouping of social justice concepts, 
including parents, innocent victims of rape or abuse, stigma and discrimination, and 
equal worth of life. Prevention efforts focused on high-risk populations has upstream 
effects benefiting population health outcomes, thus linking these two concepts under 
the theme of population effects/prevention. Sustainability by means of co-payments or 
public funding, and human capital preservation are grouped under an economics 
theme. Several criteria related to women of childbearing age, pregnant women, and 
mothers, with focus on prevention of transmission, prevention of orphans, ease of 
access, and the social good of keeping mothers alive seem to co-occur. These 
criteria are grouped under the theme titled women/mothers. Once criteria were 
grouped around the themes developed by cluster analysis, the themes were rank 
ordered by the frequency of occurrence of their associated criteria (Table 2.2). 
 
Mapping of HIV/AIDS criteria to healthcare decision-making 
criteria 
Criteria identified through the systematic review were compared to the healthcare 
decision-making criteria presented by Guindo et al (Guindo et al., 2012). All 30 
criteria in the HIV/AIDS set were mapped to the criteria and classifications in the 
healthcare set. The mapping resulted in 17 themes to be developed that were 
common to both HIV/AIDS and the healthcare set. Two additional criteria - gender 
and age (specifically adults) – found no occurrence in the healthcare set (Table 2.3). 
 
The most frequently occurring themes in the common set were vulnerable and needy 
population, disease severity, equity/fairness/justice, and efficacy/effectiveness, all 
occurring in more than half of the articles reviewed in this study. The latter two are 
also the most frequently occurring criteria in the healthcare set. However, the first 
two occur in only about 22 percent of healthcare set articles. In fact, the greatest 
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discrepancy between the HIV/AIDS sets and the healthcare set occurs over these 
two criteria of disease severity and vulnerable and needy populations, with nearly a 50 
percent point difference between the two sets. 
 
Table 2.3 HIV/AIDS related criteria grouped by healthcare 
classifications 






Vulnerable and Needy Population 75.9 22.5 
Disease Severity 72.4 22.5 
Equity, Fairness, and Justice 72.4 42.5 
Efficacy/Effectiveness 69.0 52.5 
Economic Impact1 44.8 22.5 
Org. Requirements & Capacity to Implement 44.8 32.5 
Access 41.4 35.0 
Budget Impact 37.9 22.5 
Gender 31.0 0.0 
Sustainability 31.0 10.0 
Epidemiology 27.6 32.5 
Cultural Aspects 27.6 15.0 
Population Effect 24.1 17.5 
Age - Adult 20.7 0.0 
Health Benefits 17.2 22.5 
Cost-Effectiveness 17.2 42.5 
Stakeholders Interest and Pressure 17.2 30.0 
Safety 3.4 35.0 
Quality of Care 3.4 2.5 
Note: 1 includes Financial Impact, Poverty Reduction and Opportunity Cost 
 
Certain criteria from the healthcare set did not successfully map to the HIV/AIDS 
set. For example, patient reported outcomes, individual effects, need, clinical 
guidelines and practices, pre-existing use, cost, value, resources, insurance 
premiums, quality of evidence, legislation, skills, flexibility of intervention, 
characteristics of intervention, appropriate use, barriers and acceptability, 
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integration and system efficiencies, population priorities, utility, solidarity, ethics 
and moral aspects, as well as the overall context criteria, did not appear in the 
articles selected for this review. 
 
Stratification of criteria 
Equity took up the top ranking position in every mode of stratification of the 
articles in this review. Severity of disease shared the top ranking position in both 
strata when articles were stratified by administrative level, by their 
normative/descriptive character, and by their date of publication. When articles 
were stratified by income level of the country being studied, severity of disease was 
the top ranked criterion only among the upper income country set. And when 
stratified by the epidemic type of the country being studied, severity of disease was 
the top ranked criterion only among the concentrated epidemic country set. 
 
Stratification by administrative level found 17 articles to have a national or 
subnational focus, and 12 articles focused globally or regionally. Only three criteria 
differed in their ranking by 50 percent or more between the two strata: Health 
outcomes, adherence (psychological), and age. Health outcomes were only a concern at 
the global level, with no articles in the national set considering it as a criterion. 
Only two articles out of twelve with a global focus cited adherence and age as 
criteria, whereas approximately 60 percent of national set articles cited these as 
criteria. Feasibility was the second highest ranked criteria in the global set, on par 
with equity. However, in the national set, feasibility was ranked at the median of the 
criteria. Human capital, the third ranking criteria in the global set of articles, was 
also lower ranked in the national set, appearing at the fifth of eleven ranking 
positions (Appendix B). 
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Overall, stratification of the articles by their characterization as normative or 
descriptive did not show significant differences between the two sets. 
Nevertheless, four criteria showed a 50 percent or higher variations in their 
ranking between the two sets. Adherence (psychological) ranks third in the 
descriptive set, but appears infrequently in the normative set. Health outcomes, 
feasibility, and efficacy all appeared frequently in the normative set, but infrequently 
in the descriptive set (Appendix C). 
 
Articles with a national level focus were stratified by the gross national income 
(GNI) per capita of the country being studied. The articles were divided into an 
upper income set and a lower income set at the median GNI per capita value of 
$1,380. Six criteria showed a 50 percent or more difference in ranking between the 
two sets. Four of those criteria, adherence (psychological and structural), human capital, 
and sustainability, were ranked higher in the lower income set, whereas affordability 
and cost-effectiveness were ranked higher in the upper income set (Appendix D). 
 
Stratification of the articles by the type of epidemic showed significant differences 
in ranking of five criteria. Adherence (both psychological and structural), fairness, 
pregnant women, and efficacy all show a difference of 50 percent or more in ranking 
between concentrated and generalized epidemics. All these criteria were more 
frequently elicited in the generalized epidemic set than the concentrated epidemic 
set, except for the efficacy criterion, which never occurs in the generalized epidemic 
set. Both sets rank high-risk populations in the lower half of their criteria list 
(Appendix E). 
There is only one significant difference between the set of criteria before and after 
the year 2007. The criterion feasibility appears in over 70 percent of articles from 
2000 to 2007. But from 2007 onward, only 20 percent of articles elicit this criterion. 
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All other criteria have less than a fifty percent difference in ranking when stratified 




This study set out to explore the criteria relevant to the prioritization of the HIV 
response. It also compared the criteria specific to the HIV response to the broader 
health sector criteria. The criteria found are impressive in quantity and diversity, 
spanning issues of public health, social justice, and economic efficiency. Equity and 
severity of disease were the most frequently cited criteria for prioritization. 
Stratification by the administrative level of focus of articles, normative or 
descriptive nature of articles, year of publication of articles, and country income 
level provided further evidence that equity and severity of disease are the most 
important criteria at global and national level, in use and in normative guidance, 
over the past 14 years. 
 
Two important themes were developed in the analysis of the HIV/AIDS criteria: 
women/mothers and social justice. These two criteria themes are unique to the HIV 
response in that they underline the feminization of HIV and AIDS, and signify the 
ethical imperative of prioritizing the most marginalized populations despite higher 
costs per life-year saved (Moatti, Marlink, Luchini, & Kazatchkine, 2008; Rosen, 
Sanne, Collier, & Simon, 2005b).  Indeed, the initial slow response to the epidemic 
can be attributed to the stigma suffered by the socially marginalized and 
economically disadvantaged, who were the predominant victims of the disease 
(Michaelis, 2002). Gender mainstreaming, and particularly a focus on women and 
girls, has been historically lacking in the objectives or strategies of health programs 
(Briones-Vozmediano, Vives-Cases, & Peiro-Perez, 2012; T. S. Ravindran & Kelkar-
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Khambete, 2007). In contrast, the HIV response has recognized the dynamics 
between genders that act as barriers to women’s access to treatment and care 
(Dixon, Gibson, McPake, & Maleta, 2011; Metz, 2008), and prioritized populations 
based on gender for a number of years (Johansson, Jerene, & Norheim, 2008; 
Richter, Hicks, Earnshaw, & Honeycutt, 2008). 
 
There are clear gaps between the health sector and HIV response, in terms of 
criteria for prioritization, which has implications for both improving the HIV 
response priority setting, but also for any consideration of integration of treatment 
and prevention of HIV and AIDS into the health systems like non-communicable 
diseases or sexual and reproductive health (Sidibé, Piot, & Dybul, 2012). The 
widest gap in criteria for prioritization occurs around the consideration of severity 
of disease and vulnerable and needy populations, which are frequently elicited in the 
HIV response, but less frequently in the broader health sector. 
 
Demand for prevention, treatment and care outpacing resource availability has 
meant prioritizing those in urgent need (Daniels, 2004), hence the frequent 
reference to severity of disease criterion in the HIV/AIDS set. In fact, the most 
commonly used criteria for rationing anti-retroviral treatment in the past decade 
has been the WHO guidelines on CD4 cell count, itself a measure of severity of 
disease (WHO, 2013a). HIV also affects the wellbeing of those infected, and in a 
vicious cycle the most vulnerable populations, including women, young people, 
and marginalized groups, are most at risk of infection (Bradshaw et al., 2008). 
Criteria that prioritize the vulnerable and needy populations are therefore given a 
more prominent focus in the HIV response, as reflected in the frequent reference to 
the criteria that prioritizes this group. 
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These two criteria perhaps best illustrate the success of the HIV response in 
framing the public health and emergency response approach to the epidemic, 
within the context of social justice and development. Emulation of the successes 
and lessons from the HIV response, including the criteria used for priority setting, 
can only serve to strengthen the health system, as synergies with the health sector 
are pursued. Consideration of policies and practice of integration must be 
accountable to the key criteria of the HIV response. 
 
Stratification of the articles by their characterization as normative or descriptive 
shows that feasibility appears infrequently in the descriptive set, although it is the 
second most important criteria in the normative set. This difference in ranking may 
be due to a lack of consideration of resource needs in allocation models of the HIV 
response (Alistar & Brandeau, 2012; Hunsmann, 2012; Kumaranayake & Watts, 
2001).  The gap between the normative and descriptive ranking of the feasibility 
criterion further stresses the work remaining in operationalizing certain criteria 
deemed important to an effective response. 
 
Observations from the stratification of criteria by the administrative level of their 
elicitation suggest that national and sub-national criteria are more prone to have an 
individual patient level of prioritization (e.g. psychological adherence, age) whereas 
the global and regional set criteria focus more on societal level priorities (e.g. 
human capital, health outcomes). In essence, this is a dilemma of public health ethics 
versus ethics of individual patient care that manifests itself in priority setting 
(Benatar, 2006). 
 
Assuming that access to treatment and care is more scarce in lower income 
countries than upper income countries, it can be inferred that lower income 
countries would prioritize patients who benefit society, consider human capital 
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preservation, and limit treatment to those who are most likely to succeed on 
treatment by adherence to medication. This rational is corroborated by the findings 
of this study. The findings also show that criteria of affordability and cost-
effectiveness are ranked higher in the upper income set, suggesting that those 
countries with fewer resource constraints are more concerned with optimization of 
the resource allocation to maximize the benefit to cost ratio. 
 
A notable difference when stratifying articles by the income group of the country 
under study is over the criteria of stigma and discrimination. These criteria are not 
mentioned in the articles focused on the upper income countries, whereas over one 
third of the articles in the lower income group elicit the criteria. Factors of 
education, health literacy, and negative attitudes towards high-risk groups are 
frequently linked to socio-economics status (Lim et al., 2013; Parker & Aggleton, 
2003; Waite, Paasche-Orlow, Rintamaki, Davis, & Wolf, 2008). A plausible 
explanation for the frequent reference to stigma and discrimination in the lower 
income country strata may be the low knowledge on modes of transmission and 
consequent negative attitudes toward people living with or at higher risk of HIV 
and AIDS. 
 
An important finding from the stratification of criteria by epidemic type is the 
ranking of the criterion on prioritization of high-risk populations. While this criterion 
should hypothetically weigh more in concentrated epidemics, which by definition 
are concentrated in key high-risk populations, the generalized epidemic set shows 
only a slightly lower ranking of this criterion than the concentrated epidemic set. 
Moreover, high-risk populations ranks in the lower half of all criteria, irrespective of 
stratification of the criteria in this study, despite this population being a key driver 
of the epidemic, and most-at-risk of being infected. 
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The growing body of literature eliciting criteria for prioritization demonstrates the 
increased interest in explicit consideration of multiple criteria in health policy 
decisions. Publications eliciting criteria peaked in 2005, which may be due to the 
increased focus on priority setting at the end of the WHO 3-by-5 initiative (World 
Health Organization, 2003). Among the criteria elicited, the only significant change 
before and after 2007 was around the criteria of feasibility. Frequently cited before 
2007, references to feasibility have diminished over time. The dominance of 
feasibility in the pre-2007 era can be attributed to the weak information and ill-
defined measure of this criterion (Baltussen et al., 2013; Defechereux et al., 2012; 
Mahapatra, 2002), which makes its use favorable in reason-based, political 
decision-making processes (Baltussen & Niessen, 2006; Keren & Bruin, 2003). The 
gradual movement toward evidenced based programming, aided by improved 
monitoring of the HIV response, vis-à-vis a persistent deficiency in quantitative 
measurements of feasibility, can be related to the waning elicitation of this criterion 
in priority setting in recent years.  Wider availability of pharmaceutical treatments 
and prevention interventions provides another possible explanation for the 
declining emphasis on feasibility over the years. 
 
Cost-effectiveness is a salient strategy for prioritization in the HIV response among 
major donors and multilaterals (GFATM, 2012; Hogan, 2005; PEPFAR, 2008; The 
World Bank, 2011). The most widely used tool currently available for national and 
global HIV response planning is the GOALS model, which optimizes on cost and 
epidemic effect (Alistar & Brandeau, 2012; Forsythe, Stover, & Bollinger, 2009). 
Cost-effectiveness is also the fourth most frequently reported criterion in health 
prioritization (Guindo et al., 2012). Nevertheless, findings from this study show 
that cost-effectiveness is an infrequently cited criterion in the HIV response priority 
setting overall. At every administrative level, in concentrated and generalized 
epidemics, among normative and descriptive articles, over the past 14 years, cost-
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effectiveness as a criterion consistently ranks in the lower half of all criteria 
considered. Only among high-income countries does this criterion get frequently 
mentioned. This linkage may be attributed to the weak health information system 
in low- and middle-income countries, where the quality information needed to 
make informed, reliable decisions on the most cost-effective strategy is unavailable 
(Health Metrics Network, 2008). Otherwise use of cost-effectiveness as a criterion for 
priority setting at the global level by donors and multilaterals does not generalize 
well to its promotion and application in the national context. 
 
This study has required lifesaving treatment to be included in the package of 
interventions of the HIV response. Although there is a tendency for reviewed 
criteria in this study to consider how treatment can be rationed, prevention is not 
excluded from the review. Moreover, an answer to rationing of treatment would 
also answer the analogous question about how to ration preventative measures 
(Metz, 2008). 
 
The grouping of criteria was approached in this study with themes identified by 
existing frameworks and classifications, and followed by applying hierarchical 
cluster analysis to explore membership of criteria in any new groups. An 
alternative approach would have been to start with the quantitative cluster 
analysis on the disaggregated criteria and then qualitatively explore the mapping 
of the identified themes to existing frameworks and classifications. However, given 
the large number of criteria in the disaggregated set, to maintain an adequate 
degree of freedom in the analysis, this latter approach would have required a 





This chapter synthesizes the literature on HIV response priority setting, taking 
stock of criteria used and articulating discrepancies with criteria from the broader 
health sector. The review identified 30 unique criteria fitting into 18 categories. 
These categories can be used in future studies and policy reviews not only to 
identify which criteria are particularly relevant to national HIV program priority 
setting, but also to determine conceptual conflicts that exist between pairs of 
criteria. 
 
Three important findings emerged in the present review.  The first concerns the 
frequent elicitation of equity and severity of disease as important criteria to consider 
in priority setting in the HIV response. A second area concerns the clustering of 
criteria around themes of social justice and women/mothers.  The third finding 
emerged in the categorization of criteria around healthcare categories where 
vulnerable and needy population ranked as the top criterion.  These findings together 
form a societal perspective of HIV as a severe disease that disproportionately 
affects vulnerable groups, particularly women and girls.  Recognizing the priorities 
that contributed to the success of the HIV response thus far while acknowledging 
the work remaining ahead, it is crucial then for the prioritization of the HIV 
response in the post-2015 era to be as much grounded in social justice as it is in 
optimum public health outcomes. 
 
The review also noted the scarce elicitation of cost-effectiveness and high-risk 
populations as criteria, in low- and middle-income countries and concentrated 
epidemics respectively.  Weak health information systems and stigma for at-risk 
groups present some possible barriers to effective application of the criteria in 
resource poor settings. There is a need for more research exploring other barriers 
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that prevent these criteria from being considered in different contexts.   Only with 
better information, explicit criteria, and rational decision-making processes, can the 
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National Strategic Plans (NSP) guide the HIV response in countries and help 
planners make informed decisions to change the epidemic’s trajectory. Given the 
importance of evidence for decision-making, this study explores the extent of data 
use in the NSP. 
 
An instrument was developed to measure evidence use in NSP. The internal 
reliability and external validity of the instrument were tested. NSP’s of 21 countries 
in Africa were assessed with the instrument. 
 
Our results show increasing evidence use over the years, which is consistent with 
studies that suggest increasing investments on monitoring and evaluation are 
paying off in terms of improved generation of evidence. Data on epidemic drivers 
were the most frequently used. Expenditure data and impact/outcome evaluation 
were the least frequently used data type for planning. Evidence on key populations 
at risk was largely absent. 
 
Our instrument provides an objective analysis of evidence-based planning in the 
HIV response.  Our results suggest that with regard to the NSP, the generated 






Evidence helps to rationalize and improve the quality of decisions. Evidence 
influences policy and planning by facilitating the recognition of problems, rational 
decision-making, monitoring, evaluation and forecasting (Adrien et al., 2008; 
Haskins & Baron, 2011; Rivlin, 1971). Evidence-based health policies guide and 
justify actions that are linked to improved health outcomes (Brownson, Chriqui, & 
Stamatakis, 2009; The World Bank, 2007; WHO, 2013b). Hence, health information 
forms one of the six pillars of a strong national health system (Health Metrics 
Network, 2008). 
 
Given the importance of evidence to improve health outcomes, the WHO 
Framework for National Health Policies, Strategies and Plans (WHO, 2010) calls for 
a robust situation analysis as an input to the development of national health 
policies. Also, a policy tool is made available for the joint assessment of national 
health strategies and plans (known as the JANS tool). The tool is used to support 
the review of national health plans (IHP+, 2013). 
 
Similar to the national health plans, National Strategic Plans (NSP) on HIV and 
AIDS outline the vision for the national HIV response, the desired results, and the 
approach to achieving them. As early as 1998, the United Nations guided the 
development of NSP on HIV and AIDS to help planners make informed decisions 
to improve the epidemic situation (UNAIDS, 1998). The concept of a single action 
plan that coordinates the work of all partners in the HIV response, was formally 
endorsed by major donors, international organizations, and national governments 
in 2004 (UNAIDS, 2004b, 2004d). NSP on HIV and AIDS typically cover a period of 
several years and involve many areas of development. These plans are used to 
attract and sustain funding from the national budget and external donors. 
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Therefore, NSP on HIV and AIDS need to make careful prioritization, be evidence-
driven, and use many different information sources. 
 
A look into the planning process for development of NSP illustrates how inclusion 
of evidence in the NSP is related to discussion of the evidence in the planning 
process. Planning for development of the NSP starts with an assessment and 
analysis of the country situation and response (UNAIDS, 1998; UNDG, 2003). 
During the analysis phase sources are identified and relevant documents are 
collected and analyzed, and reports are produced and circulated for comments. 
The situation analysis will have laid the groundwork for the NSP, with a 
continuation of working programs in the new plan, and exclusion of initiatives that 
are irrelevant or not working. The final draft of the strategic plan is circulated 
widely and finalized following a consultation workshop with all major interest 
groups involved in the HIV response. The entire planning process is also 
documented in the final strategic plan. 
 
While several instruments have been developed to assess national health plans 
(Ciliska, Thomas, & Buffett, 2012; IHP+, 2013; WHO, 2010), there are no validated 
instruments for the evaluation of NSP on HIV and AIDS. As HIV and AIDS is a 
multi-sectorial program in nature, involving different planners, and following 
different conventions and frameworks than other health programs, an assessment 
of evidence in NSP on HIV and AIDS also requires a tailored instrument. The aim 
of this chapter is to develop an instrument that is specific to the evaluation of NSP 
on HIV and AIDS. We also aim to validate the instrument and use the instrument 
to assess quality of evidence used in NSP, using information on Sub-Saharan 
Africa over the period 1998-2014. The process of instrument development includes 
mapping of a number of existing assessment tools, reconciliation, pre-testing, and 
instrument adjustments. The instrument validation process involves the 
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exploration of reliability, internal consistency, construct validity, responsiveness, 
and external consistency. 
 
The instrument developed in this chapter applies content analysis methods to 
review of NSP. Content analysis is a qualitative method of research to analyze text 
data. This method examines the characteristics of the language in documents to 
classifying text into categories of similar meaning (USGAO, 1996; Weber, 1990). 
Content analysis of the NSP provides basic insights on use of quality evidence, but 
there is no broader analysis of the context of the NSP. 
 
The instrument developed in this chapter measures the use of evidence in policy 
planning and programming. Measures based on this instrument can be important 
for donors like The Global Fund to fight AIDS, Tuberculosis and Malaria and other 
organizations who base their funding on performance. Such measures can help 
them to justify the rationality of their decisions for funding a given program 
(Alfven et al., 2014; Peersman, Rugg, Erkkola, Kiwango, & Yang, 2009). The 
measures can also be valuable for the countries included in the study that want to 
address their evidence gaps. And the instrument can be useful for other countries 





Since no appraisal instrument exists to score and rank NSP on HIV and AIDS 
based on the quality and use of evidence, we developed such an instrument. Our 
study draws on the Handbook on Planning and Managing for HIV/AIDS Results 
(The World Bank, 2007), and the Guide to the Strategic Planning Process for a 
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National Response to HIV/AIDS (UNAIDS, 1998). This handbook was used to 
select domains of evidence and divide them into categories of evidence. Additional 
domains and categories were identified based on the Joint Assessment of National 
Health Strategies Tool and Guidelines (IHP+, 2013), the Compendium of Critical 
Appraisal Tools for Public Health Practice (Ciliska et al., 2012), and the WHO 
Framework for National Health Policies, Strategies and Plans (WHO, 2010).  
 
The desk review mentioned above identified independent domains of evidence for 
the draft appraisal instrument. Each domain of evidence had a number of 
categories and its own scale for rating the NSP. Measurement of evidence quality 
was operationalized by the extent to which these categories were present in the 
NSP. The sum of the category ratings across all domains of evidence in the 
appraisal instrument operationally defined the use of evidence in the NSP. For 
each domain, the NSP were rated on the domain-related scale. For this purpose, 
specific search terms were created to identify domains of evidence in the NSP. For 
example, search terms to identify evidence under the domain of Program Data 
included “coverage”, “reach”, and “distribution”. The scales of the domains for 
scoring the NSP range from zero (indicating no evidence in that domain) to an 
integer between one and six (indicating the presence of one or more independent 
and measurable categories of evidence in the given domain). This range is the 
aforementioned operational measurement of the quality of evidence used in each 
domain of evidence. 
 
In several domains of evidence a distinction is made between “qualified” evidence 
and providing the evidence itself. Operationally, “qualified” evidence means the 
NSP talked about levels or trends of data in relative terms, without giving 
numerical data values. For example, if an NSP stated that funding for HIV was 
“insufficient” without stating how much funding was available, the NSP was rated 
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as having “qualified” indication of funding. Similarly, if an NSP stated that new 
HIV infections were “increasing”, without giving the HIV incidence rate, that NSP 
would be rated as having “qualified” trend in epidemiological data. By giving 
valued measurements a higher score than qualified evidence, we operationalized 
the quality of evidence use in NSP in relevant domains of evidence. 
 
The draft appraisal instrument was piloted on five NSP on HIV and AIDS. These 
NSP were randomly selected from among the 27 NSP that would be evaluated in 
the study. The one rater who carried out the pilot evaluation of five NSP was the 
same person who would evaluate the full set of 27 NSP. Piloting of the instrument 
identified new domain categories which were added to the appraisal instrument. 
When categories reached saturation – defined as no new categories identified in 
two successive reviews of NSP – the categories of that domain were considered 
complete. After dealing with redundant and missing domains, the final appraisal 
instrument included twenty-one domains and more specific categories (Figure 3.1). 
 
Instrument use and data analysis 
The appraisal instrument was applied to the NSP on HIV and AIDS of 21 priority 
countries (Table 3.1). Countries in Sub-Saharan Africa were rank-ordered based on 
the estimated number of people living with HIV and AIDS. The 21 countries that 
account for two thirds of all people living with HIV and AIDS globally were 
selected for inclusion in the study. Selected countries are in Sub-Saharan Africa 
where the HIV epidemics share similar modes of transmission. All 21 countries 
had at least one NSP available in English or French. 
 
Following standard content analysis methods (USGAO, 1996; Weber, 1990), the 
appraisal instrument that we developed, was applied to score the NSP on HIV and 
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AIDS, i.e. to score their quality and extent of evidence along the twenty-one 
domains of the appraisal instrument. The application of the appraisal instrument 
involved two phases of document review. First, the text of the documents was 
screened in detail to identify content related to the domains. Sentences or phrases 
containing information related to the domains were identified and recorded in the 
instrument. Second, search terms associated with the domains were entered into 
the search tool of the document browser to identify and highlight any evidence 
that may have been missed in the first screening of the documents. 
 
After the completion of the document review, the content recorded for each 
domain was analyzed and classified in the relevant categories of that domain. The 
domain categories to which relevant content was assigned thus determined the 
score for that domain. For example, an NSP that included national HIV prevalence 
rates disaggregated by gender and age would receive a score of 2 under the 
domain Disaggregation of Epidemiological Indicators according to the appraisal 
instrument (Figure 3.1). After scoring the NSP, the individual domain scores were 
normalized to a range of [0,1] and their sum was taken as the overall score for the 
NSP evaluated. 
 
Results of the NSP scores over time were analyzed, both within countries and 
among all countries. Frequency of use of domains of evidence in the NSP was 
analyzed, as well as the variance in scores of domains of evidence. The crosscutting 
theme of key at-risk populations, which is relevant for multiple domains of 
evidence, was analyzed across countries. One particular population, men who 
have sex with men (MSM), was selected for focused cross-analysis. While other key 
populations may have larger burden or population size in particular countries, 
MSM were selected for the cross analysis because they are a stigmatized key 











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 3.1 Countries reviewed in this study, their estimated number of 
people living with HIV and AIDS (PLWHA), and their National 
Strategic Plans included in the review 
Country 
Estimated # of 
PLWHA* 
National Strategic Plan date(s) 
South Africa  6,300,000  2000-2005 
Nigeria  3,200,000  2005-2009 
Kenya  1,600,000  2000-2005, 2005-2010 
Mozambique  1,600,000  2010-2014 
Uganda  1,600,000  2007-2011, 2011-2015 
Tanzania  1,400,000  2003-2007 
Zimbabwe  1,400,000  2006-2010, 2011-2015 
Zambia  1,100,000  2006-2010 
Malawi  1,000,000  2010-2012 
Ethiopia  790,000  2010-2015 
Cameroon  600,000  2011-2015 
DR Congo  440,000  2014-2017 
Côte d'Ivoire  370,000  2011-2015 
Lesotho  360,000  2011-2015 
Botswana  320,000  2003-2009 
Angola  250,000  2003-2008 
Namibia  250,000  1999-2004, 2011-2016 
Ghana  220,000  2001-2005, 2006-2010 
Chad  210,000  2012-2015 
Rwanda  200,000  2005-2009 
Swaziland  200,000  2006-2008, 2009-2014 
Note: * Estimated number of People Living with HIV and AIDS (PLWHA) from 2014 
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Reliability of the instrument 
After all NSP were scored, a random sample was rescored to check the reliability of 
the instrument. The reliability of the instrument was assessed using Intraclass 
Correlation (Rousson, Gasser, & Seifert, 2002), which involves a single researcher 
rating multiple subjects (Shrout & Fleiss, 1979). Ten NSP were selected to allow an 
adequate Intraclass Correlation Coefficient above 0.75 (Gwet, 2007). These ten NSP 
were selected at random from the set of 27 NSP and rescored following the 
procedure described previously. 
 
In a reliable instrument, scores on similar items are related and consistent. This 
internal consistency of the appraisal instrument was tested with Cronbach’s Alpha 
(Cronbach, 1951).  Cronbach Alpha coefficients between 0.7 and 0.9 are interpreted 
as reliable (Gliem & Gliem, 2003; Tavakol & Dennick, 2011). Higher Cronbach 
Alpha coefficients suggest redundancies in questions, and lower coefficients 
suggest no correlation between the related questions that are supposed to measure 
a common concept.  By successive removal of domains and recalculation of the 
Cronbach Alpha, redundant domains were identified and excluded from the 
instrument.  
 
Validity of the instrument 
The validity of the appraisal instrument was tested by comparing the use of 
evidence for planning with measures of good governance (Kaufmann, Kraay, & 
Mastruzzi, 2013). Accurate information, meaningful participation of stakeholders 
and evidence-based planning are thought to be vital to rule of law and democratic 
governance (Boţa-Avram, 2013; IRMT, 2002; Malyshev, 2006; Woodford & Preston, 
2013). Therefore, we expect to see a correlation between the evidence use scores 
and the regulatory quality index of the World Governance Indicators.  Evidence 
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use scores were also validated against the strength of auditing and reporting 
standards of the Global Competitiveness Index from the World Economic Forum 
(WEF, 2014). Both of these measures rely on functioning monitoring systems and 
availability of evidence. 
 
In correlation analysis of the evidence use scores and regulatory quality dimension 
of the World Governance Indicators, NSP of Democratic Republic of Congo was 
excluded since no World Governance Indicator values are available for a 
corresponding year. Outliers were identified and removed using the Tukey 
method (Tukey, 1977). All external validity tests were coded and tested in the 




The 27 NSP on HIV and AIDS were rated using the appraisal instrument 
developed in this study.  The mean score received by the rated NSP was 9.1 out of 
a maximum of 21 points, where the maximum score represents an NSP with 
perfect information along all 21 distinct domains of evidence measured by the 
instrument. The 2011-2015 NSP from Zimbabwe received the highest score of 14.83, 
and the 2003-2007 NSP from Tanzania received the lowest score of 4.25. 
 
In checking the reliability of the instrument, rescoring of ten NSP resulted in a 
mean score of 8.5 compared to a mean score of 9.0 in initial scoring of the same set. 
Scatterplot of the initial scores against the rescores showed a definite trend (Figure 
3.2), although offset from the zero intercept. These differences were likely to be 
systematic errors due to the rater becoming familiar with the NSP being rated, also 
called the learning effect of the rater (Rousson et al., 2002). Calculation of the 
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Intraclass Correlation Coefficient resulted in a coefficient value of 0.88, 95% CI 
[0.59 – 0.97], which is interpreted as sufficient reliability of the appraisal 
instrument. Analysis of internal consistency of the instrument demonstrated 
acceptable reliability, with the Cronbach’s Alpha coefficient calculated at 0.75. 
 
Figure 3.2 Scatterplot of intra-rater agreement in use of instrument to 
assess evidence use in NSP 
 
 
Note: Identity line is plotted as a reference. 
 
In testing the validity of the instrument, the regulatory quality index of World 
Governance Indicator showed a strong association with the evidence use scores 
(Spearman’s rho coefficients of 0.54, p<0.05). This World Governance Indicator can 
be interpreted as being strongly correlated with the evidence use score produced 
by the appraisal instrument. Auditing and Reporting Index of the Global 
Competitiveness Index indicators had a strong correlation with evidence use 
(Spearman’s rho coefficient of 0.48, r = 0.086).  
 
There is a noticeable trend in increasing scores over the years (Figure 3.3), 
indicating that the types of evidence used in NSP are more diverse and the NSP 
y = 0.7143x + 1.6685 
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quality is greater today than it was in the past. The increasing trend in the score 
over time is observed over all NSP reviewed, but also within successive NSP of 
four countries. Only one country, Uganda, showed a decline in the score over 
successive NSP. 
 
Figure 3.3 Appraisal instrument scores on quality and use of 
evidence in NSP over time 
 
 
Data on Epidemic Drivers and Risk Factors was the highest scored domain of 
evidence used in the NSP. It appeared in some form in every NSP reviewed. 
Expenditure Data and Impact/Outcome Evaluation were equally the lowest scored 
domains of evidence used in the NSP (Table 3.2). When domains of evidence were 
clustered around four themes (Figure 3.1), the Epidemic and Programmatic cluster 
had the highest score followed by Community and Political Preferences and 
Resources clusters. The Research and Evaluation evidence domain cluster had the 
lowest score and also the lowest variance on its cluster score. Modes of 
Transmission/Patterns of Infection and Information and Evidence as Resources 
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the bottom quartile and top quartile of scored NSP. Seven of the 27 NSP did not 
include participation of Civil Society in the planning process.  Six of the NSP did 
not include participation of Non-Governmental Organizations. 
 
Table 3.2 Domains of evidence and mean score received for NSP 
rated using the appraisal instrument 
Domain Item Mean Score 
Score 
Variance 






Recent epidemiological data  
 
0.65 0.12 
Potential partners as resources 
 
0.65 0.14 
Community and political preferences 
 
0.58 0.12 
Trends in epidemic 
  
0.56 0.19 
Modes of transmission/patterns of infection 0.56 0.19 








   
0.47 0.17 
Information and evidence as resources 0.41 0.15 






Projections of epidemic 
  
0.26 0.19 
Program effectiveness studies 
 
0.21 0.08 









Impact/Outcome evaluation  
 
0.13 0.07 
Expenditures      0.13 0.09 
 
Four domains of evidence had search terms related to key populations at risk of 
HIV or key populations were a category in these domains of evidence.  These four 
domains of evidence - Disaggregation of Epidemiological Data, Modes of 
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Transmission, Community and Political Preferences, and Potential Partners as 
Resources - had mean scores above the median. These four domains of evidence 
also had the highest score variance across the countries. One key population at 
risk, MSM, was selected for further analysis in the domains of evidence in the NSP. 
Only three out of the 27 NSP reviewed demonstrated any evidence for MSM, and 
only one NSP reported the size of this key population. Ten NSP did not mention 
MSM at all, and four mentioned that despite being a key population, evidence is 
lacking for MSM. Two NSP stated that homosexuality is illegal and therefore no 




This study builds on previous research that suggests investments in monitoring 
and evaluation systems are paying off in terms of improved generation of evidence 
(Alfven et al., 2014; Peersman et al., 2009). It overcomes some of the limitations of 
those studies in the use of self-reported data over a short period of time, with an 
objective analysis of use of evidence for planning based on validated instruments.  
Our results further suggest that with regard to NSP, evidence is not only being 
generated, but also used in planning, and that evidence use in NSP is increasing 
over the years. 
 
There is still a gap in reaching optimal levels of evidence use in NSP, with scores of 
recent plans remaining below the midpoint of the appraisal instrument maximum 
score. The results indicate that there is more evidence used in NSP in terms of 
surveillance of the epidemic and monitoring of HIV programs than in research and 
evaluation. Evidence from evaluation and research are noticeably absent in the 
plans, particularly impact evaluations and operations research. These results are 
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consistent with expert opinion that evaluation is a neglected area of health 
programs, particularly in HIV and AIDS (Bennett, Boerma, & Brugha, 2006; 
Boerma & Stansfield, 2007). However, a recent survey and evaluation gap analysis 
by the International Initiative for Impact Evaluation (3ie) indicated that there is a 
strong evidence base on the effectiveness of HIV programs, with Sub-Saharan 
Africa being a leader in impact evaluations (Rankin, Heard, & Diaz, 2016). An 
explanation for these contradictions may be that although evaluative evidence is 
available, it is not generated in a timeframe aligned with the national strategic 
planning process to be used effectively (Oliver, Innvar, Lorenc, Woodman, & 
Thomas, 2014). 
 
Overall, there is adequate evidence related to key populations in the NSP. 
However, there is also great variance across NSP in scores on evidence that related 
to key populations at risk of HIV. A particular gap observed is in data on MSM, 
which may be due to lack of evidence generation activities for this key population 
at risk of HIV, or lack of will to use the available data. The 3ie has developed an 
Evidence Gap Map, which highlights where few or no recent, high-quality impact 
evaluations or systematic reviews exist on particular topics. Their report similarly 
observes that LGBTQ adolescents are a top group with weak programming 
evidence (Rankin et al., 2016). 
 
Given the remaining gap in evidence, the appraisal instrument can serve the NSP 
development process. National steering committees, setup to develop the plans, 
may request reviews of previous NSP using the appraisal instrument to learn 
about areas of weakness in evidence use and quality. The reviewers can then make 
recommendations to either improve evidence generation where there are gaps in 





Before signing a grant agreement, the Global Fund uses a Capacity Assessment 
Tool (CAT) to collect information and rate the capacity and systems in place to 
implement the grant, including monitoring and evaluation systems (The Global 
Fund, 2015).  While the CAT supports self-reporting on the strength of monitoring 
and evaluation systems, we believe the instrument developed in this study adds 
objective measures of the strength of NSP. Considering the strength of evidence 
used in NSP as an indicator of monitoring and evaluation performance, the 
appraisal instrument presented here can supplement the CAT, and support grant 
allocation decisions by the Global Fund. 
 
Funding decisions of many development agencies and donors, like the Global 
Fund, Global Alliance for Vaccines and Immunization, European Commission, and 
Millennium Challenge Account, are tied to evidence-based planning and 
interventions (The Global Fund, 2009). Meanwhile, donor funding for the HIV 
response is expected to decrease (The Kaiser Family Foundation & UNAIDS, 2013). 
As a result, the economic incentive to use evidence for planning will decrease in 
countries that rely on foreign aid for their HIV response. As countries move 
toward domestic financing of monitoring and evaluation, the influence of donors 
and development partners on the decision-making process are also expected to 
reduce.  Integration of HIV into the broader health sector also implies that some 
elements of HIV monitoring systems may become weak in the process, while 
sustainability of the overall Health and HIV response gain strength from 
integration. 
 
To maintain the gains in evidence-based planning, governments will need to 
remain vigilant in the generation and use of information for planning at policy, 
program, and facility levels. At the global level, the incentive for a continued use of 
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evidence could be created by including measures of evidence-based planning in 
international benchmarks of governance, which are set as targets in national 
development plans. Countries aiming to increase their governance score, in order 
to attract foreign investments, may set a strategy to improve the use of evidence-
based planning. In addition, by standardizing the indicators in the appraisal 
instrument across countries, development agencies and donors can better allocate 
resources to countries and domains based on evidence generation capacity and 
use. When considering incentives for evidence-based planning, the use of evidence 
as well as the effectiveness of those plans should be considered, in order to prevent 
situations of rewarding words without action. Evidence use, and its possible 
association with optimal decisions, in lower- and middle-income countries should 
also be compared with high-income countries (Nutbeam, 2004; Sanderson, 2009; K. 
Smith, 2013). 
 
The instrument developed in this study was assessed for its reliability and external 
validity. The significant correlations with indicators of regulatory quality, auditing 
and reporting, which rely on strong availability and use of evidence, validate the 
results seen in scoring of evidence use in NSP.  Although scores in the retest of the 
NSP differed slightly from the initial test, the direction and scale of the difference 
suggests that it is likely due to the rater becoming familiar with the NSP being 
rated. Therefore, the instrument can be said to be sufficiently reliable. 
 
The instrument developed in this chapter applies content analysis methods to 
review NSP. Since there are a number of existing tools that our instrument is built 
upon, we are not working from a completely naïve perspective that is the hallmark 
of conventional content analysis (Hsieh & Shannon, 2005). However, the approach 
of mapping existing tools to develop the instrument does come with the challenge 
of a bias toward the existing domains of evidence, and blinding the researcher 
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from other possible categories. Content analysis of the NSP provides basic insights 
on use of quality evidence, but there is no broader analysis of the context of the 
NSP. Therefore the results of the instrument rely on the credibility and reliability of 
the instrument and the users of the instrument. 
 
Due to resource limitations, only one individual, who was involved in the 
development of the instrument, rated the NSP in this study. While we strived to 
make the instrument objective in its assessment of evidence quality and use in 
NSP, we do not know if other raters would score the same NSP differently. The 
instrument ultimately depends on those who apply it to use it correctly to say to 
what extent quality evidence was used in the NSP.  
 
Our study considers the elements of evidence use in NSP, and involvement of 
practitioners and community members in NSP development, although it does not 
further investigate the representativeness of the evidence, use of the best available 
evidence, or critical assessment of the evidence, that would qualify it as 





Decision-making in the absence of evidence is not optimal. However, decision-
making with an abundance of evidence, criteria, and stakeholders is no simple task 
either. With numerous criteria for decision-making, policymakers have a 
challenging task of sorting through available information and making optimal 
decisions to achieve the desired health and social outcomes.  However, human 
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beings are limited in their ability to make rational decisions when confronted by an 
overload of scenarios. 
 
This chapter has identified a lack of evidence from evaluation and research in the 
NSP, which may benefit from better alignment in timing of evaluations with the 
national strategic planning process. While this chapter shows that available 
evidence is being used in planning, it cannot prove that optimal decisions are 
being made with the evidence.  Further longitudinal studies are needed to 
plausibly associate evidence use in NSP with optimal decisions. Moreover, 
evaluation is needed to see if implementation based on the NSP reflects the use of 
evidence in the NSP, and how well or poorly those plans perform when based on 
evidence, compared to ad-hoc planned interventions (Klein, 2000; Wye et al., 2015). 
To overcome the individual errors and also to ensure inter-rater agreement among 
raters, several raters should apply the instrument, and the consistency of their 
scores should be tested. 
 
The appraisal instrument in this chapter was only applied to national plans. 
However, the instrument may also be applied to agency specific plans to assess the 
level of use of evidence. Comparison of the use of evidence in planning by agencies 
can reveal the variations and consistency in breadth of evidence use, and 
characterize the evidence-based planning culture of agencies. The Country 
Operation Plan of the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) is 
one potential candidate for assessment of evidence use vis-à-vis evidence use in 
NSP (PEPFAR, 2015). 
 
Evaluation of the national planning process before and after an evidence 
generating activity could help identify barriers and enablers to evidence use at the 
national level. The appraisal instrument developed in this study may provide the 
 
 65 
metrics to measure change in evidence use in NSP.  Of interest is the effect of 
community ownership and involvement in evidence generation on the scale of its 
use in planning and policy making, particularly in countries identified as lacking 
evidence for key populations at risk of HIV. Actions along these lines could 
contribute to realizing the potential of evidence to improve quality of policy 




Chapter 4: Choices in Surveillance of HIV: 
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Estimation of the size of populations at high risk of HIV is a key activity in the 
surveillance of the HIV epidemic. The existing framework for considering future 
research needs may provide decision-makers with a basis for a fair process of 
deciding on the methods of the estimation of the size of key populations at risk of 
HIV. This study explores the extent to which stakeholders involved with 
population size estimation agree with this framework, and thus study updates the 
framework. 
 
We conducted 16 in-depth interviews with key informants from city and provincial 
governments, NGOs, research institutes, and the community of people at risk of 
HIV. Transcripts were analyzed and reviewed for significant statements pertaining 
to criteria.  Variations and agreement around criteria were analyzed, and emerging 
criteria were validated against the existing framework. 
 
Eleven themes emerged which are relevant to the estimation of the size of 
populations at risk of HIV in Viet Nam. Findings on missing criteria, inclusive 
participation, community perspectives and conflicting weight and direction of 
criteria provide insights for an improved framework for the prioritization of 
population size estimation methods.  
 
The findings suggest that the exclusion of community members from decision-
making on population size estimation methods in Viet Nam may affect the 
validity, use, and efficiency of the evidence generated. However, a wider group of 
decision-makers may introduce diverse definitions, weight and direction of 
criteria. Although findings here may not apply to every country, the principles of 
fair decision-making, value of community participation in decision-making and the 





Estimation of the size of populations at risk of HIV is a key activity in the 
surveillance of the HIV epidemic and management of the response. Key 
populations at risk of HIV include, but are not limited to, men who have sex with 
men, people who inject drugs, and sex workers. Estimation of the size of these key 
populations is used in three areas of a national HIV response: policy, intervention, 
and research. In the first area, policymakers use size estimation data to advocate 
for, mobilize resources for, and prioritize prevention and care programs targeted at 
key populations at risk of HIV. The second area concerns organizations involved in 
interventions for key populations at risk of HIV, such as providing clean needle 
and syringe distribution to people who inject drugs. These organizations need to 
know the size of their target population in order to plan for, and provide adequate 
services to particular sub-populations, and monitor the performance of their 
activities. In the third area, researchers make use of size estimates in evaluating the 
impact of interventions for key populations at risk of HIV on the overall HIV 
epidemic, and recommending ways to shift from pilot projects to achieving larger 
scale coverage of HIV prevention and care programs (UNAIDS, IMPACT, & FHI, 
2003; UNAIDS & WHO, 2010; Vandepitte et al., 2006). 
 
Viet Nam is a country with a concentrated HIV epidemic, with an estimated 0.4% 
prevalence of HIV among the adult population, an incidence of 0.21 per 1,000 
population, 8,600 AIDS-related deaths, and approximately 110,000 people living 
HIV receiving anti-retroviral treatment in 2015 (UNAIDS, 2015). HIV prevention, 
treatment, care and support services are managed nationally by the Viet Nam 
Administration of HIV/AIDS Prevention and Control in the Ministry of Health 
with support from multilateral agencies such as the Global Fund, and bilateral 
programs such as the United States President’s Emergency Plan for AIDS Relief 
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(PEPFAR) (Vietnam Ministry of Health, 2006). The HIV surveillance system in Viet 
Nam was established in the early 1990s collecting epidemiological and behavioral 
data (Viet Nam Ministry of Health, 2007; Vietnam Ministry of Health, 2006). 
Among the surveillance activities, a number of estimates of the size of key 
population at risk of HIV were attempted in Viet Nam (Hien, Long, & Huan, 2004; 
Nadol, 2012; Tuan, Tuan, Thanh, Quang, & Sabin, 2014). Some of these methods 
estimate the key at-risk population sizes based on a simple multiplier of the 
general population, using assumptions developed by the Viet Nam HIV estimates 
and projection technical working group (Nadol, 2012). Other methods use police 
census information or program data from the Ministry of Labor, Invalid and Social 
Affairs working with drug users to estimate the size of populations at risk of HIV 
(Hien et al., 2004; Nadol, 2012). More recently, capture-recapture and multiplier 
methods have been applied to estimate the size of populations at risk of HIV 
(Safarnejad, Nga, & Son, 2017; Tuan et al., 2014). Still other methods of key at-risk 
population size estimation with a number of design decisions exist that have not 
yet been tried in Viet Nam, such as the network scale-up method, the survey-
surveillance discrepancy method, or the “never married” method (Catania, 
Canchola, & Pollack, 2002; Marcus, Hickson, Weatherburn, & Schmidt, 2013; 
UNAIDS & WHO, 2010). 
 
The concurrent use of multiple methods of size estimation has been justified to 
validate and interpret the results (Abdul-Quader, Baughman, & Hladik, 2014; 
WHO, 2014a; Yu, Calleja, Zhao, Reddy, & Seguy, 2014). However, in transitioning 
economies like Viet Nam, where funding for HIV programs by donors is rapidly 
decreasing, and the increase in national funding is unable to keep pace to cover the 
funding gaps, difficult choices are faced in prioritizing HIV surveillance activities 
such as population size estimation. The limits to the magnitude of resources that 
can be spent on surveillance constrains the national HIV program’s ability to 
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conduct population size estimation studies with multiple concurrent methods 
(Magnani, Sabin, Saidel, & Heckathorn, 2005). 
 
Financial cost constraints are not the only force driving decisions in choice of 
population size estimation method. Decision-makers must also consider the social 
costs of their decisions related to the methods of surveillance (Center for Disease 
Control and Prevention, 2010; Lussier, Richard, Bennett, Williamson, & Nagpurkar, 
2012), and specifically methods of population size estimation (Herek, Capitanio, & 
Widaman, 2003; Herek, Kimmel, Amaro, & Melton, 1991; Matthews & Velleman, 
1997). Social costs can include for example perpetuation of stigma and 
discrimination toward marginalized groups, such as men who have sex with men, 
and people living with HIV (GNP+, 2016). For example, in examining the link 
between AIDS stigma and support for name-based reporting, Herek et al. highlight 
that such policies in surveillance “may evoke anxiety and encounter resistance to 
the extent that it is perceived as insensitive to – or even fostering – preexisting 
AIDS stigma” (Herek et al., 2003).  
 
As decision-makers are being confined to deciding on the “right” size estimation 
method (Vadivoo et al., 2008), fair and explicit consideration of a broad set of 
criteria for prioritization of population size estimation methods becomes 
imperative. A number of comprehensive approaches exist for health program and 
research priority setting that define procedures for eliciting criteria and dealing 
with conflicting criteria (Rudan et al., 2010). Accountability for Reasonableness 
(A4R), Combined Approach Matrix (CAM), and Interactive Technology 
Assessment (iTA) are examples of such approaches (Daniels & Sabin, 2000; 
Ghaffar, Collins, Matlin, & Olifson, 2009; Grin, Graaf, & Hoppe, 1997). Essential 
National Health Research (ENHR) and the Council on Health Research for 
Development (COHRED) also provide guidance which has been used in 
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prioritizing health research in developing countries (Montorzi, Haan, & 
IJsselmuiden, 2010; Okello, Chongtrakul, & The COHRED Working Group on 
Priority Setting, 2000; Rudan et al., 2010). 
 
Despite availability of these approaches many health priority setting exercises 
develop their own, unique methods, because of contextual particularities of 
priority setting (Viergever et al., 2010). The Framework for Considering Study 
Designs for Future Research Needs developed by the Agency for Healthcare 
Research and Quality (AHRQ) is one framework that specifically considers 
different study designs for future research needs (Carey et al., 2012). The AHRQ 
framework is intended to standardize the terminology and process in prioritizing 
health research. The two salient features of the AHRQ framework that distinguish 
it from the aforementioned health priority setting approaches and make it 
appropriate for use in this study, are the focus on prioritizing both research and 
methods of research, and the explicit articulation of criteria related to the selection 
of research design and methods. In a series of methods papers, AHRQ 
recommends some criteria and procedures for consistent application in the 
selection of research design for future research needs (Andrews, 2013; O’Haire et 
al., 2011). The framework is not intended to be prescriptive, and it lacks a clear 
description of stakeholder involvement in deliberations, or processes to deal with 
conflicts and dependencies of criteria. Although the framework has been 
successfully used in the United States, to our knowledge it has not been applied in 
developing countries. This framework can potentially be relevant for evaluating 
the appropriateness of the design of a study focused on size estimation in Viet 
Nam. 
 
The use of the AHRQ framework is more so appropriate for Viet Nam as it can 
help to improve accountability and participation in Viet Nam’s HIV Strategy and 
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HIV surveillance activities including population size estimation (National 
Committee for AIDS Drug and Prostitution Prevention and Control, 2012; Viet 
Nam Administration of HIV/AIDS Control, 2007). Participation of multiple 
stakeholders (including members of the community who have a stake in the 
decisions made) to elicit explicit and transparent criteria that play a part in making 
decisions, is a precondition for a fair priority setting process (Daniels & Sabin, 
1997, 2000). Involvement of multiple stakeholders in decision-making processes is 
grounded in democratic theory (Abelson, Forest, et al., 2003; Scheer, Garcia, Laan, 
Burg, & Boenink, 2014; UNAIDS, 2010a) and the constructivist tradition (Leys, 
2003). The process of research priority setting frequently engages researchers and 
government but meaningful involvement of other key stakeholders are less 
frequent (McGregor, Henderson, & Kaldor, 2014; Tromp, Prawiranegara, Subhan 
Riparev, et al., 2015). A recent review of 27 national HIV plans found that only 9 
plans had specified the community group or civil society involved in the planning 
process (Chapter 3). One reason for limited participation of these stakeholders in 
decision-making processes is the risk of not reaching consensus, which may lead to 
less acceptance and trust in the results. Another reason for the limited 
stakeholders’ participation is that stakeholders, particularly non-expert members 
of the community, often perceive their values and arguments are not properly 
considered in national HIV plans. 
 
The AHRQ framework may provide a basis for a fair process of deciding on the 
HIV surveillance methods including methods of estimation of the size of key 
populations at risk of HIV. This study aims to explore the extent to which diverse 
stakeholders involved with HIV surveillance agree with the AHRQ framework. In 
doing so, we will update the framework, and contextualize it for the problem of 
deciding on a method of size estimation for key populations at risk of HIV in Viet 
Nam. An updated framework based on a wide stakeholder involvement will 
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facilitate its use in a fair decision-making process, conforming to the A4R 
framework (Daniels & Sabin, 1997, 2000). Findings of this study may give other 
transitioning-economy countries insights into relevant criteria for prioritization of 
population size estimation methods among other HIV surveillance activities and 





We designed a qualitative study to capture various perspectives of the size 
estimation process, including selection of appropriate method, implementation of 
the method, and use of the generated evidence. The study took place in 2015 in Ho 
Chi Minh City and Vinh City. Ho Chi Minh City is a highly urbanized city, with 
the largest population in Viet Nam (7,123,340 inhabitants in 2009) (Vietnam 
Ministry of Planning and Investment & UNFPA, 2010), whereas Vinh City is a 
provincial city of 230,000 inhabitants and it is considered to be one of the poorest 
cities in Viet Nam (Sustainable Cities Programme, United Nations Human 
Settlements Programme, & United Nations Environment Programme, 2002). The 
data collection method of the study was in-depth interviews with key informants 
who were previously involved in population size estimation studies. 
 
Key informants 
The study used a purposive, non-random sampling strategy. Since there is no 
hypothesis being tested and no associated level of confidence in any test results in 
this study, the number of key informants was not specifically pre-defined. The 
focus was on reaching as many informants as possible within a pre-defined period. 
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The key informants were selected through personal contacts based on criteria of 
availability, subject matter knowledge, and representation of the diversity of 
stakeholders. In each city, we intended to identify one health program manager 
representing the Provincial AIDS Program, one technical expert from an NGO or 
research institute involved in surveillance, and one individual from the community 
of people at risk of HIV in Viet Nam. The motivation behind selecting these three 
groups was that they encompass the actors who have a stake in the decision-
making in surveillance activities, including population size estimations, at the 
provincial level in Viet Nam. These three groups - representing government, 
research and development partners, and community members - are referenced by 
the Greater Involvement of People Living with HIV principle formalized at the 
1994 Paris AIDS Summit, and also reflect the membership structure of the Country 
Coordinating Mechanism of the Global Fund at the central level (GFATM, 2013; 
Joint United Nations Programme on HIV/AIDS, 1999). 
 
As this qualitative study ran concurrently with a size estimation demonstration 
pilot, participants in that study facilitated the selection of key informants for this 
study. Following the first interviews, the key informants were asked to nominate 
other candidates from their organization or network to be interviewed. We asked 
the key informants to suggest individuals who would be representative of their 
peers and who would be likely to speak candidly with us. No individuals refused 
to participate. We completed 16 in-depth interviews in total. 
 
Data collection 
Verbal and written information about the study were given to each potential key 
informant. Participation was voluntary and the respondents were informed that 
they could withdraw at any time and that all data would be treated confidentially. 
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Individual verbal informed consent was obtained from the participant at the 
beginning of each interview. The survey protocol and instrument material used in 
this study, and the concurrent population size estimation pilot, were reviewed and 
approved by the Institutional Review Board of the Hanoi School of Public Health 
(Hanoi, Viet Nam). An interview guide with open-ended questions aided the focus 
of the interviews (see Appendix G for an outline of the topics and probing 
questions). There is flexibility in the interview guide to offer space for key 
informants to raise other issues that they might consider to be pertinent. A table 
describing the methods of size estimation and the acknowledged strengths and 
weakness along common criteria established by standards setting bodies, was 
introduced to the key informants to aid the interviews (Appendix H). All 
interviews were conducted in Vietnamese and later transcribed in English. 
 
The interviews followed an informal format. Pre-defined questions in the interview 
guide directed the conversation to those topics that matter to the study, while ad 
hoc questions followed the direction of the conversation. The interviews were 
conducted while interviewer and key informant were seated at a public or private 
location chosen by the key informant. The procedures and setting, and the existing 
relationships of the research team with the key informants made the interviews 
similar to a ‘conversation with a purpose’ (Burgess, 1984; Carpiano, 2009). The 
approach created an open situation in which experiences and perceptions (positive 
and negative) could be openly shared, without the key informants fearing they 
were being too critical. However, all respondents were assured of the 
confidentiality of the data and that the interviews are intended to be a non-
judgmental but formative learning opportunities. 
 
Trained investigators with experience in in-depth interviewing for qualitative 
research conducted the interviews. Interviews lasted from 30 to 90 minutes. All 
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interviews were conducted in person and audio recorded (with the key informants’ 
consent) and were transcribed verbatim. The transcripts were translated to English 
by the interviewers. Interviews were conducted in August-November, 2015. The 
authors’ experience and observation as a participant in discussions and decisions 
on methods of surveillance were also used as an input to the exploration of the 
research questions in this study. 
 
Analysis 
Transcripts were analyzed according to qualitative research guidelines. Transcripts 
were read several times by one investigator to search for and code the key 
informant’s most significant statements pertaining to criteria. The emerging codes 
were recorded in a codebook, which included a compilation of the codes, 
illustrative quotes attributed to respondent profiles, and statements that guided the 
use of the code. Codes that seemed to have similarities were grouped into thematic 
patterns based on the consensus of all three investigators. Disagreements about 
grouping of codes into thematic patterns were resolved through a discussion until 
consensus was reached. There were no occasions that consensus could not be 
reached. The emerging themes were documented and maintained as a permanent 
record of our analysis progress. These steps were repeated until no new themes 
emerged. Criteria for choosing the population size estimation methods were 
extracted from the emerging themes, arrayed by the profiles of the key informants. 
This combined process allowed us to compare and contrast themes within and 
between the different key informant profiles and different sites. Comparison and 
contrast of views of themes between key informants also involved identifying 
sources of variation or agreement. Emerging criteria were validated against the 






In-depth interviews were carried out with 16 key informants. There were five key 
informants representing the government, three key informants representing NGOs 
and research institutes, and eight key informants representing the community of 
people at risk of HIV. There were an equal number of key informants participating 
from Vinh City and Ho Chi Minh City. Information on location of key informant 
interviews and their group membership is provided in Table 4.1. 
 
Table 4.1 Key informants location of interview and group 
membership 
Key informant Location of interview Group membership 
1 Vinh City Government 
2 Vinh City Government 
3 Vinh City Government 
4 Vinh City NGO/Research Institute 
5 Vinh City NGO/Research Institute 
6 Vinh City Community 
7 Vinh City Community 
8 Vinh City Community 
9 Ho Chi Minh City Government 
10 Ho Chi Minh City Government 
11 Ho Chi Minh City NGO/Research Institute 
12 Ho Chi Minh City Community 
13 Ho Chi Minh City Community 
14 Ho Chi Minh City Community 
15 Ho Chi Minh City Community 
16 Ho Chi Minh City Community 
 
 
In the analysis of the data collected in the interviews, 11 themes emerged as having 
particular relevance to the process of selecting the method for the estimation of the 
 
 78 
size of populations at risk of HIV. Table 4.2 summarizes the 11 emerging criteria 
theme and how they relate to the criteria in the AHRQ framework. In the following 
sections, for each criteria theme, we present the summary of findings, along with 
quotations from key informants that express common views or concepts. The 
criteria themes are ordered alphabetically for easier reference. 
 
Appropriate for the community 
Key informants shared several concerns that were grouped under the appropriate 
for the community criterion. Less than half of all key informants interviewed 
mentioned this criterion (n=7). But within the sub-group of eight key informants, 
who are also at-risk population community members, the majority mentioned this 
criterion (n=6). The most common concerns were about methods that make the 
subjects in size estimation studies feel uncomfortable and stigmatized. For 
example, strangers calling gay individuals at their home and asking detailed 
questions about their sexual behavior. Another concern was about the type and 
value of incentives given to participants in population size studies. One key 
informant talking about incentives given to people who inject drug to participate 
in surveys said, “they don’t want mobile phone credit, they want money”. When 
asked why they want money, the key informant said, “to buy their next dose of 
drug.” The question of what is appropriate for the community to ensure participation 
in the population size estimation remains a valid criterion to consider alongside 
others. This criterion is closely linked with the community participation criterion (see 
below), in that the involvement of peers in the studies helps to avoid the situation 

















































































































































































































































































































































































The importance of the participation of the community in size estimation studies 
was reiterated by most of the key informants (n=13), including three participants 
from the government, two participants from NGOs and research institutes, and 
eight participants from the community of people at risk of HIV. They cited 
examples of recruiting peer-educators to help identify hotspots, building 
relationships with establishment workers to allow access to interview the at-risk 
populations, and working with local authorities to triangulate data for improved 
accuracy. The latter involvement of local authorities also helps to reassure 
participants in size estimation studies about the legality of the study, which was 
cited by one key informant as a common concern particularly in provinces. 
Community participation is also a means to ensure learning for the community, 
which is linked to the sustainability and repeatability and long-term cost-
effectiveness of the study methods. Five key informants, all of whom came from 
the community of people at risk of HIV, considered community learning as an 
important aim of community participation. 
 
It is not just the relations and networks that matter in population size estimation 
studies, but also the reputation of the investigators. The key informants told us that 
when participants in studies trusted the investigators, they were more forthcoming 
and honest, and complete in their disclosure. Trusted members of the community 
are privileged to receive unadulterated information from their peers, which helps 
to generate accurate and reliable size estimates. 
 
Communities of key populations, like any social networks, are not symmetrically 
connected, and members of the community vary in the strength of their ties. Local 
knowledge about the “sociometric stars” (individuals whose high regard among 
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their peers enables them to recruit their peers (Wejnert & Heckathorn, 2008)) and 
hidden community members increases the speed of reaching the desired number 
of participants in size estimation studies, as well as the reach of the study to a 
diverse range of community members. One key informant however, refuted the 
notion of community participation to improve recruitability, saying that “hidden 
populations never take part in community activities”, so the involvement of 
community peers and social networks do not amount to universal recruitability. 
 
Confidentiality 
While nine key informants considered confidentiality as a criterion in the selection 
of methods for size estimation, most of those key informants were at-risk 
population community members (n=6). The level of confidentiality they mentioned 
ranged from total anonymity to discretion. One key informant contextualized the 
confidentiality issue in relation to the level of stigma in the region where studies 
are conducted: “In Ho Chi Minh City, confidentiality is not a big deal but in non-
urban areas where stigma is high, people might not want to leave phone 
numbers.” Another key informant said that providing personal information had 
also to do with the self-stigma: “ones who are ‘closed status’ will not provide it”, 
referring to those who are not open with their friends and family about their 
homosexuality, HIV status, or other socially stigmatized status. Key informants 
familiar with self-administered surveys noted that the privacy and confidentiality 
inherent in self-administered surveys improved the data accuracy by reducing 
social desirability bias that are more prevalent in face-to-face surveys. 
 
Contrary to the sentiments that confidentiality should be a criterion, one key 
informant experienced in implementing size estimation studies, noted that “people 
report to local government authorities if they are asked to take part in a survey. 
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They want reassurances”. In other words, attempts to keep the survey confidential 
are futile, because people are afraid they are doing something illegal. This implies 
that confidential surveys may conflict with the criterion of feasibility (see below). 
 
Cost/Resources 
More than one half of the key informants had something to say about costs and 
resources required for population size estimation (n=9), including five participants 
from the government, three participants from NGOs and research institutes, and 
one participant from the community of people at risk of HIV. The views on 
cost/resources varied widely among participants. One thought that cost should be 
the last criterion, while another placed it as the main criterion, preferring a low-
cost method. One key informant addressed the concerns about cost by suggesting: 
“method should have flexibility to keep costs down by using volunteers”. Another 
key informant refuted the idea, giving an example of their experience using 
student volunteers: “One year we used students to do mapping. They could not 
identify the correct location of drug users or sex workers. Where there were drug 
users, they said no. Where there were many females but it turns out they were not 
female sex workers”. The key informant went on to propose enlisting the help of 
community members, drug users turned peer-educators, in the size estimation 
studies. Another key informant further qualified this proposal by suggesting that 
“quality and number of staff with adequate capacity” should be considered when 
estimating resource needs.  
 
Data validity 
Data validity, expressed as reliability and accuracy of data, was the most 
frequently cited criterion in considering the methods of population size estimation 
(n=13). There was little divergence in terms of how accurate the generated data 
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should be. Several key informants talked about “acceptable”, “adequate”, and 
“reasonable” data validity (n=3). One key informant said, “70 to 80 percent 
accuracy is good enough; doesn’t need to be 100 percent accurate”. Another key 
informant affirmed this opinion, saying “just get closer to the truth”. 
 
There was more divergence in how important the data validity criterion is vis-à-vis 
other criteria. Some key informants considered it a sub-criterion of cost/resources 
(n=4). “Given available resources, we should aim to produce good results. If 
resources are limited, we should aim to produce adequate results” one key 
informant explained. Another key informant stated that data accuracy depended 




Half of the key informants expressed some preferences - either longer or shorter – 
for the duration of size estimation studies (n=8). One key informant reasoned that 
“time required for implementation should be short, so that the estimates can be 
repeated often for update of the data”, suggesting that repeating the exercise over 
and over again will reinforce the reliability of the data. A key informant who had 
also been a participant in a recent size estimation study of men-having-sex-with-
men, had a different perspective: “[they] like the quick-to-fill surveys, though it is 
probably skipping many additional questions that would improve reliability”. 
Both key informants ultimately agreed that reliability was the desired outcome, 
despite duration of the study. 
 
Other differences on duration were around the accuracy of short duration studies. 
“Time for census should be increased to identify if a person is from [this province] 
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or here temporarily” said one key informant, while another pointed out: “seasonal 
nature of sex work makes some methods inaccurate, because of extended time 
required for the method”. However, they conceded that longer duration studies 
came at higher cost as well. A critical perspective of duration as a criterion came 
from a key informant who considered it “a sub-criterion after considering the 
urgency of the data needed.” 
 
Equity 
A few key informants made references to the differences in the applicability of the 
population size estimation methods in different geographical areas: rural versus 
urban areas (n=4). The most frequent reasons included geographic grouping of key 
populations in hotspots, more prevalent use of Internet and mobile devices in 
urban areas, and better roads and access in cities than rural mountainous 
provinces. Not all opinions however favored urban environments, with one key 
informant saying: “rural studies are easier; people are more likely to answer 
honestly”. 
 
Two key informants invoked the differences in the methods’ ability to work for 
different key populations. Methods that rely on recognition or identification of 
hotspots were questioned for particular key populations: “Female sex workers are 
easier to recognize, gather in hotspots; men who have sex with men use social 
networks, so reach is less costly” one key informant stated. 
 
Age of people at risk of HIV also factored into the size estimation methods’ 
equitable application to all populations. Community activism is relatively new in 
Viet Nam, so younger gay men are more involved with the LGBT community and 
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therefore it is easier to recruit their help in size estimation studies when the study 
aims are aligned with community aims. 
 
Feasibility 
All factors that are external to the methods of size estimation, such as the 
environment and history, which affect the decision to select one method over 
another are considered issues of feasibility. Two recurrent external factors 
mentioned in the interviews were ‘willingness to participate’ and ‘structures in 
place’. These factors were merged to develop the criterion of feasibility. Majority of 
key informants mentioned this criterion (n=12), including all at-risk population 
community members who were interviewed (n=8). 
 
For two key informants, the notion of ‘willingness to participate’ stemmed from 
the at-risk population’s sense of community and civil duty towards that 
community.  That is, the stronger the sense of community among the members, the 
more willing they would be to participate in the size estimation studies, thus 
making the study more feasible (see criterion on Community Participation). Key 
informants also noted ‘convenience for participants’ as a factor in determining the 
willingness to participate (n=4). This convenience was both in terms of how easy 
the questions in the surveys would be to answer, but also how convenient the 
process would be for participation. An online survey for example would be easier 
to organize for participants and investigators, than a face-to-face interview that 
would require organizing a convenient time and place for both. 
 
Key informants mentioned that ‘stigmatized subjects’ and ‘survey fatigue’ are two 
deterrents to the participation in size estimation mentioned (n=4). In the former 
case, one key informant said: “if the theme is sensitive and involves stigma, it is 
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difficult to do”.  In the latter case, survey fatigue is a result of a long history and 
large volume of surveys and surveillance activities – often without the 
involvement of the community – that has diminished the ability of new surveys to 
recruit participants, and therefore diminishes the feasibility of future size estimation 
studies. 
 
Key informants frequently talked about ‘structures in place’ that make size 
estimation studies more feasible (n=8). Key structures elicited in the interviews 
included technologies, like Internet and mobile network access, to facilitate 
surveys. Other structures in place included key population gathering hotspots, 
social networks of key populations, and physical infrastructure such as roads to 
reach rural mountainous provinces. Experienced investigators were also noted as 
making a positive contribution to the feasibility of study methods. In the absence of 
these structures in place, the choice of methods for size estimation diminishes 
along with the feasibility of the study methods. 
 
Impression of method 
One of the themes that developed in the interviews, and the third most frequently 
cited criterion, was around the impressions that the key informants held about the 
method of size estimation, and how that impression affected their choice of 
method (n=10). In reference to various methods, the key informants used phrases 
like “sense of seriousness”, “seems exclusive”, “seems rigorous”, “more 
professional”, “have confidence in”, “state-of-art”, and “novel”. In probing the key 
informants, one said “people like things related to technology”, in reference to 
novel methods of using social media for size estimation. The impression of 
“exclusiveness” was explained by another key informants as being created by 
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disqualifying some respondents: “I was surprised by the limited number of 
invitees”, one said, “not like the typical poll created online”. 
 
The most compelling explanation came from a key informant who explained the 
criterion from the perspective of decision-makers: “simple methods are often seen 
with skepticism, whereas more complicated methods carry more weight. 
Perception of people about the method matters. Sometimes people prefer more 
complicated methods, because it sounds more scientific and so it must produce 
better results. A method that involves simple counting might be suspected to be 
too easy to be true. Sometimes, in order to get buy-in, we may need to rely on more 
complicated methods.” 
 
The impression that the key informants had of a method was clearly a criterion for 
the selection of that method. Novel methods were positively considered by the key 
informants. This novelty of method addresses survey fatigue, increases interest 
and recruitment of participants, and improves acceptance of results by 
stakeholders. However, two key informants who had been involved in recent size 
estimations as investigators recalled “the novelty of the method made it a painful 
process”, and felt “anxious” about getting results. Novel methods also lacked the 
historical data to validate the reliability of their results. 
 
Repeatability 
A criterion that is closely linked to, but distinct from the community participation 
and cost criteria in choice of population size estimation is the repeatability of the 
method. Only one key informant mentioned this criterion. It speaks about 
sustainability and the long-term cost-effectiveness of a method as the community 
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learns how it works and applies it using volunteers in the community. As the key 
informant put it, a method that “people can learn and do it later”. 
 
Risk 
An important but seldom mentioned criterion was the dependence of the methods 
on uncontrollable factors (n=1). This theme emerged from a conversation with one 
key informant who was involved in a recent respondent driven sampling survey, 
where referrals were trickling in too slowly and jeopardizing the validity of the 
results, and also increasing the overall cost of running the study. Methods of 
population size estimation that use respondent driven sampling carry more 
uncertainty because they depend on people’s willingness to refer. This uncertainty 





We explored the perspectives of multiple stakeholders in Viet Nam who were 
previously involved in population size estimation studies, on criteria relevant to 
selecting methods of population size estimation for surveillance of HIV epidemic, 
and the extent to which these criteria agree with the AHRQ framework for 
Considering Study Designs for Future Research Needs (Carey et al., 2012). Our 
findings are consistent with the AHRQ framework, but our work further clarifies 
the dimensions of this framework when applied to population size estimation 
methods, and extends it to include three newly identified criteria: repeatability, risk, 
and equity. The latter equity criterion was defined in terms of methods that are 
appropriate for different age groups, at-risk populations, and urban/rural settings. 
The addition of these criteria to the AHRQ framework will increase its breadth and 
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relevance to the prioritization of methods for estimation of size of populations at 
risk of HIV. 
 
In addition to the new criteria identified, it is important to note that some other 
criteria would have been missed if the study did not include a diverse group of 
stakeholders. While all key informants from the government, NGOs and research 
institutes considered cost an important criterion, only one key informant from the 
community of people at risk of HIV thought this criterion was important. 
Conversely, community participation was considered a criterion by the majority of 
key informants, but no key informants from the government, NGOs and research 
institutes saw it as an opportunity for community learning. Our findings illustrate 
the dichotomy of views of stakeholders on criteria for prioritization of methods of 
size estimation, and underlines the importance of an inclusive and interactive 
process that considers the opinion of technical experts, health managers, but also 
the community that is the beneficiary of the evidence-based services (Grin et al., 
1997; Ham & Coulter, 2001; Vuorenkoski, Toiviainen, & Hemminki, 2008). An 
important implication of this finding at the national level is the need for inclusive 
decision-making that involves the community. While participation of community 
members in strategic planning of the HIV response in Viet Nam is affirmed 
(National Committee for AIDS Drug and Prostitution Prevention and Control, 
2012; Viet Nam Administration of HIV/AIDS Control, 2007), their participation in 
technical and scientific decisions like those of population size estimation methods 
must also be supported. This ”democratization of expertise” may well require 
investments in technical literacy of community based organizations to strengthen 
their role in decision-making or grass-roots movements for community-driven 
policies in research, science and technology (Beeker, Guenther-Grey, & Raj, 1998; 




Among criteria elicited by multiple key informants from diverse groups, 
perspectives of how a criterion is defined sometimes diverged significantly. 
Feasibility, for example, is a criterion that is often elicited in research prioritization 
(McGregor et al., 2014; Montorzi et al., 2010; Okello et al., 2000).  In our 
conversations, key informants from the government, NGOs and research institutes 
defined feasibility in terms of structural enablers in place to support the method, 
such as mobile telephone technology, roads to get to remote villages, and 
experienced investigators.  We call this the systems perspective of the criteria. Key 
informants from the community of people at risk of HIV, clarified feasibility in 
terms of the individual recruits’ willingness to participate in the size estimation 
studies – due to convenience of participation, interest in the novelty of the method 
and the learning opportunity, and a sense of community or civil duty to their 
community. We call this perspective the community perspective of the criteria. 
Another instance in our study where the community and system perspectives are 
evident, is in the discussions around duration. One key informant spoke about 
duration from the perspective of an individual survey taker (community 
perspective), while another took the perspective of the entire duration of a size 
estimation study (system perspective). Our study points out the importance of this 
dual perspective to help decision-makers derive a more complete and legitimate 
definition of the criteria. 
 
Moreover, the findings suggest that feasibility of some methods may depend as 
much on the systems and structures in place, as it does on the strength of ties 
within the community of participants who are the subjects of the study. In line 
with the recommendations of Johnston et al. (Johnston, Whitehead, Simic-Lawson, 
& Kendall, 2010), our findings point out a specific need for better evidence about 
the strength of ties within the community, as an indicator of their willingness to 
participate in population size estimation studies. The strength of ties can be 
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measured for example by conducting a survey in the community, recruiting 
participants through RDS, and asking respondents to grade their relationship with 
the person who referred them using profiles of relationships developed by Spencer 
and Pahl (Spencer & Pahl, 2006) or using Dunbar’s theoretical boundaries of social 
contacts (Dunbar, 2011). 
 
Where there was agreement on the definition of criteria, key informants sometimes 
differed in how important they considered one criterion vis-à-vis others. In 
prioritization frameworks, these relative differences are called the weight of the 
criteria (Marsh et al., 2016; Marsh, Lanitis, Neasham, Orfanos, & Caro, 2014). 
Another crosscutting theme that emerges in reviewing the criteria elicited in this 
study is that there were differences among the key informants about the direction 
of some criteria.  These differences were sometimes considerably varying, with 
some key informants seeing a criterion as a positive factor for selecting a method, 
and others seeing it in a negative light. Criteria that exhibited these differences in 
weight and direction include confidentiality, cost/resources, data validity, duration, 
equity and impressions of method. The weight and direction of criteria affect the 
priorities in methods of population size estimation when the criteria are applied. A 
number of structured procedures exist to quantifying the criteria weights and 
directions of the criteria. Such procedures include discrete choice experiments, 
conjoint analysis, ranking and rating of criteria (Marsh et al., 2016, 2014). These 
procedures would be an important addition to the AHRQ framework to prioritize 
methods of population size estimation. 
 
The findings above on missing criteria, inclusive participation, community 
perspectives and conflicting weight and direction of criteria, provide insights that 
help us improve the AHRQ framework in its application to the prioritization of 
population size estimation methods. These findings underline the importance of 
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inclusion of diverse group of stakeholders, particularly the community of people at 
risk of HIV. These findings and recommendations are also in line with the 
expectations of the authors of the AHRQ framework for it to be refined and 
contextualized in the future (Carey et al., 2012).  
 
To our knowledge, at the time of this study there is no known application of the 
AHRQ framework in developing country settings or to HIV surveillance. This 
study furthers our understanding of methodological issues that may be faced in 
applying the framework. Comparison of the study findings in Viet Nam, to best 
practices found in literature, allows us to provide a number of suggestions to 
clarify the role of stakeholders in the priority setting process: 
 
First, our results showed a number of potential conflicts and dependencies 
between criteria identified. For example, two key informants in our study had 
different definitions of the duration criterion, but ultimately agreed that reliability 
was the desired outcome. Youngkong et al., who conducted a systematic review of 
health care priority setting in low-income countries, posit that differences in 
definitions of criteria may be dependent on culture and perspectives of the 
stakeholders (Youngkong et al., 2009). They predict that in joint discussions with 
relevant stakeholders a more suitable set of criteria may be obtained. Guidance on 
multi-criteria decision-making recommends focusing the group discussion on 
organizing criteria into a hierarchical structure, and combining criteria when there 
is potential redundancy and decomposing criteria when alternative definitions of 
criteria are elicited (Mabin & Beattie, 2006). This process of representing the 
decision analysis jointly is believed to have an indirect value in raising 




Second, our results showed potentially different weight and directions assigned to 
the criteria by a group of stakeholders. Kerr and Tindale have discussed the use of 
a number of approaches to group decision-making (Kerr & Tindale, 2004). Perez et 
al present use of fuzzy set theory to model and deal with vague or imprecise 
options, alternatives, and opinions of several decision-makers (Pérez, Wikström, 
Mezei, Carlsson, & Herrera-Viedma, 2013). Shukla and Auriel suggest a framework 
for conducting criteria weight analysis under multi-stakeholder scenarios, but with 
an emphasis on transparency, avoidance of conflicts, low cognitive load, and 
taking into account multiple decision-makers with different perception of criteria 
(Shukla, Auriol, & Hipel, 2016). It is the latter approach that we recommend for the 
management of diverse definitions, weight and directions of criteria when a wider 
group of decision-makers, including community members, are consulted in 
decisions on population size estimation methods. 
 
The primary aim of this study, like other qualitative research, is to provide a rich, 
contextual understanding and not to generalize results, so representative 
samplings is not as important as the ability of the selected participants to provide 
their diverse perspectives (Horsburgh, 2003; Leung, 2015; Polit & Beck, 2010). 
Nevertheless, the depth and coverage of those perspectives on population size 
estimation methods is limited in our study by the time allowed with few key 
informants in few locations, and how the key informants were selected. We tried to 
overcome the limitation in the external validity of our study by employing the four 
strategies recommended by Sharan Merriam (Merriam, 1995). These include (1) 
providing enough details in our study so that readers can determine how closely 
their situation matches it, (2) using multiple sites to allow for application to a 
greater range of similar situations, (3) comparing the specific criteria in this study 
to the broader criteria of health research in the AHRQ framework, and (4) 
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sampling within the key informants to ensure representation of the relevant three 
stakeholder groups. 
 
The AHRQ framework was selected for this study because it provided us with a 
standardize terminology, fair process, and basic set of criteria to compare against 
our findings in Viet Nam. Although there is a lack of application of the framework 
outside of the United States, an aim of this study was precisely the applicability 
and relevance of this framework to decisions on methods of size estimation for key 
populations at risk of HIV in Viet Nam. 
 
Another limitation of this study was that no focus group discussions were 
conducted. Without a debate to test the strength of opinions of key informants on 
any particular subject, vis-à-vis their peers, we cannot be certain how strongly 
individuals believe in their opinions. On the other hand, the in-depth interview 
format did allow some valid, but less popular, points of view to be exposed. The 
selection of key informants was through introductions from the seed key 
informants. It is possible that key informants refer individuals similar to 
themselves in perspectives and experience. However, private interviews with the 
key informants, and conducting interviews in two separate cities, help to ensure 
the independence and trustworthiness of the results. 
 
We intended to identify and interview a diversity of key informants, both 
geographically and also in their representation of key stakeholder groups. We 
succeeded in recruiting equal number of participants from Ho Chi Minh City and 
Vinh City. In terms of representation of the three key stakeholder groups, there 
were fewer representatives from NGOs and research institutes, and greater 
representation from the community members, due to their availability at the time 
of the interviews. This could have led to some skewing of relevant criteria in our 
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results toward the community perspective. However, the comparison of the criteria 
elicited in this study to the criteria in the AHRQ framework gives some external 
validation of the results. 
 
In the analysis of the interviews all three investigators were involved in the 
categorization and thematic grouping of codes. However, only one investigator 
codified the transcripts. While multiple coders would have added rigor and 
richness to the results, it would have required far more time to review the 
transcripts and reconcile the codes generated. Having one investigator coding the 





Findings of this study suggest that exclusion of community members from 
decision-making around key at-risk population size estimation methods in Viet 
Nam may be contributing to reduced validity, use, and efficiency in evidence 
generated from these types of surveillance activity. A wider group of decision-
makers, including community members among others, may introduce diverse 
definitions, weight and direction of criteria. Based on these findings, and best 
practices in the decision-making literature we developed a number of 
recommendations to update and contextualize the AHRQ framework to decisions 
around HIV surveillance and population size estimation in Viet Nam. 
 
For Viet Nam, we think the AHRQ framework does not have all the criteria that 
are relevant to stakeholders, and these criteria should be added and considered in 
future studies. We also suggest using the dual “systems perspective” and 
“community perspective” help clarify the different definitions of common criteria. 
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When these two perspectives are conflicting, we recommend a process of 
organizing criteria into a hierarchical structure jointly with relevant stakeholders, 
and conducting a criteria weight analysis under a multi-stakeholder scenario. 
 
The lessons from Viet Nam may not apply to every country with a transitioning 
economy. And the lessons from the HIV response may not apply to every 
emerging epidemic. However, some of the principles of fair decision-making, 
value of community participations in decision-making and the expected challenges 
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With the decline in funding for Viet Nam’s HIV response, there is a need for 
prioritizing a package of interventions in an HIV programs, although there is a gap 
in the research on the relative importance of multiple criteria for that prioritization. 
This study elicits preferences and the trade-offs made between different HIV 
programs by stakeholders and decision-makers in Viet Nam, while paying 
attention to how social and professional characteristics shape their preferences. 
 
This study uses self-explicated ranking and discrete choice experiments to 
determine the relative importance of five criteria - effectiveness, feasibility, cost-
effectiveness, rate of investment and prevention/treatment investment ratio - when 
stakeholders evaluate and select hypothetical HIV programs. 
 
Our findings show that the feasibility criterion is more important to participants 
when they choose an HIV program, than other criteria. The participant’s 
professional characteristics have a significant effect on the importance of some 
criteria. In the self-explicated ranking effectiveness ranks highest and the cost-
effectiveness criterion ranks low in importance across all groups.  
 
This study has shown that the preferred HIV program in Viet Nam is feasible, 
front-loaded for sustainability, has a higher proportion of investment on 
prevention, saves more lives and prevents more infections. Similarities in 
government and civil society rankings of criteria are grounds for future policy 





The first case of HIV infection in Viet Nam was reported in December 1990 in Ho 
Chi Minh City. By December 2003, 76,180 infections were reported in Viet Nam 
and 6,550 people had died of AIDS related causes (General Statistical Office at the 
National Institute of Hygiene and Epidemiology/Vietnam and ORC Macro, 2006; 
The Government of the Socialist Republic of Viet Nam, 2004). By December 2015, 
there were 255,000 people living with HIV and over 128,000 people had died from 
AIDS-related illnesses since the start of the epidemic (UNAIDS, 2015). 
 
Viet Nam’s HIV epidemic is concentrated among three key population groups 
defined by risk behaviors and a high prevalence of HIV: people who inject drugs, 
men who have sex with men and female sex workers (Vietnam Authority of 
HIV/AIDS Control, 2013). The main route of transmission is through injecting 
drugs followed by sexual transmission. By 2015, the estimated number of new 
infections had decreased by 50 percent from the peak of the epidemic in 2003, 
thanks to prevention initiatives for key populations, including the provision of 
clean needles and syringes, provision of condoms, methadone maintenance 
therapy, and antiretroviral treatment (UNAIDS, 2015; Viet Nam Ministry of 
Health, 2014). 
 
International donors have provided substantial support to Viet Nam’s HIV 
response.  In 2005, The U.S. President's Emergency Plan for AIDS Relief (PEPFAR), 
Asian Development Bank, World Bank, UK Department for International 
Development (DFID), The Global Fund to fight AIDS, Tuberculosis and Malaria 
(GFATM), and Australian Agency for International Development were financing a 
significant portion of the HIV programs (Vietnam Ministry of Planning and 
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Investment, 2015). Viet Nam’s recent reclassification as a lower middle-income 
country, introduced a challenge in financing of the HIV response (World Bank, 
2013) because most donors provide more official development assistance to lower 
income countries than other income groups (United Nations Development 
Programme & Bureau for Development Policy, 2011). By 2015, only GFATM and 
PEPFAR remained in Viet Nam to provide funding for the HIV response, including 
funding 95% of the costs of Anti-retroviral Treatments (Health Finance & 
Governance, 2014). The national HIV program faced sustainability issues due to 
the substantial decline in external donor funding commitments beyond 2017 
(Vietnam Ministry of Health, 2016). The rapid phase out of donors has alarmed the 
government of Viet Nam. Therefore, the Deputy Prime Minister has called on the 
international donor community to give the country more time to transition to 
domestic funding of the HIV response, including use of social health insurance for 
curative care (Minh, 2016). 
 
Global shortfalls in funding for the HIV response make it unlikely that the 
withdrawal of international funding will slow down in Viet Nam.  The 2016 report 
of the Kaiser Family Foundation and UNAIDS indicated that donor funding to 
support the HIV response efforts in low- and middle-income countries, had 
declined for the first time in five years (KFF & UNAIDS, 2016). “Donors faced 
many competing funding demands, including humanitarian emergencies and the 
refugee crisis, all against a backdrop of fiscal austerity in a number of countries”, 
explained Jen Kates, Kaiser Family Foundation Vice President and Director of 
Global Health and HIV Policy (UNAIDS, 2016f). 
 
In 2012, after a decade of financial support to Viet Nam’s HIV response, the World 
Bank and DFID ended their funding. Their recommendation for Viet Nam before 
exiting was to refocus the government funding of HIV prevention programs on 
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provinces in the country based on epidemiological impact, infrastructure, and 
ability of communities to mobilize resources (Zhang et al., 2012). In 2014, Viet 
Nam’s Ministry of Health, with support from UNAIDS, developed the Investment 
Case, which identified priorities and the most effective approaches for the National 
HIV response (Viet Nam Ministry of Health, 2014). Although commendable, the 
Investment Case limited the prioritization criteria to effectiveness and cost-
effectiveness. And while other criteria, like sustainability, were mentioned as 
principles, there was no explicit use of other criteria for priority setting. Faced with 
shrinking donor funds, future prioritization initiatives in Viet Nam may lean 
further towards prioritizing the cost-effectiveness of the HIV program package, 
while neglecting other relevant criteria.  
 
Given the limited funding, there is a growing interest in generating evidence on 
the criteria to guide priority setting in the HIV response (Baltussen, Youngkong, 
Paolucci, & Niessen, 2010; Hogan, 2005; Kabaniha, 2014; Leelahavarong et al., 2011; 
Tromp, Prawiranegara, Siregar, Jansen, & Baltussen, 2016; Youngkong, Baltussen, 
Tantivess, Koolman, & Teerawattananon, 2010). A number of studies have 
considered multiple criteria explicitly to prioritize specific prevention interventions 
(Leelahavarong et al., 2011; Newman, Cameron, Roungprakhon, Tepjan, & Scarpa, 
2016; Verguet, 2013) or HIV treatment (Baltussen et al., 2013; Walensky et al., 2010). 
In Indonesia and Pakistan, a broad set of HIV interventions in the national HIV 
response were considered, and stakeholders were involved in self-explicating the 
importance of criteria for priority setting (Husain, Kadir, & Fatmi, 2007; Tromp, 
Prawiranegara, Subhan Riparev, et al., 2015). A Thai study used more rigorous 
experimental methods to rate criteria that guide priority setting, involving 
decision-makers as well as stakeholders living with or at higher risk of HIV, 
thereby reducing the bias in self-reported importance of criteria (Youngkong et al., 
2010).  The design of the Thai study considered prioritization of targeted 
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interventions rather than the program package of interventions. In a number of the 
mentioned studies, diverse stakeholder groups were convened to consider one 
criterion for prioritizing HIV interventions, while other studies convened a limited 
group to consider multiple criteria. The aforementioned studies were limited in 
terms of a narrow focus on a limited set of interventions, a lack of involvement of 
key stakeholders, or use of less rigorous study designs. These limitations 
collectively have left a gap in the research on the relative importance of multiple 
criteria for prioritizing a package of interventions.  
 
This study elicits preferences and the trade-offs made between different HIV 
programs by relevant stakeholders and decision-makers in Viet Nam. In other 
words, given several criteria for deciding on a HIV program, how much of one 
criterion are they willing to give up for improvements in another criterion. We also 
pay attention to how differences in social and professional characteristics of 
stakeholders and their agency affiliations shape preferences for HIV program 
criteria in Viet Nam. This study is innovative in its use of discrete choice 
experiments (DCE) and self-explicated ranking to establish the relative importance 
of a set of criteria for prioritizing Viet Nam’s HIV response. 
 
DCE are based on well-tested theories that provide an explanation of choice 
behavior (Louviere, Flynn, & Carson, 2010). These experiments place individuals in 
scenarios where they have to make a choice between options presented to them. In 
that decision-making process, the individual considers the criteria that define the 
options, and the trade-off in criteria they are going to make in choosing one option 
over another option.  Data from the individual choices can then be used to quantify 
the relative importance of the criteria. DCE have been used extensively to examine 
preferences and priorities in health care [e.g., (Green & Gerard, 2009; Larson et al., 
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2015; Luyten, Kessels, Goos, & Beutels, 2015; Mirelman et al., 2012; van de Schoot, 
Pavlova, Atanasova, & Groot, 2017)].  
 
This study contributes to Viet Nam’s HIV policy-making by clarifying what criteria 
are being considered in prioritizing the programs in the National HIV response, 
and how different stakeholders view the importance of those criteria. Other 
countries can adopt this transparent and accountable process during their national 




This study used two methods to elicit stakeholders’ preferences for and choices of 
HIV programs. The first method was a straightforward self-explicated ranking of 
criteria. The second method used the DCE method to determine the relative 
importance of criteria to stakeholders when they evaluate and select HIV 
programs.  
 
DCE is a type of hypothetical experiment that is widely used in the health field to 
quantify preferences.  The experiment imitates a situation when a stakeholder 
must make a choice between two or more options. Each option has the same set of 
attributes as the other option but the values of these attributes are varied to make 
the option different from the other. In this study, the DCE attributes are referred to 
as “criteria”, which is the common term used in priority setting and operations 
research. The variance of the criteria was fixed to two levels. To reduce the 
cognitive burden required by the respondents (stakeholders and decision-makers), 
the number of choice scenarios presented to them was minimized using orthogonal 
arrays. Each choice scenario contained two HIV programs. During the experiment, 
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the choice scenarios were presented to the respondents consecutively, and the 
respondents were asked to take their time to select the HIV program they preferred 
most in each choice scenario. 
 
Selection of criteria and levels 
The most frequently used criteria identified in a systematic review of literature 
served as a basis for the DCE in this study (Chapter 2). The full set of 18 criteria in 
the systematic review were reviewed with HIV experts working in Viet Nam to 
assess their relevance to the country’s HIV epidemic and response. Based on that 
assessment, five criteria of a HIV program were selected: effectiveness, feasibility, 
cost-effectiveness, rate of investment and prevention/treatment investment ratio. 
The first three of these criteria were characterized as program outcomes. The last 
two criteria were characterized as program inputs.  
 
All criteria had dichotomous levels. These criteria levels were generated based on 
investment case scenarios developed for Viet Nam in 2014 (Viet Nam Ministry of 
Health, 2014). The investment case scenarios were developed using the AIDS 
Epidemic Model (AEM).  AEM is a standard estimation and projection tool used in 
modeling the epidemic in countries with concentrated epidemics. The AEM uses 
input program and epidemiological data to estimate the future impact of the 
proposed policies and program coverage levels, as well as the size of the 
investment required. One of the assumptions that was used in the selection of 
criteria levels, was that the AEM projections went until 2030, when international 
and national goals are to be met. Additionally, it was assumed in the AEM 
estimations that funding would be capped to the current level of spending, and 
should not be expected to increase beyond current levels. Table 5.1 presents all 
criteria, their levels and coding for the analysis. 
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Study instrument, DCE design and DCE validity  
Prior to the DCE, the questionnaire presented an operational definition of each 
criterion, and asked respondents to manually rank the criteria according to the 
importance they attached to each of the criteria. This step allowed the comparison 
of self-explicated ranking with the DCE weighted ordering of the criteria. It also 
allowed a common understanding of the criteria by the participants prior to 
starting the DCE. 
 
To limit the number of combinations of scenarios and avoid information overload 
by participants in the DCE, criteria were limited to five with two levels each (see 
Table 5.1), which resulted in a total of 32 (25) possible profiles.  A subset of those 32 
profiles was chosen on the basis of a fractional experimental designs library of 
orthogonal arrays (Hedayat, Sloane, & Stufken, 1999). The fractional factorial 
design included a subset of eight profiles that allowed the estimation of all main 
effects.  The construction of eight profiles and related coding is presented in Table 
5.1. 
 
One of the eight profiles defined by the fractional factorial design was selected as 
the basic profile, and the rest were used as alternative profiles. The basic profile 
was selected to create realistic and challenging decision situations for participants 
in the experiment. Then seven choice scenarios were created where respondents 
were asked to choose between the basic profile and one of the alternative profiles 
based on their preference for the criteria for prioritizing the HIV response. A 
sample choice scenario from the DCE is presented in Figure 5.1. This DCE design 
minimized the number of comparisons (choice scenarios) respondents had to make 
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The survey that presented the DCE also collected information on the respondent’s 
social and professional characteristics. These data were used to assess how 
individual factors influence decision-maker’s stated preferences. The assessed 
characteristics included age, sex, nationality, professional experience, and 
engagement in decision-making in Viet Nam’s HIV response. The complete survey 
instrument is included in Appendix I. 
 





Study setting and participants 
The DCE was conducted in Viet Nam, where the HIV response involves 
development partners, civil society, and the central and provincial state 
institutions. The study aimed to reach 60 participants who had been involved, or 
currently are involved, in the decision-making in Viet Nam’s HIV response, with 
similar number of respondents from government, international development 
partners, and civil society organizations respectively. The motivation behind 
selecting these three groups was that they encompass the actors who have a stake 
in the decision-making in the HIV response. These three groups are referenced by 
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the Greater Involvement of People Living with HIV principle formalized at the 
1994 Paris AIDS Summit (Joint United Nations Programme on HIV/AIDS, 1999), 
and are also reflected in the membership structure of the Country Coordinating 
Mechanism of the GFATM (GFATM, 2013). The proportion of individuals in the 
three groups may not represent the same proportion of individuals who were 
involved in decision-making processes in Viet Nam at the time of the study, 
however. For example, the GFATM Country Coordinating Mechanism involves 7 
individuals from the government, 6 from international development partners, and 
11 from civil society organizations (Country Coordinating Mechanism Vietnam, 
2015). The steering committee for development of the investment case scenarios 
involved 3 individuals from the government, 6 individuals from international 
development partners, and no civil society members, although the latter were 
involved in consultations to obtain inputs “on their priorities for the response in 
future” (Viet Nam Ministry of Health, 2014). The National Strategic Plan for 
HIV/AIDS Prevention and Control in Viet Nam was developed with active 
participation of the three groups, but the extent of that participation or process of 
prioritization has not been documented (The Government of the Socialist Republic 
of Viet Nam, 2004, 2006). 
 
Participants were identified in a two-stage selective sampling of individuals 
knowledgeable or responsible for decision-making. In the first stage, the 
researchers identified seed individuals in government, civil society, and 
development partners. Seed individuals are initial study participants who recruit 
their social or professional peers (Heckathorn, 1997). In the second stage, the seed 
individuals initially nominated twenty individuals each within their network to 
potentially respond to the questionnaire. If some invited individuals did not 
respond or were unable to respond to the questionnaire, the seed individuals sent 
five new invitations to potential respondents. This process continued until the 
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quota of 60 participants with similar number of respondents from the three groups 
was reached. The nominated individuals received a web link to anonymously 
respond to the survey. All eligible participants were informed of the purpose of the 
study and notified that they can exit the survey at any time and choose to have all 
their answers be deleted. Thus, informed consent to participate was provided by 
each respondent. 
 
Pilot of the study 
The DCE was piloted with four participants. As a result of the pilot, the ordering of 
choice scenarios was revised to start with the simplest task (with two differences 
between the two profiles) to the most difficult task (with four differences between 
the two profiles). The choice scenarios were also formatted to be displayed 
horizontally, compared to the vertical presentation customary in DCE. This 
allowed the respondents to give equal attention to all criteria of the profile, and 
reduced the dominance of the criterion on top. Finally, where graphs were used to 
illustrate the meaning of criteria, footnotes were added to further clarify those 
graphs. 
 
Survey administration, data collection and analysis procedure 
The DCE survey was administered electronically on the LimeSurvey platform 
using a standardized questionnaire. The participant choices were coded 0 if the 
basic profile was selected as the preferred profile and coded 1 if the alternative 
profile was selected as the preferred profile. 
 
The data collected were inserted in Excel and cleaned of any inconsistent answers 
to the DCE scenarios. Two respondents provided a combination of responses that 
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were categorized as inconsistent answers. Firstly, if a respondent selected a high 
feasibility program over a cost-effective program (choice scenario 2), then selected 
a program with constantly increasing costs and high proportion of spending on 
treatment over a cost-effective program (choice scenario 3), and then selected a low 
feasibility, low proportion of spending on treatment, and decreasing cost program 
which is highly cost-effective (choice scenario 4), that respondent’s answers were 
deemed inconsistent. Secondly, if a respondent selected an effective program over 
a program with decreasing costs (choice scenario 1), then selected a highly feasible 
program over a cost-effective program (choice scenario 2), and then selected a cost-
effective and decreasing cost program over a feasible and effective program (choice 
scenario 7), that respondent’s answer were deemed inconsistent. The DCE results 
of the two respondents who provided inconsistent responses were removed from 
the data set.  
 
The cleaned dataset was imported into Stata for analysis. For the analysis of the 
DCE data, a binary logit regression with random intercepts was used. First, the 
main-effect model was estimated using the responses of all respondents. Then the 
responses were disaggregated by group membership – government, civil society, 
development partners – and the main effects model was estimated for each group, 
and the results were compared. Data from the self-explicated ranked criteria were 
analyzed using descriptive statistics, and ordered by the modes of the criteria 
ranks. The DCE results were compared to the self-explicated ordering of criteria in 
qualitative terms. 
 
Social and professional characteristics may have an effect on the choices of 
stakeholders and decision-makers. Descriptive statistics were calculated for social 
and professional characteristics of the respondents. After estimating the main 
effects, interactions of the criteria with the social and professional characteristics of 
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the respondents were added to the model. A backward stepwise regression 
procedure was conducted to obtain a reduced model consisting of statistically 




Of the 82 people invited to participate in the survey, 69 (84%) agreed and 
completed the survey. Survey respondents include 31 (44%) females and 38 (56%) 
males. The majority of respondents (44%) are between 41 and 50 years old. The 
majority of respondents (76%) are Vietnamese nationals. There are nearly equal 
proportions of respondents from civil society, government, and development 
partners, with 20 (29%), 26 (38%), and 23 (33%) representatives respectively. Most 
respondents (91%) are involved in decision-making and more than one half (65%) 
are responsible for decision-making. Information on all social and professional 
characteristics is provided in Table 5.2. 
 
The self-explicated ranking of the criteria based on all responses shows that 
effectiveness is the most important criterion for respondents with 43% of 
respondents ranking this criterion very high. Feasibility is the next highest ranked 
criterion followed by sustainability, cost-effectiveness and treatment to prevention 
spending ratio. When responses are disaggregated by agency, effectiveness 
remains the most important criterion and treatment to prevention spending ratio 
remains the least important criterion. Most civil society respondents (60%) and 
development partner respondents (48%) select effectiveness as their most 
important criterion, while government respondents are equally split on feasibility 
and effectiveness as their top criteria (27% and 27%). The results of the self-




Results of the logit regression of the main effect model, after removing the 
inconsistent responses, are shown in Table 5.4. The results for the main effect 
model show that overall the feasibility criterion is most important to the 
respondents when choosing a hypothetical HIV program, followed by 
sustainability, treatment to prevention spending ratio, and effectiveness. The 
coefficient of cost-effectiveness in the main-effects model is not statistically 
significant. However, the main effect model does not account for the social and 
professional characteristics of the respondents. The influence of these 
characteristics can be seen in the reduced model with interactions. 
 
Specifically, the reduced model with interactions shows that several interactions of 
criteria with social and professional characteristics of the respondents have a 
significant effect (Table 5.4). The backward stepwise regression finds six interaction 
terms that are statistically significant. Two interaction terms are with the 
effectiveness criterion. Those interactions are with respondents who are currently 
working, or have worked, in programming and respondents who are currently, or 
have been, involved in decision-making. Two other interaction terms are with the 
sustainability criterion. Those interactions are with respondents who are currently 
working, or have worked, in management and respondents who are currently, or 
have been, responsible for decisions. One interaction is with the criterion of the 
ratio of treatment to prevention spending. That interaction is with respondents 
who are currently working, or have worked, in management. Another interaction 
term is with the feasibility criterion. That interaction is with respondents who are 
currently, or have been, responsible for decisions. All interactions, except for the 
interaction of sustainability with working in management, have an overall negative 






































































































































































































































































































































































































































































































































































































































important   
Least 
Important Mode Median Mean σ² 
Criteria 1 2 3 4 5 
    
All Stakeholders 
         Effectiveness 43% 29% 16% 7% 4% 1 2 2.0 1.01 
Cost-effectiveness 14% 20% 13% 38% 14% 4 4 3.2 1.22 
Sustainability 14% 19% 28% 28% 12% 3 3 3.0 1.13 
Treatment/Prevention 6% 4% 17% 10% 62% 5 5 4.2 1.25 
Feasibility 22% 28% 26% 17% 7% 2 3 2.6 1.10 
Dvlp. Partners 
         Effectiveness 48% 26% 9% 13% 4% 1 2 2.0 1.10 
Cost-effectiveness 13% 22% 13% 30% 22% 4 4 3.3 1.25 
Sustainability 4% 26% 26% 30% 13% 4 3 3.2 1.02 
Treatment/Prevention 4% 4% 30% 9% 52% 5 5 4.0 1.18 
Feasibility 30% 22% 22% 17% 9% 1 2 2.5 1.19 
Government 
         Effectiveness 27% 38% 31% 0% 4% 2 2 2.1 0.83 
Cost-effectiveness 15% 8% 12% 58% 8% 4 4 3.3 1.17 
Sustainability 23% 15% 27% 27% 8% 3 3 2.8 1.19 
Treatment/Prevention 8% 4% 8% 8% 73% 5 5 4.3 1.30 
Feasibility 27% 35% 23% 8% 8% 2 2 2.3 1.02 
Civil Society 
         Effectiveness 60% 20% 5% 10% 5% 1 1 1.8 1.05 
Cost-effectiveness 15% 35% 15% 20% 15% 2 2 2.8 1.16 
Sustainability 15% 15% 30% 25% 15% 3 3 3.1 1.15 
Treatment/Prevention 5% 5% 15% 15% 60% 5 5 4.2 1.21 






Table 5.4 Result of the discrete choice experiment on criteria for 
prioritizing the HIV response 
Dependent variable 






Independent variables (coding under variables) β SE Β SE 
Δ Effectiveness 0.71* 0.328 5.48* 1.577 
    0 = no change, remains 4 million years of life saved 
    1 = increases, 5 instead of 4 million years of life saved 
Δ Cost-effectiveness 0.24 0.296 0.18 0.317 
    0 = no change, remains $6 return for every $1 invested 
   -1 = decreases, $5 instead of $6 return for every $1 invested 
Δ Sustainability 1.31* 0.336 1.38* 0.583 
    0 = no change, spending increases and then decreases 
   -1 = changes to spending constantly increases 
Δ Treatment/Prevention 0.78* 0.312 1.49* 0.466 
    0 = no change, greater investment in prevention 
   -1 = changes to greater investment in treatment  
Δ Feasibility 1.98* 0.327 3.19* 0.616 
    0 = no change, remains low feasibility 
    1 = increases, high feasibility instead of low feasibility  
Constant 0.89 0.669 0.72 0.709 
     
  Interaction Terms 
    (w/ Δ Effectiveness): works in programming 
  
-1.72* 0.563 
(w/ Δ Effectiveness): involved in decision-making 
  
-3.62* 1.457 
(w/ Δ Sustainability): works in management 
  
1.20* 0.539 
(w/ Δ Sustainability): responsible for decisions 
  
-1.20* 0.590 
(w/ Δ Treatment/Prevention): works in management 
  
-1.16* 0.512 
(w/ Δ Feasibility): responsible for decisions 
  
-1.41* 0.633 




 pseudo r-squared 0.19   0.24   































































































































































































































































































































































































































































































































































































































































































































































































































































DCE analysis results by agency show that development partners, civil society, as 
well as government respondents all rank the feasibility criterion high. 
Sustainability, the ratio of treatment to prevention spending, and feasibility are in 
the top three criteria of both civil society and government respondents. 
Effectiveness is highly ranked by the development partners only. The coefficients 
of other criteria do not carry sufficient statistical weight to confidently say how 




All else being equal, participants prefer a program that is most feasible, front-
loaded for sustainability, has a higher proportion of investment on prevention, 
saves more lives and prevents more infections, and is more cost-effective although 
this latter criterion does not show a statistically significant effect on the choices in 
the DCE.  
 
The self-explicated ranking of criteria finds the “effectiveness” criterion to be the 
highest ranked criterion by respondents. This is in keeping with previous studies 
in rating importance of criteria in Asia that also found effectiveness to be the most 
important criterion for prioritizing interventions in the HIV response (Tromp, 
Prawiranegara, Subhan Riparev, et al., 2015; Youngkong et al., 2010).  A systematic 
review of criteria in priority setting of HIV and health care also found effectiveness 
to be among the highest cited criteria in the literature (Guindo et al., 2012) (Chapter 
2). Similar to these previous studies, during the self-explicated portion of this 
study, criteria were presented to participants as concepts without quantification, 
for example in terms of lives saved. However, during the DCE in this study, the 
effectiveness criterion dropped to fourth place according to its ranked importance 
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to the respondents. This difference between the self-explicated ranking and DCE 
ranking may suggest the presence of social desirability bias in the self-explicated 
ranking. That is, when confronted with the general notion of a criterion such as 
effectiveness or sustainability, respondents may rely on their principles to 
determine its importance. However, when given more specific trade-off tasks 
during the DCE, for example to compare programs with nominal gains in lives 
saved at lower feasibility, the respondents may rely on their professional expertise 
to make their decisions. This phenomenon is further reinforced by the effectiveness 
criterion being consistently ranked highest by respondents from all different 
agency affiliations during self-explicated ranking, suggesting that the respondents’ 
agency affiliations do not influence their decision. However, during the DCE only 
development partners ranked the effectiveness criterion high. Furthermore, DCE 
results show that the interaction of program effectiveness with professional 
characteristics of “working in programming” and “being involved in decision-
making” significantly lower the ranking of the effectiveness criterion, suggesting 
that when the same respondents are asked to rank the program options, the ones 
with professional responsibilities in delivering program recommendations 
reconsider their priorities and lower their ranking of program effectiveness as a 
criterion vis-à-vis other criteria. 
 
Another finding from the interaction results is the difference in ranking of criteria 
by respondents who have worked in management of HIV programs. Compared to 
the average response, those who worked in management rate prevention/treatment 
ratio lower and rate sustainability of programs higher. These results indicate some 
theoretical consideration in the decision-making of program managers based on 
financial models (Atun et al., 2016), giving a longer term view of the sustainability 
of the program even though it requires a large upfront investment. The program 
managers also consider a lower investment in prevention to offset a higher 
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investment in treatment, which also indicates a theoretical approach given the 
mathematical models that suggest universal test and treatment programs could 
drive HIV eradication (Granich, Gilks, Dye, De Cock, & Williams, 2017; Montaner 
et al., 2010) even though a more pragmatic view based on empirical evidence 
suggests many barriers in the cascade of care to link and retain patients in 
treatment (Gardner, McLees, Steiner, del Rio, & Burman, 2011; Kilmarx & Mutasa-
Apollo, 2012; Raymond, Hill, & Pozniak, 2014). 
 
The interaction terms also show that those responsible for decisions rate the 
feasibility and sustainability criteria lower than the average respondent. This is 
consistent with the traditional model of public service governance where decision-
makers are concerned with the outcomes of the programs they choose, and 
feasibility and sustainability are considerations for actors at different levels of their 
hierarchical organization (Hanson, 2012). Program planning is often sequenced 
from objective analysis, to activity planning, and ending with analysis of risks, 
with outcome results considered in the initial stages, and feasibility and 
sustainability considered in the later stages (Örtengren, 2004). This planning 
process is likely to have contributed to a program option that reflects more 
strongly the effectiveness criterion that is considered earlier in the process than 
other relevant criteria considered later in the planning process. Other iterative 
models of planning or greater involvement of stakeholders at all stages of planning 
may be needed to ensure relevant criteria are considered at appropriate decision 
points. This perspective is gaining traction in the recognition that the problems and 
solutions of public health cannot be solely owned by the government but require 
collaboration and engagement of multiple stakeholders (Institute of Medicine (US) 




Feasibility and sustainability are ranked highly both in the DCE as well as the self-
explicated ranking. Although respondents from the civil society and government 
differ in the ordering of these two criteria in the DCE, their responses indicate that 
they agree the two criteria are the most important for prioritizing HIV programs. 
This result can be useful in the advocacy for greater involvement of the civil society 
in the priority setting process together with the government, since it brings to light 
that there are more points of agreement than differences between the two groups. 
While development partners agree with the government and civil society on the 
importance of the feasibility criterion, they consider the program effectiveness as 
their second most important criterion. Future priority setting processes may 
consider the level of importance of these criteria to different stakeholders, and 
develop program options that cater to their values. The transparency in options 
and weight of criteria according to different stakeholders will facilitate and focus 
discussions around trade-offs that need to be made and between whom. 
 
The coefficient for the cost-effectiveness criterion was not significant in the 
regression analysis. In other words, the difference between the preference weight 
of the more cost-effective program and the less cost-effective program was not 
statistically significant.  There could be two reasons for this: either we are unable to 
estimate the coefficients efficiently with the model used (e.g. too small difference 
between the levels of that criterion with no significant effect on the choice), or there 
is too much heterogeneity in the preferences for the cost-effectiveness criterion. 
The cost-effectiveness criterion however ranks low in self-explicated rankings, 
across all groups. This seems surprising if we consider the extensive use of the 
criterion for prioritization in healthcare, and guidelines developed for cost-
effectiveness analysis of healthcare programs (Edejer et al., 2003; Guindo et al., 
2012; Neumann, 2004). However, a comparable phenomenon is observed in some 
Central and Eastern European countries with similar political-economy histories to 
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Viet Nam, where cost-effectiveness is considered a “soft” criteria in healthcare 
priority setting (Kaló et al., 2013; Kaló, Gheorghe, Huic, Csanádi, & Kristensen, 
2016). 
 
Between 2006 and 2010, the national HIV programs resulted in an estimated 
401,600 fewer disease adjusted life years (DALY) at an estimated cost of $248 for 
each DALY averted (Pham et al., 2015). The DCE results in this study indicate a 
preference for 5 million years of life saved from death and disease between 2016 
and 2030, and $315 for each DALY averted. These findings demonstrate that the 
stakeholders in this study prefer greater effectiveness of HIV programs in the 
future, but do not expect much change in the cost-effectiveness of the HIV 
programs. The 2014 national investment case (Viet Nam Ministry of Health, 2014) 
used two criteria of effectiveness and cost-effectiveness to rank several modeled 
HIV programs. Similar to findings of this study, effectiveness was prioritized over 
cost-effectives in the ranking of the choices. The investment case also considered a 
scenario where resource needs increase over time, as the “worst-case scenario”, 
which is consistent with results of the DCE in this study on the sustainability 
criterion. The currently implemented national HIV program can also indicate the 
ratio of treatment to prevention spending. Recently prevention has accounted for 
close to 25% of funds of the HIV response, indicating that the national plan leans 
toward lower prevention spending, whereas findings of this study indicate a 
preference for greater prevention spending.  
 
Overall, the DCE method is shown to be effective and feasible in establishing 
priorities in Viet Nam. It provides additional important information beyond what 
the self-explicated ranking of criteria provides, such as the comparative importance 
of one criterion against another. It also explains the direction of criteria that is 
preferred by the respondents. For example, whether they prefer greater prevention 
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or greater treatment in the prevention/treatment ratio criterion. However, the DCE 
also requires a large number of respondents to make reliable estimates, which may 
not be feasible in countries with a small program and few people involved in 
decision-making at the central level to respond to the questionnaire. With few 
respondents, the number of criteria to be considered may be limited, jeopardizing 
the validity of the results.  
 
This study has several strengths and limitations that need to be acknowledged. The 
strength of this study is in considering a broad set of criteria relevant to the 
country, and ranking them with experimental and self-explicated methods for 
improved accuracy and precision. Our study also involves multiple groups of 
stakeholders representing the different perspectives of those who should be 
involved in prioritizing Viet Nam’s HIV response. This study has fewer 
participants in the DCE than other similar studies. Although we tried to reach a 
maximum number of actors with experience or expertise in decision-making on 
HIV programs, the HIV space in Viet Nam is ultimately limited by the size of the 
epidemic and response. Given the limited number of potential participants, and 
the desire to minimize the cognitive load of the DCE, a limited number of criteria 
are considered for prioritization from the full set. 
 
This study occurs at a transition period in Viet Nam, as official development 
assistance to the HIV response is being reduced, and greater domestic investments 
including social health insurance are being mobilized to cover the gap left by the 
donors. The stakeholders’ ranking of the criteria for prioritizing HIV programs 
presented here may be a reflection of the current context in Viet Nam, which could 






Findings of this study show that there are greater similarities between the ranking 
of criteria by government and civil society than there are differences. The process 
and results in elicitation of the importance of the criteria can inform future policy 
dialogues between the stakeholders to find common grounds in priority setting. 
The results also highlight the need to reconsider the classical hierarchical models of 
planning in Viet Nam, and utilize innovative models of planning that allow inputs 
of informed stakeholders at relevant stages of the HIV program planning process. 
The results may also be useful for other developing countries in a transition period 
to visit or revisit the criteria used to prioritize their HIV programs. In donor 
supported countries, the transparent process of eliciting criteria for HIV program 
prioritization can be an additional requirement for funding proposals that 
demonstrates wide stakeholder consultation, and evidence-based planning and 
prioritization.  
 
As Viet Nam moves closer to becoming an upper-middle-income country, and 
donors transition away from direct support of the HIV response, the importance of 
certain criteria for prioritizing the HIV program package will need to be re-
evaluated. Cost-effectiveness is one criterion used prominently in the past 
investment case analysis of Viet Nam’s HIV response, but ranks lower in this 
study. Going forward, this criterion should again be considered centrally once 
programs transition from donor support to domestic financing, and standalone 
HIV programs integrate back into the general healthcare system, and evidence 










The principle focus of this dissertation is on the appropriateness and applicability 
of the MCDA framework to prioritizing the HIV response. It takes this perspective, 
while considering the two problems that afflict prioritization processes: lack of 
stakeholder involvement and lack of quality evidence for decision-making. In the 
introduction chapter of this dissertation four questions were formulated for 
investigation. These four questions are related to the four objectives for this 
dissertation: 1) identify the globally relevant criteria to prioritize the programs, 
policies, investments, workforce and technologies that are utilized in responding to 
the HIV epidemic, 2) assess the extent to which reliable and good quality evidence 
is available, accessible and used in planning for the HIV response, 3) understand 
the difference that the inclusion of diverse stakeholders make in decision-making 
processes of the HIV response, 4) measure the observed importance that different 
stakeholders attach to relevant criteria for prioritizing the HIV response. 
 
To meet the objectives of the dissertation, four studies have been conducted. Thus, 
the four objectives are addressed in the four successive chapters of the dissertation 
respectively. Chapter 2 of this dissertation systematically reviews the criteria 
relevant to the HIV response. Chapter 3 reviews the quality and extent of evidence 
used in planning the HIV response. Chapter 4 explores the underlying causes of 
gaps in evidence, and the value provided by involvement of stakeholders in the 
process of priority setting. Chapter 5 conducts an experiment to study the 
preferences and trade-offs made between different HIV programs by multiple 




6.2 Main statements based on research findings 
 
This section presents the key crosscutting findings from the various chapters of this 
dissertation. These findings are presented in the form of five statements followed 
by a short elaboration of the statement’s origins, its policy implications, and any 
suggestions for future research. 
 
Statement 1: To be effective, the process of priority setting of the 
HIV response requires an iterative, multi-stakeholder approach 
 
Findings of this dissertation demonstrate that in the numerous planning stages of 
an HIV program, it is important to consider who is involved, because who is 
involved is ultimately related to what criteria are considered, and the criteria 
considered determine the program components that are prioritized (Chapter 5). 
Strategic involvement of multiple stakeholders in various stages of the planning 
process can ensure that relevant criteria are considered comprehensively, 
accurately defined and rated in their importance. Involvement of multiple 
stakeholders however also introduces conflicts in definition and rating of criteria 
for priority setting (Chapter 4). These conflicts need to be addressed not by 
exclusion of stakeholders whose definitions or rating of criteria differ from the 
norm, or coercion to force a common viewpoint, but a systematic way of eliciting 
and weighting criteria from multiple perspectives (Chapter 4). The DCE in this 
dissertation demonstrated an effective method to bring clarity to differences in the 
ranking of criteria. DCE can be used to either weight criteria for consideration of 
different voices, or to show that there may be similarity among stakeholders, and 
in either case their inclusion would further legitimize the process of priority 
setting. DCE is also preferred over self-explicated ranking methods of weighting 




The linkage between health outcome effects and the decision-making process are 
not explored in this dissertation. However, other research in corporate behavioral 
strategy demonstrates that investments in decision-making processes have greater 
returns than investments on evidence generation and analytics (Lovallo & Sibony, 
2010). That is not to say that evidence generation and analytical work is 
unimportant. Rather, it says that there is a strong relationship between process and 
analysis, and “superb analysis is useless unless the decision process gives it a fair 
hearing” (Lovallo & Sibony, 2010). Recommendations based on findings in Chapter 
4 of this dissertation underline the direct and indirect value of the process of 
representing the decision analysis jointly. Another process recommendation, based 
on findings on the importance of criteria at various levels of planning, is to 
consider an iterative model of planning to ensure that relevant criteria are 
considered at appropriate decision points (Chapter 5). Steele et al observe that in 
many real examples of decision-making, criteria are not easily understood by 
stakeholders (Steele, Carmel, Cross, & Wilcox, 2009). Therefore the iteration 
process also applies (and was applied in Chapter 4 and 5) to ensuring a common 
and complete understanding of the choices and criteria by the stakeholders. This 
iterative approach to decision process is consistent with recommendations of 
operational research in the application of MCDA in spatial planning processes 
(Monnikhof & Bots, 2000). These recommendations taken together reinforce the 
applicability of the MCDA framework, which includes procedures to identify 
courses of actions in a manner that is analytically robust and consistent in light of 
the available evidence and stakeholder preferences (Marttunen, 2011). 
 
An important recommendation based on the review of evidence in past plans is for 
the generation of program evaluation evidence to be synchronized with the 
planning process so that timely evidence is used effectively in priority setting 
 
 128 
(Chapter 3). Overall, the findings of this dissertation show that an effective 
approach to priority setting of the HIV response requires a review of criteria, 
modeling of program options based on quality evidence, and analysis of criteria 
weights for prioritizing program options (Chapter 2, 4, 5). 
 
This dissertation has studied the priority setting processes of the HIV response at a 
moment in history when AIDS is in transition from a global emergency to a chronic 
disease (World Health Organization, 2017). The evidence reviewed in the 
dissertation has spanned globally, although specific chapters have concentrated on 
case studies to explore interpretation and use of criteria by multiple stakeholders 
in a priority setting process while isolating variance in social, political and 
economic factors. While the guidance and instruments developed in the course of 
this dissertation have demonstrated utility and reliability, their relevance to other 
phases of the HIV epidemic, to different social, political and economic settings, and 
to other emerging or ongoing epidemics will require further investigation.  
 
Statement 2:  The global fall in HIV funding and the reintegration 
of HIV programs into the health sector have renewed the focus on 
feasible and sustainable programs 
 
The systematic review of criteria conducted in Chapter 2 of this dissertation 
suggested that there is a noticeable difference in the elicitation of the criteria of 
feasibility and sustainability before and after 2007. Chapter 2 hypothesized that the 
less frequent elicitation of these criteria prior to 2007 may be due to a gradual 
movement away from reason- or value-based decision-making. The reason-based 
decision-making occurs when for example politicians are pressured to seek and 
construct a ‘reason’ to justify their choice in the context of deficient evidence on 
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criteria for evaluating their options (Goodwin & Wright, 2004; Keren & Bruin, 2003; 
Shafir, Simonson, & Tversky, 1993). The hypothesis then goes on to predict that 
evidence-based decision-making and programming is aided by improved 
monitoring and evaluation systems that produce evidence along the relevant 
criteria. An alternative hypothesis was also proposed in Chapter 2 that the 
increasing availability of pharmacological HIV treatment and prevention methods, 
with more reliable outcomes and proven feasibility in various settings, might have 
contributed to a decline in the emphasis on feasibility criteria. In Chapter 3, we saw 
that the first of these two hypotheses is more probable with overall evidence use 
increasing in HIV planning, while evidence on sustainability and operations 
research to assess feasibility remains weak. 
 
More recently, the importance of feasibility has come to the forefront of the 
discussion on the selection of health interventions and activities in LMIC (Diaconu 
et al., 2017; Guindo et al., 2012; Hosek et al., 2013; Niëns, 2014; Terwindt, Rajan, & 
Soucat, 2016). In Chapter 4 of this dissertation, the majority of key informants, 
including all at-risk community members interviewed, mentioned the feasibility 
criterion. And when a group of decision-makers and stakeholders in Vietnam were 
asked to rank the criteria most important for focusing HIV programs, feasibility 
and sustainability came out high on the list (Chapter 5). In that experiment, 
operational definitions were attached to the criteria and linked to program options 
with measurable characteristics. The high ranking of feasibility and sustainability 
in the experiment further reinforces the notion that criteria that are well defined 
and measured are ones that will get used in this era of evidence-based planning. 
The implication here is that if there are no measures for a program, an intervention, 
or an at-risk population, then they may be neglected. Or as the UN Secretary 





The systematic review of literature prior to 2014 in Chapter 2 of this dissertation 
showed that lower income countries elicit feasibility less frequently than upper 
income countries, and sustainability is nearly equally elicited in both income 
groups. The feasibility and sustainability are far more frequently elicited in 
normative guidance than in literature describing current programs, attributed to 
the lack of consideration of resource needs in the HIV response. The recent 
observation of frequent elicitation of these criteria (Chapter 4) and their high 
ranking in selecting HIV programs (Chapter 5) in Viet Nam coincides with the 
decline in donor spending to address HIV in LMIC since 2014 (Chapter 1). The 
transition and integration of donor funded programs into domestic funded health 
sector are likely refocusing attention on resource allocation in the HIV response, 
and contributing to the resurgence in consideration of feasibility and sustainability 
of HIV programs. 
 
The resurgence of feasibility and sustainability is reassuring in underlining a 
pragmatic approach with a long-term view of the HIV response to end AIDS as a 
public health threat. There are two consequences to this renewed focus to be 
watched with caution as countries implement programs with criteria of feasibility 
and sustainability foremost in their sight. 
 
First, as noted in other statements, who defines what feasibility means and how it 
is defined matters. It needs to be underlined again here that involvement of 
stakeholders in different stages of priority setting will be critical for a fair and 
rational outcomes. Oversight at the highest level of government will be required to 
ensure that the progress toward feasible programs does not translate to a 
decentralization of decision-making to program experts who may exclude lay 
stakeholders due to the lack of technical expertise, but is rather an upward 
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channeling of information for multi-stakeholder policy setting (Rayner, 2003). This 
former technocratic approach to decision-making is a means of exclusion of non-
state actors and stakeholders without technical expertise from the priority setting 
process (Boivin, Lehoux, Burgers, & Grol, 2014; Kantrowitz, 1975). 
 
Second, the higher ranking of feasibility and sustainability in terms of importance 
for prioritizing HIV programs, comes with an intertemporal trade-off with other 
criteria such as cost-effectiveness, epidemic effect, or equity being ranked lower in 
importance (Bansal, Chapardar, & Gehman, 2016). This is an expected and 
accepted outcome of fair decision-making based on multi-stakeholder decided 
criteria (Danziger, Montal, & Barkan, 2012). However, it should also be clear that 
this increased emphasis on pragmatism would bear a cost, financially and also in 
terms of potential years of life saved from disease (Marsh et al., 2016). In this 
situation, a transparent process based on evidence along the clearly defined 
criteria, will support HIV policies as trade-offs are made. It will also ensure 
accountability to the stakeholders who are ultimately affected by the implemented 
programs (Yamin, 2008). 
 
The systematic review of criteria in Chapter 2 included those from both lower and 
middle-income countries as well as upper income countries. The observations from 
the LMIC were further investigated with a review of plans in lower and middle-
income countries in Sub-Saharan Africa (Chapter 3). Chapter 4 and 5 focused on 
one LMIC, Viet Nam, to further validate and update the trend toward refocusing 
the HIV response on feasible and sustainable programs. The criteria emerging from 
the systematic review in Chapter 2 were ranked based on the frequency of their 
appearance in literature. The criteria were ranked in Chapter 5 based on observed 
choices of decision-makers in an experimental setting. This difference in method, 
and the geographical coverage in the application of the methods, prevents us from 
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comparing the two rankings of criteria in Chapters 2 and 5. While the case of Viet 
Nam’s HIV response may not be generalized to all LMIC with an HIV epidemic, 
the trends observed in Viet Nam as well as reports and review from other LMIC 
warrant further investigation of the renewed focus on feasible and sustainable 
programs in other countries. 
 
Statement 3: The use of evidence in HIV planning and policy-
making has been increasing over the years, particularly use of data 
on drivers of the epidemic 
 
Chapter 2 of this dissertation proposed that weak health information systems and 
stigma for key populations at risk of HIV present some barriers to effective 
application of the criteria in resource poor settings. It does so by limiting the 
available evidence base for operationalizing criteria, which may deter decision-
makers in considering criteria without adequate measures. This condition was 
tested in Chapter 3 where a review of national strategic plans for HIV and AIDS 
control and prevention in Sub-Saharan Africa revealed that with the increasing 
strength of monitoring and evaluation systems over the years, the type of evidence 
used today in planning is more diverse and of higher quality than in the past. 
Therefore, the availability of evidence as a precondition for application of criteria is 
met. 
 
According to the findings of Chapter 3 in this dissertation, while evidence use is 
increasing, there is still considerable room for improvement in breadth and quality 
of evidence used in national HIV plans. In particular, there is poor quality and 
coverage of evidence for key populations at risk of HIV, which is attributed to 
inadequate surveillance methods for these groups (Chapter 4). Although 
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monitoring and evaluation systems have increased in strength over the years 
(Peersman et al., 2009), findings in Chapter 3 demonstrated that there is more 
evidence that is used in planning which comes from HIV program monitoring than 
from HIV program evaluation and research. Impact evaluations and operations 
research were two particular types of evidence that were sought in the review of 
national HIV plans (Chapter 3), but were noticeably absent. Evidence on operation 
and impact of HIV programs tells planners if the programs are implemented the 
right way, and if they are having an effect in curbing the HIV epidemic (UNAIDS, 
2008). Therefore, it is critical for good planning to have evidence available from 
operations research and impact evaluations (Hargreaves et al., 2016; Malhotra & 
Zodpey, 2010). 
 
Analysis of choices of program managers in selecting hypothetical HIV program 
options in Chapter 5 indicated that they may be relying on modeled data instead of 
operations research to decide on their preferred program options, based on criteria 
of sustainability and increased investments in treatment over prevention. This 
means that the use of modeled data is preferred by managers over operations 
research, and clarifies the lack of operations research in national strategic plans 
(Chapter 3). 
 
As noted in the introduction of this dissertation, donor funding for the HIV 
response has been declining in recent years (KFF & UNAIDS, 2016; UNAIDS, 
2016d). With reduced investments from bilateral and multilateral sources, the need 
for the involvement of these donors in the national HIV program priority setting 
processes would also decrease. And with fewer donors at the national decision-
making table, the autonomy of national stakeholders to negotiate the package of 
interventions that make up the national HIV response become stronger, and less 
pressured by supranational level interests (Henriksson et al., 2017; OECD, 2011). 
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This less politicized negotiation process, together with improved availability of 
evidence, may potentially contribute to the observed increase in reliance on 
evidence to drive the HIV planning and policy making (Dean & Sharfman, 1996). 
Another contributing factor to the use of evidence in HIV planning and policy may 
be a gradual turnover of leadership, between public health leaders who started in 
the HIV response reapplying their knowhow from other health challenges, to a 
new generation of leaders who have worked their way up from HIV programming 
to policy making and are acutely aware of what programs work, and the evidence 
needs to scale those programs nationally (Pfeffer & Sutton, 2006). 
 
Notwithstanding the gaps in quality and coverage of evidence used in planning of 
HIV programs, the overall trend in increasing use of evidence is encouraging, but 
it also implies an imminent challenge for decision-makers to process the volume of 
information and exercise sound judgment (Christodoulou, Karacapilidis, 
Tzagarakis, Dimitrova, & de la Calle, 2014). Considering the multiple criteria that 
exist in evaluating HIV programs, and the high stakes of the decisions, a strategy 
for effective management and use of the information for decision-making is 
necessary. The strategy will need to consider the multiple stakeholders who should 
be involved in the decision-making and the costs of transfer of- and their 
orientation with- the available evidence. Another challenge will be the analysis of 
the diversity of information, including both qualitative and quantitative data. The 
strategy may opt to use innovative analytical methods or mathematical modeling 
of scenarios to aid decision-makers with processing of the volume and diversity of 
data. 
 
Evidence availability and use in planning is only one component in ensuring 
desirable outcomes. Further evaluation is needed to see if evidence-based planning 
produces better outcomes than ad-hoc planning (Chapter 3). In addition to volume 
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and variety of evidence becoming available for use, the speed with which evidence 
is generated also requires further investigation. 
 
Statement 4: The gaps and variance in quality evidence on key at-
risk groups take the focus away from these populations in national 
strategic plans and programs 
 
In Chapter 2 of this dissertation a systematic review of literature to identify criteria 
used in the HIV response priority setting revealed low attention to high-risk 
populations. High-risk populations ranked in the lower half of all criteria elicited, 
irrespective of stratification, and even in concentrated epidemic countries, where 
by definition the epidemic is concentrated among high-risk populations. This 
phenomenon prompted further investigation in Chapter 4, of the extent to which 
key populations are considered in national strategic plans for HIV control and 
prevention, and what evidence on key populations is available and used. A 
subsequent review of national strategic plans in Chapter 3 noted a gap in evidence 
on key populations at risk of HIV, particularly men who have sex with men. 
Drivers of this gap in evidence were explored in Chapter 4 through interviews 
with surveillance specialists and members of the at-risk community. These 
discussions revealed stigmatization of subjects as a main deterrent to participation 
in surveillance activities, which in turn contributes to reduced validity, use, and 
efficiency in evidence generated from surveillance. Additionally, the identified 
conflicting views on criteria between key populations and technical experts on 
selection of methods of surveillance, and the key populations’ lack of technical 
skills in surveillance methods, may be contributing to these stakeholders not being 




Without the generation of evidence by the community and for the community, 
resulting data may not be trusted for use in the national planning process (Innes & 
Booher, 2004). And without evidence, the national plans will continue the cycle of 
taking attention away from the key populations. Psychologist Daniel Kahneman 
has labeled this latter concept as follows: “what you see is all there is” (Kahneman, 
2011). It refers to the human bias in using the readily available information and 
ignoring the quality and coverage of evidence needed to make informed rational 
decisions. 
 
A critical consequence of the reduced focus on key populations in national plans 
and programs is attenuated progress in controlling HIV in the concentrated 
epidemics (Oberth & Whiteside, 2016). Leaving epidemics among key at-risk 
populations unchecked can result in a resurgence of HIV cases in the community, 
but also create the potential spillover effect of the epidemic to the lower risk 
vulnerable groups, such as intimate partners of the key at-risk populations, as well 
as infants born to the women living with HIV (UNDP, 2015). Programs to curb 
infections among key at-risk populations in generalized epidemics can also benefit 
the overall epidemic acting through modes of transmission. 
 
Recent normative guidance to close the evidence gap and support improved 
decision-making by seeking to engage with patients and consumers is encouraging 
(Califf et al., 2016). Implementation research in lay-person engagement in HIV 
surveillance and evidence generation on key at-risk populations is also promising 
(Safarnejad et al., 2017). Further piloting and scaling up of innovative methods to 
engage the key at-risk populations in surveillance of communicable diseases is 
recommended to address the persistent gaps in evidence. While engagement of the 
community in community monitoring also addresses the stigma and 
discrimination barriers, a more direct approach to stigma reduction is 
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recommended in addition to create an enabling environment for prevention and 
harm reduction programs to work. A promising method that has been 
demonstrated to durably reduce stigma for transgender people in the United States 
is door-to-door canvassing (Broockman & Kalla, 2016).  
 
The review of national plans in Chapter 3 of this dissertation, where the gaps in 
evidence on key at-risk populations were noted, and the subsequent exploration of 
the underlying reasons for the gaps in Chapter 4, focused on mostly LMIC and 
where the majority of people living with HIV reside. Therefore, caution should be 
exercised in generalizing the statement to all countries. Further research in upper-
middle- and upper- income countries would be required to explore if gaps in 
evidence on key at-risk groups exist there. Specific case studies could corroborate if 
the explanatory factors for at-risk group evidence gaps identified in this 
dissertation translate well to other countries. 
 
Statement 5: Epidemic control and reduction of stigma for key at-
risk groups requires their involvement in the HIV response 
priority setting process 
 
In Chapter 2 of this dissertation, social justice emerged as a distinct theme in the 
review of criteria for priority setting in the HIV response, with stigma and 
discrimination as both a cause and a consequence of the epidemic. Stigma and 
discrimination was in fact frequently elicited as a criterion in Chapter 2, 
particularly in LMIC. This frequent elicitation is related to low knowledge among 
the population about modes of transmission of HIV, and consequent negative 
attitudes toward people living with or at high risk of HIV. The evidence available 
on stigma and discrimination, programs on knowledge transfer to the community, 
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and involvement of key at-risk populations in planning were further explored in 
Chapter 3 and 4. 
 
The review of national strategic plans in Chapter 3 revealed that while evidence 
use is increasing, evidence on key populations is not adequate, and there is low 
involvement of key populations in the planning process to affect improved 
evidence use. So what are the incentives or disincentives of involvement of key 
populations in the priority setting process? In Chapter 4, we observed that the 
involvement of key populations ensures that a broad and comprehensive set of 
criteria are considered. Participants from the key population group who were 
interviewed for Chapter 4 considered that ‘community participation’ in 
surveillance is an important criterion for selection of surveillance methods. 
However, no technical experts or health managers mentioned ‘community 
participation’ as a criterion. This further reinforces the notion that key populations 
are not included in technical dialogues on evidence generation, because the experts 
and managers do not consider it important (Chapter 4). It also reflects a broader 
trend in participation of citizenry from different perspectives in decision-making. 
In his thesis, Toward a Rational Society, Habermas posits that since World War II 
science and rationalization has been becoming mainstreamed and formalized in 
political discussions, so it further excludes the citizens from purely political 
discussions because politicians are orienting themselves to strictly scientific 
arguments in the exercise of their public function (Habermas, 1971). 
 
By delegating political decisions to the technical context, important value decisions 
are taken out of the hands of the citizen stakeholders. With further decentralization 
and delegation of decision-making, the space for decision criteria of relevant 
stakeholders becomes successively smaller, and the number of the citizen 
participants able to participate in the process becomes successively smaller. This 
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kind of technocratic decision-making, where the experts decide, is often applied to 
scientific decisions. Sociologist Dorothy Nelkin questions the ability of technocratic 
approach to settle value conflicts, concluding that "increased technical information 
often tends to increase polarization” in already conflict-ridden fundamental 
political choices (Nelkin, 1981). 
 
The forewarning of marginalization of key stakeholders in technocratic decision-
making may imply a solution that involves centralized political decision-making at 
a level that allows access to the widest stakeholder involvement and input. 
However, studies point out that a greater number of citizen stakeholders who can 
be involved, is related to lower level of their active involvement (Cogan, Sharpe, & 
Hertzberg, 1986) and greater deliberation may even lead to further entrenchment 
of previously held views (Abelson, Eyles, et al., 2003). Thus, while decentralized 
decision-making with formalized technical roles for participating stakeholders or 
centralized decision-making with passive consultation with stakeholders may be 
desirable from the perspective of reaching consensus, or at best to show 
accountability, from the perspective of a fair and legitimate process, they are not. 
Given the previously mentioned importance of community participation in 
surveillance activities, an alternative recommended policy is for investments to be 
made in technical literacy of community-based organizations to strengthen their 
role in decision-making or grass roots movements for community-driven policy 







6.3 Concluding remarks 
 
This dissertation has looked at the issue of involvement of stakeholders in the 
decision-making process of the HIV response in terms feasibility of such 
involvement, gains in improved evidence, and the acceptability of the outcomes of 
the decisions made. It has not looked at the costs associated with greater 
involvement of a diversity of stakeholders in the priority setting process. It has also 
not assessed the existing capacity, readiness, or willingness of stakeholders to 
participate in decisions. These assumptions vary from country to country, and 
between key populations groups and they should be examined carefully prior to 
deciding on a course of action in stakeholder involvement. 
 
Overall, this dissertation has shown that the elements of the MCDA framework are 
applicable to prioritizing the HIV response. There is readiness for the application 
of the framework in terms of evidence availability, defined criteria, and feasibility 
of involvement of multiple stakeholders in the process, with noted gaps and areas 
of improvement. As the financial resources and political will to end the AIDS 
epidemic as a public health threat wanes, findings and recommendations of this 
dissertation can give guidance on a fair, accountable and transparent path to 
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Appendix B: Comparison in Ranking after Stratification by 











Equity 1 1 Severity of Disease 
Severity of Disease 2 2 Feasibility 
Adherence – Psych. 3 2 Equity 
Age 3 3 Human Capital 
Adherence – Structural 4 4 Health Outcomes 
Fairness 5 4 Stigma and Discrimination 
Gender 5 4 Affordability 
Human Capital 5 5 Equal Worth of Life 
Pregnant Women 5 5 Adherence - Structural 
Affordability 6 6 Efficacy 
Access Selection Committee 7 6 Fairness 
Coverage 7 6 Pregnant Women 
Feasibility 7 6 High-risk Populations 
Sustainability 7 6 Sustainability 
Accessibility 8 7 Adherence – Psych. 
Cost-Effectiveness 9 7 Age 
Equal Worth of Life 9 7 Gender 
Mothers 9 7 Coverage 
Parents 9 7 Accessibility 
High-risk Populations 9 7 Cost-Effectiveness 
Childbearing Age Women 9 8 Mothers 
Stigma and Discrimination 9 8 Parents 
Unemployed 9 8 Childbearing Age Women 
Efficacy 10 8 Unemployed 
Innocent Victim 10 8 Innocent Victim 




Appendix C: Comparison in Ranking after Stratification by 












Severity of Disease 1 1 Severity of Disease 
Equity 2 1 Equity 
Adherence – Psychological 3 2 Feasibility 
Age 4 3 Human Capital 
Adherence – Structural 5 3 Stigma & Discrimination 
Human Capital 6 3 Efficacy 
Fairness* 6 3 Health Outcomes 
Pregnant Women 7 4 Gender 
Affordability 7 4 Pregnant Women 
Gender 8 4 Accessibility 
Coverage 8 4 Sustainability 
Feasibility 9 4 Equal Worth of Life 
Stigma & Discrimination 9 4 High-risk Populations 
Accessibility 9 4 Age 
Sustainability 9 4 Cost-Effectiveness 
Access Selection Committee 9 5 Childbearing Age Women 
Innocent Victim 10 5 Coverage 
Mothers 10 5 Affordability 
Parents 10 5 Fairness 
Efficacy 11 5 Adherence – Structural 
Equal Worth of Life 11 5 Adherence – Psychological 
High-risk Populations 11 6 Unemployed 
Childbearing Age Women 11 6 Innocent Victim 
Unemployed 11 6 Mothers 
Health Outcomes 12 6 Parents 




Appendix D: Comparison in Ranking after Stratification by 
Income Level of Country in Articles in Which Criteria were 
Elicited 
Criteria  










(Lower Income Set) 
Equity 1 1 Equity 
Severity of Disease 1 2 Adherence – Psychological 
Affordability 2 3 Adherence – Structural 
Age 3 4 Human Capital 
Cost-Effectiveness 3 4 Gender 
Coverage 3 4 Severity of Disease 
Fairness 4 4 Fairness 
Feasibility 4 4 Age 
Access Selection Committee 5 5 Sustainability 
Accessibility 5 5 Pregnant Women 
Adherence – Psychological 5 6 Parents 
Adherence – Structural 5 6 Stigma and Discrimination 
Equal Worth of Life 5 6 Unemployed 
Efficacy 5 6 Feasibility 
Gender 5 7 Coverage 
Pregnant Women 5 7 Mothers 
High-risk Populations 5 7 Childbearing Age Women 
Health Outcomes 6 7 Access Selection Committee 
Human Capital 6 7 Accessibility 
Innocent Victim 6 7 Equal Worth of Life 
Mothers 6 8 Affordability 
Parents 6 8 Innocent Victim 
Childbearing Age Women 6 8 Efficacy 
Stigma and Discrimination 6 8 High-risk Populations 
Sustainability 6 9 Cost-Effectiveness 




Appendix E: Comparison in Ranking after Stratification by 
Epidemic Type of Focal Country in Articles in Which Criteria 
were Elicited 
Criteria  










(Generalized Epidemic Set) 
Equity 1 1 Adherence – Psychological 
Severity of Disease 2 1 Equity 
Access Selection Committee 3 2 Fairness 
Affordability 3 2 Age 
Age 3 3 Pregnant Women 
Cost-Effectiveness 3 3 Adherence – Structural 
Efficacy 3 3 Severity of Disease 
Adherence – Psychological 4 4 Gender 
Adherence – Structural 4 4 Human Capital 
Coverage 4 5 Coverage 
Feasibility 4 5 Feasibility 
Gender 4 5 Affordability 
Human Capital 4 6 Accessibility 
Parents 4 6 Equal Worth of Life 
High-risk Populations 4 6 Stigma and Discrimination 
Sustainability 4 6 Unemployed 
Accessibility 5 6 Sustainability 
Equal Worth of Life 5 7 Access Selection 
Committee 
Fairness 5 7 Innocent Victim 
Health Outcomes 5 7 Mothers 
Innocent Victim 5 7 Childbearing Age Women 
Mothers 5 7 Parents 
Pregnant Women 5 8 Cost-Effectiveness 
Childbearing Age Women 5 8 High-risk Populations 
Stigma and Discrimination 5 9 Efficacy 
Unemployed 5 9 Health Outcomes 
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Appendix F: Comparison in Ranking after Stratification by Date of 











Equity 1 1 Equity 
Severity of Disease 1 2 Severity of Disease 
Feasibility 2 3 Adherence - Psychological 
Human Capital 3 4 Adherence - Structural 
Adherence - Structural 4 4 Age 
Affordability 4 5 Human Capital 
Age 4 5 Affordability 
Pregnant Women 4 5 Fairness 
Sustainability 4 6 Pregnant Women 
Adherence - Psychological 5 6 Gender 
Equal Worth of Life 5 7 Feasibility 
Fairness 5 7 Access Selection Committee 
Gender 5 7 Stigma & Discrimination 
Stigma & Discrimination 5 7 High-risk Populations 
Accessibility 6 7 Coverage 
Coverage 6 8 Sustainability 
Health Outcomes 6 8 Equal Worth of Life 
Cost-Effectiveness 7 8 Accessibility 
Efficacy 7 8 Unemployed 
Mothers 7 8 Cost-Effectiveness 
Parents 7 8 Efficacy 
High-risk Populations 7 9 Health Outcomes 
Childbearing Age Women 7 9 Mothers 
Access Selection Committee 8 9 Parents 
Innocent Victim 8 9 Childbearing Age Women 
Unemployed 8 9 Innocent Victim 
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Appendix G: Interview Guide 
Participant Name |______________________| Interviewer Initials |__________| 
Date |______________________|     
 
Introduction 
I am ______________________________ from ______________________ 
General purpose of the study 
Aims of the interview and expected duration 
Who is involved in the process (and other participants who will be interviewed) 
Why the participant’s involvement is important 





Warm up [work history] 
Can you tell me a bit about what activities you are preoccupied with currently? 
 
Now I am going to ask you some questions about your experience as a 
_______ at _________. 
 






Select a size estimation method to probe with: 
For those with very good familiarity with different methods of 
size estimation, ask them to select one of the size estimation 
methods in Table 1 that they are familiar with. 
For those with limited familiarity with different methods of size 
estimation, select the census method, and describe it briefly, 
which is easy to understand for everyone. 
 
Q: what are some of the issues you see in applying this method in 
Viet Nam? 
Probe: use these framework dimensions to elicit criteria from the 
interviewee for selection of a method: 




Availability of data/ability to recruit 
Ethical/legal/social issues 
 
Probe: Use different key populations (MSM, FSW, IDU), and 
different areas (urban cities, rural provinces) to probe specific 
issues that they expect to encounter with using the method for 
estimating the size of that key population. 
 
Probe: Set some conflicting scenarios to understand importance of 
criteria to the interviewee. For example one method is costly and 
produces valid and precise results. Another is less costly but also 




Q: Before this current size estimation was started, what were 
some of your expectations?  
 
Probe: How do you think the survey would go? What did you 
think the community response would be? What did you think the 
results would be? How do you feel about the method now? 
 
Closing 
Is there anything else you think is important in selecting size estimation 
methods that you think we should talk about?  
Summarize 
Thank participant 




Appendix H: Summary of Methods of Estimating Population Size 
Method  Description Strength Weakness 






















mobile or hidden 
populations; 
Capture-Recapture Calculate total 
based on two 
independent 
samples 




Difficult to meet 
assumption in the field 
(independent, 
uncorrelated samples, 






Multiplier Calculate size 
based on a 
sub-
population 












alignment of age, 
geography, and time 
periods between two 
sources is difficult; 
data from existing 

















Difficult to use for 
stigmatized 
populations/behaviors; 
limited to households, 
schools or institutions 









about size of 
their network 






















Difficult to estimate 
average network size; 
may not represent sub-
groups/behaviors 
hidden from or 
stigmatized by general 
population; 
Source: Adapted from “Guidelines on Estimating the Size of Populations Most at Risk to 




Appendix I: The discrete choice experiment choice scenarios in the 
survey instrument 
Survey on Priority Criteria in the Viet Nam HIV Response 
 
Welcome to the survey on Criteria for HIV Program Selection in Viet Nam. This 
survey is anonymous and is carried out for academic purposes only. You may 
exit and clear the survey at any time while answering the questions, should you 
feel uncomfortable. 





Survey on Priority Criteria in the Viet Nam HIV Response 
 
Please tell us a bit about yourself: 
 
Your Gender:  
☐ Male          ☐ Female 
 
Your Age: 
☐ <22   ☐ 22-25    ☐ 26-30     ☐ 31-40     ☐ 41-50   ☐ 51-60    ☐ >60 
  
Your Country of Origin: 




☐ United Nations 
☐ Donor Agency 
☐ Research/Academic Institution 
☐ Civil Society/Community Organization 
☐ Other: ___________________ 
 




☐ Monitoring & Evaluation 
☐ Other: ___________________ 
 
Years of experience working in HIV response: ______________ 
Have you been involved in making decisions on HIV programs? 
☐ Yes                ☐ No 
 
Have you been responsible for making decisions about HIV programs? 






Survey on Priority Criteria in the Viet Nam HIV Response 
 
Imagine a situation when you have to decide on a suitable program for HIV 
response in Viet Nam, given a fixed budget. You could base your decision on 
several criteria:  
Effectiveness: Years of life saved from death or disease 
Sustainability: Maintaining or reducing resource needs 
Prevention/Treatment Spending Ratio: Spending on prevention versus 
spending on treatment 
Cost-Effectiveness: Economic returns of program versus cost of program 
Feasibility: Likelihood of achieving the expected scale and rate of increase in 
coverage set by the program 
 
Please order these criteria in terms of their importance to you if you had to 
make such a decision: 
Your most important criterion should be on the top right, moving through to your least 
important criterion. 
 
Your choices      Your ranking 
Effectiveness 
Sustainability 









Survey on Priority Criteria in the Viet Nam HIV Response 
 
In the following pages you will be presented with seven scenarios. In each 
scenario you will be asked to choose between two programs for HIV response 
in Viet Nam. All programs carry the same cost of $80 Million USD. The two 
programs presented to you in each scenario are similar in every way, except for 
those attributes that are highlighted. 
The purpose of this survey is not to find the best programs. Therefore, there is 
no wrong answer to the choices you make. Please use your values to choose 






Survey on Priority Criteria in the Viet Nam HIV Response 
 
Imagine a situation when you have to decide on a suitable program for HIV 
response in Viet Nam. 
Which of these programs would you choose? Both programs have the same 
cost of $80 Million USD. To make it easier for you, we have highlighted the 









Survey on Priority Criteria in the Viet Nam HIV Response 
 
Imagine a situation when you have to decide on a suitable program for HIV 
response in Viet Nam. 
Which of these programs would you choose? Both programs have the same 
cost of $80 Million USD. To make it easier for you, we have highlighted the 









Survey on Priority Criteria in the Viet Nam HIV Response 
 
Imagine a situation when you have to decide on a suitable program for HIV 
response in Viet Nam. 
Which of these programs would you choose? Both programs have the same 
cost of $80 Million USD. To make it easier for you, we have highlighted the 








Survey on Priority Criteria in the Viet Nam HIV Response 
 
Imagine a situation when you have to decide on a suitable program for HIV 
response in Viet Nam. 
Which of these programs would you choose? Both programs have the same 
cost of $80 Million USD. To make it easier for you, we have highlighted the 









Survey on Priority Criteria in the Viet Nam HIV Response 
 
Imagine a situation when you have to decide on a suitable program for HIV 
response in Viet Nam. 
Which of these programs would you choose? Both programs have the same 
cost of $80 Million USD. To make it easier for you, we have highlighted the 









Survey on Priority Criteria in the Viet Nam HIV Response 
 
Imagine a situation when you have to decide on a suitable program for HIV 
response in Viet Nam. 
Which of these programs would you choose? Both programs have the same 
cost of $80 Million USD. To make it easier for you, we have highlighted the 










Survey on Priority Criteria in the Viet Nam HIV Response 
 
Imagine a situation when you have to decide on a suitable program for HIV 
response in Viet Nam. 
Which of these programs would you choose? Both programs have the same 
cost of $80 Million USD. To make it easier for you, we have highlighted the 











This research focuses on the prioritization of the HIV response. Today there are 
over 37 Million people who are living with HIV although fewer than half of 
them are able to access lifesaving treatment. And while the Sustainable 
Development Goals call for ambitious targets to urgently control the epidemic 
and ends AIDS as a public health threat by 2030, global financing for the HIV 
response has stagnated in recent years and donor AIDS funding has started to 
recede. With the political and financial will to end AIDS waning, and given the 
constrained resources and ambitious targets, prioritization is urgently needed. 
 
This dissertation considers how to prioritize the HIV response using the 
structure of the multi-criteria analytical framework. This framework is a branch 
of operations research, which has been shown to work in low- and middle-
income countries to prioritize a range of development issues. It facilitates 
decision-making transparently and consistently, while considering multiple 
criteria, although experts caution that more experience is needed in its 
application. Two particular problems that commonly afflict decision-making in 
the health sector and require attention are (1) lack of quality information on 
programs and policy choices and the consequences of the choices, and (2) a 
neglect of stakeholder involvement in decision-making. 
 
The principle aim of this research is then to study the appropriateness and 
applicability of the multi-criteria analytical framework for prioritizing the HIV 
response in a multi-stakeholder decision-making process. The chapters of this 




Chapter 1 provides a timeline of the global HIV epidemic and response, 
including a history of international political and financial commitments made 
toward ending the AIDS epidemic as a public health threat. It then introduces 
the motivation for prioritization of the HIV response at this moment in the 
history of HIV and AIDS. The unsolved priority setting challenges are outlined 
and the theoretical origins and debates in the priority setting field are reviewed. 
The aim of this research and four related research questions are articulated in 
Chapter 1. The chapter then concludes with a brief outline of the dissertation. 
 
In line with the first stages of the multi-criteria decision analysis framework, 
Chapter 2 of this dissertation explores and articulates the criteria to prioritize 
the HIV response. The principle question being sought to answer in this 
Chapter is: What are the relevant criteria to prioritize the programs, policies, 
investments, workforce and technologies that are utilized in responding to the 
HIV epidemic? To respond to this question, a systematic review of literature 
was undertaken to identify the existing criteria relevant to prioritizing the HIV 
response. The review included literature since the year 2000 to present, which 
dealt with the breadth of criteria involved in decision-making and which 
included operational definitions of criteria. 
 
Cluster analysis was used to classify and structure the criteria identified in the 
systematic review into thematic groupings.  The articles from which criteria 
were drawn were stratified by the income group of countries under study, the 
administrative level, type of the epidemic, whether the article was characterized 
as normative or descriptive, and the year of publication of the article. These 
stratifications were used to explore the similarities and differences between 
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criteria, and compare their frequency of occurrence. Identified HIV and AIDS 
criteria were also compared with the criteria from the healthcare sector. 
 
From the articles that met the inclusion criteria of the systematic review, thirty 
unique criteria were identified. These criteria were subsequently clustered into 
18 thematic groups.  Equity and severity of disease were the most frequently 
occurring criteria. A theme that developed around the criteria during cluster 
analysis was on “social justice”, emphasizing the ethical imperative of 
prioritizing the most marginalized populations despite higher costs per life-
year saved. 
 
What is concerning however, is that one of the widest gap between the 
healthcare set of criteria and HIV set of criteria is around criteria of vulnerable 
populations, illustrating the gap in priorities between the sectors, and 
underlining the need to consider multi-sectorial criteria in any possible 
integration of HIV programs into the health systems. Moreover, we see 
populations at high risk of HIV infection rank in the lower half of all criteria 
regardless of stratification, even between concentrated and generalized 
epidemics, despite these populations carrying a greater burden of the epidemic, 
and most at risk of being infected. In line with the findings of Chapter 2, and 
recognizing the priorities that contributed to the success of the HIV response 
thus far, we make a recommendation that the discourse around prevention 
among high-risk and vulnerable groups be amplified in consideration of 
policies of prioritization, particularly in concentrated epidemics. 
 
In stratification of criteria, it was observed that the feasibility criterion appeared 
frequently in the normative set, but infrequently in the descriptive set, 
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suggesting that this criterion is often recommended but seldom used. 
Popularity of feasibility also declined over time, appearing less frequently after 
2007. We hypothesize this may be due to weak information systems in earlier 
years, which may make the use of criteria without operational definitions or 
metrics more favourable in reason-based, political decision-making. 
 
A challenge that emerged in Chapter 2 is how to operationalize and measure 
the identified criteria and themes in order to inform a multi-criteria priority 
setting process. In line with this question, and related to the multi-criteria 
decision analysis framework’s performance measurement stage, Chapter 3 is 
concerned with evidence availability and use in HIV response planning. The 
principle question being investigated in Chapter 3 is: To what extent is reliable 
and good quality evidence available, accessible and used in planning of the HIV 
response? 
 
To answer this question, we developed an instrument with several dimensions 
to measure the quality and coverage of evidence used in national HIV plans. 
Using standard content analysis, we reviewed 27 NSP from 21 countries. These 
countries are home to two out of every three people living with HIV globally. 
To ensure the accuracy of measurements, we analysed the instrument’s 
reliability, internal consistency, and external validity. 
 
Our analysis of the use of evidence in national HIV planning demonstrates a 
trend in increasing evidence use over the years. This finding is consistent with 
studies that suggest increasing investments on monitoring and evaluation are 
paying off in terms of improved generation of evidence. Moreover, the types of 
evidence used in national HIV plans are more diverse and the evidence quality 
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is greater today than it was in the past. Data on epidemic drivers were the most 
frequently used type of evidence in national plans.  
 
Following the lead from Chapter 2, we also noted in our investigation of 
evidence in the national HIV plans that although overall there is adequate 
evidence related to key populations at higher risk of HIV, there is great variance 
across the plans in quality and coverage of this evidence. In particular, we 
noted only 3 of the 27 national plans provide any evidence on men who have 
sex with men, and only one provided a population size for this key population. 
Expenditure data and impact/outcome evaluation were also infrequently used 
in planning. Based on these findings, we made a number of recommendations, 
including better alignment of timing of program reviews with the national HIV 
planning processes for use of generated evidence in the decision-making, and 
incentivizing continued use of evidence by including measures of evidence-
based planning in international benchmarks of governance. 
 
Chapter 4 brings attention to a problem that often afflicts policy and planning 
in the health sector, which is lack of involvement of stakeholders in the 
decision-making. The question being asked in Chapter 4 is: What difference 
does the inclusion of diverse stakeholders make in decision-making processes 
of the HIV response? This question is approached from the perspective of the 
themes that emerged in Chapters 2 and 3, in terms of weak evidence on key at-
risk populations, and infrequent reference to these populations in low- and 
middle-income countries faced with a concentrated epidemic. Therefore a 
specific focus is taken on differences in perspectives of multiple stakeholders on 
a key evidence generation activity, surveillance of the size of key at-risk 




To explore the perspectives of different stakeholders, we conducted 16 in-depth 
interviews with health program managers, technical experts in surveillance, 
and members of the community of people at risk of HIV in one urban city and 
one rural province of Viet Nam. Transcripts of the interviews were reviewed for 
significant statements pertaining to criteria, including variations and agreement 
around those criteria. The emerging criteria were validated against an 
established framework for prioritizing evidence generation methods. Eleven 
themes emerged as having particular relevance to the evidence generation 
related to key populations at risk of HIV in Viet Nam. Findings on missing 
criteria, inclusive participation, community perspectives and conflicting weight 
and direction of criteria in this case study provide insights to help improve on 
an applied framework for the prioritization of evidence generation methods. 
 
Overall our findings suggest that stakeholder involvement improves definition 
and coverage of relevant criteria, but it introduces conflicts in weight and 
direction of the criteria. To reconcile the different perspectives and conflicts, we 
recommend a group exercise to organize criteria into a hierarchical structure, 
combining redundant criteria and decomposing alternative definitions, with the 
additional benefit of raising consciousness about the causes of conflicts. On 
criteria with different weight and direction we recommend doing a weight 
analysis under a multi-stakeholder scenario. 
 
Chapter 5 is about choices. The principles question being investigated in this 
Chapter is: How do different stakeholders rate the relative importance of 
criteria for prioritizing the HIV response? To answer this question, we designed 
a discrete choice experiment to measure the relative trade-off of criteria for 
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decision-makers and stakeholder. The discrete choice experiment was set in 
Viet Nam, and included eight HIV program scenarios that were developed 
using epidemiological estimation and projection modeling software. These 
scenarios were characterized by the top five criteria that were elicited in 
previous chapters and were deemed relevant to the context of Viet Nam. The 
five criteria were cost-effectiveness, feasibility, sustainability, treatment-to-
prevention spending ratio, and effectiveness. 
 
Based on recommendations emerging from Chapter 4, the discrete choice 
experiment included 69 participants with diverse representation from the 
government, civil society, and members of donor community or development 
partners. The participants were tasked with choosing between pairs of 
scenarios. The choices of the respondents in the experiment were analysed to 
understand the relative trade-off of criteria when choosing between the HIV 
program scenarios. The participants’ revealed choices in the discrete choice 
experiment were also compared to their stated preferences in manually ranking 
the criteria. 
 
Findings in Chapter 5 revealed that all else being equal, participants prefer a 
program that is most feasible, front-loaded for sustainability, has a higher 
proportion of investment on prevention, saves more lives and prevents more 
infections, and is more cost-effective, in that order.  The criteria of feasibility, 
sustainability and treatment-to-prevention spending ratio were all given high 
importance by participants from civil society and government, demonstrating 
that there are greater similarities than differences in choices of these two 
groups. These similarities in rankings of criteria can create common grounds for 
future policy dialogues between stakeholders. Working in HIV programming or 
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being involved in decision-making had a significant effect on how participants 
ranked the criteria. Our findings also indicate that when the relative importance 
of criteria are stratified by the participants’ professional duties, the responses 
follow closely the concerns in a traditional model of public service governance. 
That is, those involved in decision-making are more concerned with the 
effectiveness of the programs they choose, and others at lower levels of the 
governance structure have operational concerns such as the feasibility of the 
programs chosen. Given this potential filtering of criteria in top-down 
organizations, we recommend iterative models of planning or greater 
involvement of stakeholders at all stages of planning to ensure relevant criteria 
are considered at appropriate decision points in prioritizing the HIV response. 
 
Chapter 6 discusses the main findings of this dissertation in response to the 
four questions of the research: (1) What are the relevant criteria to prioritize the 
programs, policies, investments, workforce and technologies that are utilized in 
responding to the HIV epidemic? (2) To what extent is reliable and good quality 
evidence available, accessible and used in planning for the HIV response? (3) 
What difference does the inclusion of diverse stakeholders make in decision-
making processes of the HIV response? (4) How do different stakeholders rate 
the relative importance of criteria for prioritizing the HIV response? Five 
crosscutting statements respond to these questions by bringing together the 
findings from this dissertation. Those statements are as follows: 
 
Summary Statement 1 says that to be effective, the process of priority setting of 
the HIV response requires an iterative, multi-stakeholder approach. That 
proposed approach, according to the findings of this dissertation, and in line 
with the multi-criteria decision analysis framework is to (1) review the relevant 
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criteria, (2) model program options based on quality evidence and along the 
identified criteria, and (3) analyze criteria weights and score alternative 
program options in one combined step. It is also important to build iteration 
into the process. Given the potential filtering of criteria in top-down 
organizations, and since it is not possible or probable for every stakeholder to 
be involved at every stage of planning, iteration can help ensure the relevant 
criteria of different stakeholders are given adequate consideration. 
 
Statement 2 says that the global fall in HIV funding and the reintegration of 
HIV programs into the health sector have renewed the focus on feasible and 
sustainable programs. The premise of this statement is that donor funding for 
HIV has been declining in recent years. And with this decline in funding, the 
costly parallel programs devised to quickly mount an emergency response to 
the HIV epidemic are being reintegration into the health system. This 
reintegration in turn has diverted the conversation from cost and cost-
effectiveness of programs to the question of feasibility and sustainability of the 
programs. That is, taxpaying constituents whose tax-money makes up the bulk 
of official development assistance wanted to know the cost-effectiveness of the 
donor funded programs. Today, stakeholders and governments in low- and 
middle-income countries want to know if the programs they pursue are feasible 
and sustainable. 
 
Statement 3 says the use of evidence in HIV planning and policy-making has 
been increasing over the years, particularly use of data on drivers of the 
epidemic. We started our research in Chapter 3 on the premise that monitoring 
and evaluation systems have been strengthening, so quality data should be 
more available. We found in Chapter 3 that indeed evidence was available and 
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being used in program planning and policy setting. However, we also noted 
gaps in data availability and use, such as in use of operations research and 
impact evaluation. We posited that this particular gap was likely due to timing 
of availability of program reviews that made them unusable at the right time in 
planning. We also noted gaps and variance in evidence around key populations 
in planning, which brought us to statement 4. 
 
Statement 4 says that the gaps and variance in quality evidence on key at-risk 
groups take the focus away from these populations in national strategic plans 
and programs. We noticed in Chapter 4 that stigma, lack of technical 
knowledge in surveillance methods, and conflicting views of stakeholders were 
contributing factors to lack of key population involvement in evidence 
generation. This lack of involvement led to a lack of quality evidence on key 
population. Lack of quality had the consequent lack of trust in that evidence 
when and if it was used in HIV program planning. And lack of evidence use 
further reduced attention on key populations in programs. The implication here 
is that if there are no measures for a program, an intervention, or a population, 
then they may get neglected. Or as the UN Secretary General Ban Ki Moon puts 
it more simply, ”if you’re not counted, you don’t count”. 
 
Statement 5 says that epidemic control and reduction of stigma for key at-risk 
groups requires their involvement in the HIV response priority setting process. 
This statement evolved from observations across the prioritization stages which 
saw that who is involved is related to what criteria are considered. And criteria 
considered determines the program components that are prioritized. And 
program prioritization aims to achieve the stated objectives of epidemic control 
and stigma reduction. So involvement of key populations is ultimately linked to 
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the outcome of HIV programs. But we also argue in this dissertation that 
involvement without adequate capacity is not meaningful involvement. Often 
value-decisions are decentralization to technical experts as a way of exclusion of 
stakeholders who do not have the adequate technical capacity to participate, in 
what is known as technocratic decision-making. Our recommendation in this 
regard is for greater technical literacy of stakeholders, through capacity 
building. In this way, the remaining donor financing could be shifted to invest 
in technical assistance to low- and middle-income countries instead of 
programmatic assistance. 
 
This dissertation started with giving some important reasons why prioritizing 
the HIV response is important and urgent, such as the ambitious targets, the 
reduced funds, and the gap in HIV treatment. However, a critical reason that 
guides prioritization as revealed in this dissertation is social justice. 
Prioritization is in the end the very opposite of ignoring the most marginalized 
populations. Prioritization is taking the vulnerable, the oppressed and the 
abused out of the margins and placing them at the center of the response. 
Prioritization is the operationalization of an equitable HIV response. 
 
Overall, this dissertation has shown that the elements of the multi-criteria 
analytical framework are applicable to prioritizing the HIV response. There is 
readiness for the application of the framework in terms of evidence availability, 
defined criteria, and feasibility of involvement of multiple stakeholders in the 
process. As the financial and political will to end the AIDS epidemic as a public 
health threat wanes, findings and recommendations of this dissertation can give 
guidance on a fair, accountable and transparent path to prioritizing the HIV 





This section discusses the valorization opportunities offered by the dissertation. 
The topic of this research related to priority setting in the HIV response is 
highly policy relevant. The main results and policy recommendations of this 
dissertation can be relevant for a range of target audiences including 
governments, development agencies, and civil society organizations. 
 
Results of the research in this dissertation provide the first indication that 
evidence use in HIV planning and policymaking has been increasing over the 
years. However, stagnation and decline in donor funding for monitoring and 
evaluation systems, along with integration of the HIV response into the health 
sector, jeopardize the gains made in generation and use of evidence for 
planning. This dissertation makes a policy recommendation for incentives to 
sustain the use of evidence in HIV planning and policymaking. At the global 
level, these incentives could be created by including measures of evidence-
based planning in international benchmarks of governance (Chapter 3). The 
instrument introduced in this dissertation to measure evidence quality and use 
in planning could provide an input to grant allocation decisions by donors and 
development banks, as an indicator of effective decision-making and strength of 
monitoring and evaluation performance. Application of the instrument before 
and after evidence generating activities could help identify barriers and 
enablers to evidence use at the national level. 
 
The criteria emerging from the systematic review of literature in Chapter 2 
illustrate the success of the HIV response in framing the public health and 
emergency response approach to the epidemic, within the context of social 
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justice and development. As integration of the HIV response with the health 
sector is pursued, the policies and practices of integration must remain 
accountable to the key criteria of the HIV response. Integration of HIV into the 
health sector also implies some elements of the HIV monitoring system may 
become weaker in the process, while the overall sustainability of the HIV and 
health response gains strength from integration. Policymakers should consider 
this trade-off between effectiveness and sustainability in integration of the HIV 
response into the preventive health sector. 
 
While greater involvement of the community of people living with or at risk of 
HIV in planning is recommended (Chapter 4 and 5), this dissertation recognizes 
that the problems and solutions of public health must be jointly owned by the 
government and the stakeholders. Findings of this dissertation demonstrate 
that the degree of agreement between civil society and government in 
prioritized criteria around HIV program choices creates an opportunity for 
policy advocacy for greater involvement of civil society in decision-making 
(Chapter 5). The dichotomy of views of stakeholders on criteria for 
prioritization in scientific and technical decisions, underlines the importance of 
investments in technical literacy of community based organizations to 
strengthen their role in decision-making or grass-roots movements for 
community driven policies in research, science and technology (Chapter 4). 
Discrete choice experiments with program decisions in Chapter 5 demonstrate 
that theoretical models, and not empirical evidence, drive HIV program 
managers’ priorities. These findings imply that policies should be put in place 
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